
<html lang="en"     class="pb-page"  data-request-id="3bc24a87-366b-49dd-9e57-56923643b897"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-9;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm100080z"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity" /></meta><meta name="dc.Creator" content="Soo-Jeong  Choi" /></meta><meta name="dc.Creator" content="Jung-Eun  Lee" /></meta><meta name="dc.Creator" content="Soon-Young  Jeong" /></meta><meta name="dc.Creator" content="Isak  Im" /></meta><meta name="dc.Creator" content="So-Deok  Lee" /></meta><meta name="dc.Creator" content="Eun-Jin  Lee" /></meta><meta name="dc.Creator" content="Sang Kook  Lee" /></meta><meta name="dc.Creator" content="Seong-Min  Kwon" /></meta><meta name="dc.Creator" content="Sang-Gun  Ahn" /></meta><meta name="dc.Creator" content="Jung-Hoon  Yoon" /></meta><meta name="dc.Creator" content="Sun-Young  Han" /></meta><meta name="dc.Creator" content="Jae-Il  Kim" /></meta><meta name="dc.Creator" content="Yong-Chul  Kim" /></meta><meta name="dc.Description" content="To enhance the ability of indirubin derivatives to inhibit CDK2/cyclin E, a target of anticancer agents, we designed and synthesized a new series of indirubin-3′-oxime derivatives with combined sub..." /></meta><meta name="Description" content="To enhance the ability of indirubin derivatives to inhibit CDK2/cyclin E, a target of anticancer agents, we designed and synthesized a new series of indirubin-3′-oxime derivatives with combined sub..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 5, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100080z" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100080z" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100080z" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100080z" /></link>
        
    
    

<title>5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100080z" /></meta><meta property="og:title" content="5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0003.jpeg" /></meta><meta property="og:description" content="To enhance the ability of indirubin derivatives to inhibit CDK2/cyclin E, a target of anticancer agents, we designed and synthesized a new series of indirubin-3′-oxime derivatives with combined substitutions at the 5 and 5′ positions. A molecular docking study predicted the binding of derivatives with OH or halogen substitutions at the 5′ position to the ATP binding site of CDK2, revealing the critical interactions that may explain the improved CDK2 inhibitory activity of these derivatives. Among the synthesized derivatives, the 5-nitro-5′-hydroxy analogue 3a and the 5-nitro-5′-fluoro analogue 5a displayed potent inhibitory activity against CDK2, with IC50 values of 1.9 and 1.7 nM, respectively. These derivatives also showed antiproliferative activity against several human cancer cell lines, with IC50 values of 0.2−3.3 μM. A representative analogue, 3a, showed greater than 500-fold selectivity for CDK relative to selected kinase panel and potent in vivo anticancer activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100080z"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100080z">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100080z&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100080z&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100080z&amp;href=/doi/10.1021/jm100080z" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3696-3706</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100057h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1001327" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Soo-Jeong++Choi">Soo-Jeong Choi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jung-Eun++Lee">Jung-Eun Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Soon-Young++Jeong">Soon-Young Jeong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isak++Im">Isak Im</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=So-Deok++Lee">So-Deok Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eun-Jin++Lee">Eun-Jin Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sang+Kook++Lee">Sang Kook Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seong-Min++Kwon">Seong-Min Kwon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sang-Gun++Ahn">Sang-Gun Ahn</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jung-Hoon++Yoon">Jung-Hoon Yoon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sun-Young++Han">Sun-Young Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jae-Il++Kim">Jae-Il Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong-Chul++Kim">Yong-Chul Kim</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Drug Discovery, Anygen Co., Ltd., Gwangju 500-712, Republic of Korea</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">College of Pharmacy, Ewha Womans University, Seoul 120-759, Republic of Korea</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Pathology, School of Dentistry, Chosun University, Gwangju 501-759, Republic of Korea</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Pharmacology Research Center, Korea Research Institute of Chemical Technology, Daejon 305-600, Republic of Korea</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 82-62-970-2502. Fax: 82-62-970-2484. E-mail: <a href="/cdn-cgi/l/email-protection#10697f7e777378657c50777963643e71733e7b62"><span class="__cf_email__" data-cfemail="5e273130393d362b321e39372d2a703f3d70352c">[email protected]</span></a></div><div class="corresp-fn" id="fn1">#Present address: College of Pharmacy, Seoul National University, Seoul, Republic of Korea</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100080z&amp;href=/doi/10.1021%2Fjm100080z" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3696–3706</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 5, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 January 2010</li><li><span class="item_label"><b>Published</b> online</span>5 April 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100080z" title="DOI URL">https://doi.org/10.1021/jm100080z</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3696%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSoo-Jeong%2BChoi%252C%2BJung-Eun%2BLee%252C%2BSoon-Young%2BJeong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D9%26contentID%3Djm100080z%26title%3D5%252C5%25E2%2580%25B2-Substituted%2BIndirubin-3%25E2%2580%25B2-oxime%2BDerivatives%2Bas%2BPotent%2BCyclin-Dependent%2BKinase%2BInhibitors%2Bwith%2BAnticancer%2BActivity%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3706%26publicationDate%3DMay%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100080z"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3110</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">61</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100080z" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Soo-Jeong&quot;,&quot;last_name&quot;:&quot;Choi&quot;},{&quot;first_name&quot;:&quot;Jung-Eun&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Soon-Young&quot;,&quot;last_name&quot;:&quot;Jeong&quot;},{&quot;first_name&quot;:&quot;Isak&quot;,&quot;last_name&quot;:&quot;Im&quot;},{&quot;first_name&quot;:&quot;So-Deok&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Eun-Jin&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Sang&quot;,&quot;last_name&quot;:&quot;Kook Lee&quot;},{&quot;first_name&quot;:&quot;Seong-Min&quot;,&quot;last_name&quot;:&quot;Kwon&quot;},{&quot;first_name&quot;:&quot;Sang-Gun&quot;,&quot;last_name&quot;:&quot;Ahn&quot;},{&quot;first_name&quot;:&quot;Jung-Hoon&quot;,&quot;last_name&quot;:&quot;Yoon&quot;},{&quot;first_name&quot;:&quot;Sun-Young&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Jae-Il&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Yong-Chul&quot;,&quot;last_name&quot;:&quot;Kim&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;3696-3706&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100080z&quot;},&quot;abstract&quot;:&quot;To enhance the ability of indirubin derivatives to inhibit CDK2/cyclin E, a target of anticancer agents, we designed and synthesized a new series of indirubin-3′-oxime derivatives with combined substitutions at the 5 and 5′ positions. A molecular docking study predicted the binding of derivatives with OH or halogen substitutions at the 5′ position to the ATP binding site of CDK2, revealing the critical interactions that may explain the improved CDK2 inhibitory activity of these derivatives. Among the synthesized derivatives, the 5-nitro-5′-hydroxy analogue 3a and the 5-nitro-5′-fluoro analogue 5a displayed potent inhibitory activity against CDK2, with IC50 values of 1.9 and 1.7 nM, respectively. These derivatives also showed antiproliferative activity against several human cancer cell lines, with IC50 values of 0.2−3.3 μM. A representative analogue, 3a, showed greater than 500-fold selectivity for CDK relative to selected kinase panel and potent in vivo anticancer activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100080z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100080z" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100080z&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100080z" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100080z&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100080z" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100080z&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100080z&amp;href=/doi/10.1021/jm100080z" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100080z" /></input><a href="/doi/pdf/10.1021/jm100080z" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100080z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100080z%26sid%3Dliteratum%253Aachs%26pmid%3D20361800%26genre%3Darticle%26aulast%3DChoi%26date%3D2010%26atitle%3D5%252C5%25E2%2580%25B2-Substituted%2BIndirubin-3%25E2%2580%25B2-oxime%2BDerivatives%2Bas%2BPotent%2BCyclin-Dependent%2BKinase%2BInhibitors%2Bwith%2BAnticancer%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D9%26spage%3D3696%26epage%3D3706%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">To enhance the ability of indirubin derivatives to inhibit CDK2/cyclin E, a target of anticancer agents, we designed and synthesized a new series of indirubin-3′-oxime derivatives with combined substitutions at the 5 and 5′ positions. A molecular docking study predicted the binding of derivatives with OH or halogen substitutions at the 5′ position to the ATP binding site of CDK2, revealing the critical interactions that may explain the improved CDK2 inhibitory activity of these derivatives. Among the synthesized derivatives, the 5-nitro-5′-hydroxy analogue <b>3a</b> and the 5-nitro-5′-fluoro analogue <b>5a</b> displayed potent inhibitory activity against CDK2, with IC<sub>50</sub> values of 1.9 and 1.7 nM, respectively. These derivatives also showed antiproliferative activity against several human cancer cell lines, with IC<sub>50</sub> values of 0.2−3.3 μM. A representative analogue, <b>3a</b>, showed greater than 500-fold selectivity for CDK relative to selected kinase panel and potent in vivo anticancer activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13823" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13823" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclin-dependent kinases (CDKs<a class="ref internalNav" href="#fn9" aria-label=""></a><div class="NLM_fn" id="fn9"><p class="last">Abbreviations: ATP, adenosine 5′-triphosphate; CDK, cyclin dependent kinase; DMEM, Dulbecco’s Modified Eagle Medium; EI, electron impact; ESI, electro spray ionization; FAB, fast atom bombardment; HPLC, high-pressure liquid chromatography; HRMS, high-resolution mass spectroscopy; MOPS, 3-(<i>N</i>-morpholino)propanesulfonic acid; pRb, retinoblastoma protein; RPMI, Roswell Park Memorial Institute medium; SAR, structure−activity relationship; SRB sulforhodamine B.</p></div>) belong to a group of serine/threonine kinases involved in the regulation of cell cycle progression, neuronal function, differentiation, and apoptosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Their activity is tightly regulated by multiple mechanisms including binding to corresponding cyclins, of which level of expression oscillates throughout the different phases of the cell cycle.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, different CDK/cyclin complexes are activated during each cell cycle step through G1, S, G2, and M phases. Sequential phosphorylation of the retinoblastoma protein (pRb) by CDK4/cyclin D and CDK6/cyclin D in early G1 phase and by CDK2/cyclin E in late G1 phase causes the release of the E2F proteins. These transcription factors, in turn, activate a set of genes required for entry into the S-phase of the cell cycle.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> CDK2 is subsequently activated by cyclin A during the late stages of DNA replication in S-phase, and CDK2 promotes appropriately timed deactivation of E2F to prevent apoptosis triggered by persistent E2F activity.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Finally, CDK1, in a complex with cyclin A or B, is thought to be involved in regulating the G2/M checkpoint and driving cells through mitosis.<a onclick="showRef(event, 'ref2 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref7">(2, 7)</a></div><div class="NLM_p">In addition to playing roles in cell cycle control, CDK2, 7, 8, and 9 have been found to have other activities. For example, CDK2/cyclin E is important in the p53-mediated DNA damage response pathway, and CDK7, 8, and 9 are involved in the regulation of transcription initiation and elongation via phosphorylation of RNA polymerase.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Therefore, CDKs affect cell growth and survival through several mechanisms, making the appropriate regulation of CDK activity important in various cellular processes.</div><div class="NLM_p">Deregulation of CDKs by abnormally high expression of cyclins, such as cyclins D and E, or by mutation, has been observed in many human tumors.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> For example, the expression and catalytic activity of CDK2/cyclin E complexes is increased in colorectal, ovarian, breast, and prostate cancers, and elevated expression of cyclin E in primary tumors has been shown to correlate with poor survival rates in breast cancer patients.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Abnormal expression of CDK1/cyclin B complexes has also been observed in some patients with prostate adenocarcinoma and lung cancer.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">Although a report has shown that CDK2 may not be required for cell cycle progression and proliferation, recent reports suggested that melanocytes and hepatocytes may be dependent on CDK2 for proliferation and survival.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> Also, an investigation of simultaneous depletion of CDK1 and CDK2 was reported to provide increased efficacy in antiproliferation of tumor cell lines, compared with targeting either CDK1 or CDK2 alone.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Furthermore, emerging evidence indicates that certain tumor cells may require specific interphase CDKs for proliferation.<a onclick="showRef(event, 'ref7 ref15'); return false;" href="javascript:void(0);" class="ref ref7 ref15">(7, 15)</a> Thus, inhibition of CDKs may provide an effective strategy for controlling tumor growth, making CDKs attractive targets for anticancer therapy.</div><div class="NLM_p">At present, several small-molecule CDK inhibitors are undergoing clinical trials. These inhibitors are flat, small heterocyclic molecules that act by competing with ATP at the kinase ATP-binding site. Among these, flavopiridol was the first CDK inhibitor to enter clinical evaluations.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><i>R</i>-Roscovitine (a trisubstituted purine analogue)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and BMS-387032 (an aminothiazole)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> are selective for CDK2/cyclin E, and PD-0332991 (a pyridopyrimidine)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> is highly selective for CDK4/cyclin D and CDK6/cyclin D. Indirubin, a bis-indole scaffold and its derivatives, have been investigated with considerable interest as potent inhibitors targeting important protein kinases such as CDK, GSK-3β, and aurora kinases.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23-26)</a> Our research group previously described the synthesis of a series of novel indirubin analogues and the evaluation of their antiproliferative and CDK2 inhibitory activities.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Recently, we also reported other activities of the indirubin derivatives including their regulation of cellular signaling through the inhibition of Notch-1 or activation of β-catenin-mediated Wnt signaling<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> and enhancing effect of differentiation of HL-60 leukemia cells induced by conventional activators such as 1,25-dihydroxyvitamin D3 and all-<i>trans</i> retinoic acid.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Among the previously reported derivatives, 5-nitro-5′-bromo-indirubin-3′-oxime, <b>2</b>, showed the most potent antiproliferative activity (IC<sub>50</sub> = 0.79−2.9 μM) against several cancer cell lines, with the additional substitution at the 5′ position enhancing activity when compared with the 5-nitro-indirubin-3′-oxime analogue, <b>1</b> (IC<sub>50</sub> = 1.2−25.5 μM) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). However, there are lack of reports regarding the synthesis and biological evaluations exploring the effect of various substitutions at the 5′ position of indirubin skeleton. We therefore performed a molecular docking study to design and synthesize novel 5,5′-substituted indirubin-3′-oxime analogues and assessed the biological properties of these molecules, including their CDK inhibitory, antiproliferative, and in vivo anticancer activities.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of indirubin derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Molecular Docking for Designing Strategy</h3><div class="NLM_p">To address the mechanism behind the enhanced antiproliferative effect of compound <b>2</b>, we performed a molecular docking study on the ATP binding site of CDK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) using CDOCKER, a CHARMm-based molecular dynamics docking program (Discovery Studio 2.0). The X-ray cocrystal structure of CDK2 with 5-bromoindirubin was obtained from the PDB data bank (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHE">2BHE</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> After removing the ligand from the structure of complex, a binding sphere was constructed with a radius set as 8 Å. The final binding conformation of <b>2</b> was determined through molecular dynamics and final energy minimization. We found that the nitrogen at position 1′, the carbonyl oxygen at position 2, and the nitrogen at position 1 of compound <b>2</b> each formed a hydrogen bond with the hinge segments (Glu81, Leu83) of the ATP binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a). In addition, the 3′-hydroxyl group of the oxime moiety formed a hydrogen bond with the backbone carbonyl of Gln131 and the 5-nitro group contributed to a salt bridge with the side chains of Lys33 and Asp145. A depiction of the binding surface with electrostatic potential within 4 Å around the ligand, <b>2</b>, showed that the 5′-Br group may be projected toward the outer aqueous space of the ATP binding pocket in which a positively charged amino acid residue, Lys89, may be a virtual binding partner (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b). It could be hypothesized that an additional electrostatic interaction between the lone pair electrons of the 5′-Br group and the positively charged Lys89 residue may result in a higher binding affinity with CDK2 and thus contribute to the more potent antiproliferative activity of <b>2</b> compared with the 5′-unsubstituted-indirubin-3′-oxime analogue, <b>1</b>. Results of the docking study show that derivatization at the 5′-position, along with 5-substituents (Cl, NO<sub>2</sub>, F, and OCF<sub>3</sub>) on the indirubin scaffold, may be an ideal strategy for optimizing binding affinity to CDK2.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of <b>2</b> and <b>3a</b> in the ATP binding site of CDK2. (a) Network of hydrogen bonds (green dashed lines) between <b>2</b> and the backbone amino acids in the ATP binding pocket of CDK2. Binding mode of <b>2</b> with CDK2 displays three hydrogen bonds between two nitrogen of <b>2</b> and Leu83 and Glu81 in the CDK2 hinge region, additional hydrogen bond between the oxime moiety and carbonyl oxygen of Gln131, and a salt bridge formed between 5-nitro group and the side chains of Lys33, Asp145. (b) van der Waals surface of CDK2 with <b>2</b> in CPK representation. 5′-Bromo group is projected toward the outer aqueous space of ATP binding pocket that presents a positively charged amino acid residue, Lys89. (c) Network of hydrogen bonds (green dashed lines) between <b>3a</b> and the backbone amino acids in the ATP binding pocket of CDK2. <b>3a</b> forms an additional hydrogen bond between the 5′-hydroxy group and the carboxylic acid of Asp86. This may further improve CDK2 inhibitory activity. (d) Molecular surface representation of CDK2 with <b>3a</b> bound in the ATP binding site. Some important amino acids lying within binding surface are displayed. The 5′-hydroxy group is pointing out of the pocket toward the solvent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate the structure−activity relationships at the 5′ position of indirubin skeleton for CDK inhibitory and antiproliferative activities, following groups were selected for the derivatization: (1) 5′-F and 5′-Cl, which can form similar electrostatic interaction with Lys89 in a manner similar to that of the 5′-Br analogue, <b>2</b>, (2) 5′-OH, which can provide an additional hydrogen bond with CDK2 and introduce hydrophilic character at indirubin scaffold, (3) 5′-OCH<sub>3</sub> and 5′-CH<sub>3</sub>, expecting contrast effects compared with halogen-substituted analogues.</div><div class="NLM_p last">A docking model of a representative molecule, 5-nitro-5′-hydroxy-indirubin-3′-oxime derivative (<b>3a</b>), in the ATP binding site of CDK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c) showed that a new hydrogen bond may be formed between the 5′-OH group of <b>3a</b> and Asp86 in the solvent-accessible region of CDK2, with the oxime moiety of <b>3a</b> interacting with Ile10 instead of Gln131. A depiction of the binding surface with electrostatic potential within 4 Å around <b>3a</b> showed that the 5′-OH protrudes into the outer aqueous surface, solvent-accessible region (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">To synthesize the 5,5′-substituted-3′-indirubin oxime derivatives, the 5-substituted indoxyl-<i>N</i>,<i>O</i>-diacetates, <b>9a</b>−<b>d</b> were prepared from their corresponding 5-substituted anthranilic acids, <b>7a</b>−<b>d</b> with hydroxyl, chloro, fluoro, and methyl groups, respectively (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Briefly, each compound of <b>7a</b>−<b>d</b> was subjected to conditions of reductive alkylation with ethylglyoxalate, followed by hydrolysis to yield the dicarboxylic acids, <b>8a</b>−<b>d</b>. These latter compounds were finally cyclized in acetic anhydride<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to yield acetoxy, chloro, fluoro, and methyl substituted compounds, <b>9a</b>−<b>d</b>. For the 5-hydroxy analogue, the cyclized compound <b>9a</b> was obtained as a triacetate form as the phenolic hydroxyl group was also acetylated under the cyclization conditions.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 5-Substituted Indoxyl-<i>N</i>,<i>O</i>-diacetate<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (i) ethyl glyoxalate, NaCNBH<sub>3</sub>, 1% acetic acid, methanol, room temp, 3 h, 85−95%; (ii) 1N NaOH (aq), methanol, room temp, 1 h, 90%; (iii) acetic anhydride, Na<sub>2</sub>CO<sub>3</sub>, reflux, 4 h, 65−72%.</p></p></figure><div class="NLM_p">As described previously,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> the 5,5′-substituted-3′-indirubin oxime derivatives <b>3</b>−<b>6</b> were synthesized from conjugate reactions of the 5-substituted indoxyl-<i>N</i>,<i>O</i>-diacetates <b>9a</b>−<b>d</b> with 5-nitro, chloro, fluoro, and trifluoromethoxy substituted isatin analogues <b>10a</b>−<b>d</b> under basic conditions to yield the 5,5′-substituted indirubin derivatives <b>11−14</b>, followed by the reaction of each of the latter with hydroxylamine to convert the ketone groups to 3′-oxime (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The 5-substituted-5′-methoxy-3′-oxime compounds <b>16a</b>−<b>c</b> were synthesized from their corresponding 5-nitro, fluoro, and trifluoromethoxy substituted 5′-hydroxy-indirubin derivatives <b>15a</b>−<b>c</b> by methylation of the phenolic hydroxyl groups and subsequent reaction with hydroxylamine (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5,5′-Substituted Indirubin-3′-oxime Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (i) Na<sub>2</sub>CO<sub>3</sub>, methanol or methanol: water (2:1), room temp, 2−3 h, 35−65%; (ii) H<sub>2</sub>NOH·HCl, pyridine, reflux, 0.5−3 h, 65−70%.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 5-Substituted-5′-methoxy-indirubin-3′-oxime Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (i) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, acetone, room temp, 4 h, 58−65%; (ii) H<sub>2</sub>NOH·HCl, pyridine, reflux, 0.5−3 h, 65−70%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> CDK Inhibitory Activity and Kinase Selectivity Profile</h3><div class="NLM_p">The 5,5′-substituted-indirubin-3′-oxime derivatives were initially evaluated for their inhibitory activities against CDK1/cyclinB and CDK2/cyclinE at 1 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). 5-Nitroindirubin-3′-oxime, <b>1</b>, was tested together for the comparison of the effects of substitutions at the 5′-position. The inhibitory activity and selectivity of the synthesized compounds for CDK2 over CDK1 were dependent on the nature of the 5′-substitutents at the R<sub>1</sub> position. In general, 5,5′-substituted indirubin-3′-oxime derivatives showed potent inhibitory activities against CDK2 with more than 90% inhibitory potency in 1 μM, except for <b>4d</b>, <b>16a</b>−<b>c</b>. Especially, 5′-OH analogues, <b>3a</b>−<b>d</b> showed the highest inhibitory activities against both CDK1 and CDK2. Although a substitution of hydroxyl group at the R<sub>1</sub> position resulted in decreased selectivity for CDK2 over CDK1, simultaneous inhibition of CDK1 and CDK2 may have additional benefits in terms of anticancer activity according to the literature.<a onclick="showRef(event, 'ref15 ref18 ref33'); return false;" href="javascript:void(0);" class="ref ref15 ref18 ref33">(15, 18, 33)</a> Moreover, the 5′-OH group improved the water solubility of compound <b>3a</b> about 30-fold compared with compounds <b>1</b> or <b>2</b> (the data of water solubility of compounds <b>1</b>, <b>2</b>, and <b>3a</b> was shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Table S3). Low-level water solubility has been a major problem among the physicochemical properties of indirubin analogues (data not shown). In contrast to the 5′-OH-substituted indirubin-3′-oxime derivatives, the 5′-chloro and 5′-fluoro-substituted derivatives <b>4a</b>−<b>d</b> and <b>5a</b>−<b>d</b> showed potent CDK2 inhibitory activities, with 6−10-fold selectivity compared to CDK1. For example, the 5-nitro-5′-chloro-indirubin-3′-oxime <b>4a</b> was about 8-fold more potent against CDK2 than CDK1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The decreased CDK1 inhibition resulting from 5′-halogenation is further supported by results showing that the 5-nitro-5′-bromo-indirubin-3′-oxime, <b>2</b>, had decreased CDK1 inhibitory activity (IC<sub>50</sub> = 190 nM) when compared with the 5-nitro-indirubin-3′-oxime, <b>1</b>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Among the series of compounds with electron-donating groups at the 5′ position, <b>6a</b>, with a 5′-CH<sub>3</sub> group, showed potent CDK2 inhibitory activity, with 7-fold selectivity over CDK1. However, at 1 μM, the 5′-OCH<sub>3</sub>-substituted derivatives (<b>16a</b>−<b>c</b>) displayed weak or no inhibitory activities against CDK1 and CDK2.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CDK1 and CDK2 % activity in the presence of 1 μM of 5,5′-substituted indirubin-3′-oxime derivatives. New indirubin derivatives (1 μM) were tested for their inhibitory effects in the kinase activity of CDK1/cyclin B and CDK2/cyclin E. 5-Nitroindirubin-3′-oxime (<b>1</b>) was also tested for comparison. Results are presented as the mean ± standard error of the mean (SEM) of the % kinase activity of CDK1 and CDK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. CDK2/Cyclin E iInhibitory Activities of 5,5′-Substituted Indirubin-3′-oxime Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0001.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.91 ± 0.16<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">5.27 ± 0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">2.25 ± 0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">8.32 ± 0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">23.5 ± 4.34<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">11.1 ± 0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">10.1 ± 0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">76.2 ± 2.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.71 ± 0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">8.01 ± 0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">1.83 ± 0.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">60.3 ± 11.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">8.68 ± 1.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">2,950 ± 530</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">4,120 ± 450</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">8,620 ± 870</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">7.35 ± 0.21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">A series of indirubin derivatives were tested at 10 concentrations in CDK2/cyclin E kinase assay, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. IC<sub>50</sub> values were calculated from the dose−response curves.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values of <b>3a</b> and <b>4a</b> in CDK1/cyline B kinase assay are 13 nM and 195 nM, respectively .</p></div></div></div><div class="NLM_p">The structure−activity relationships of 5,5′-indirubin-3′-oxime derivatives for their CDK2 inhibitory activities were analyzed with IC<sub>50</sub> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). We found that most derivatives, except for the 5′-OCH<sub>3</sub> compounds <b>16a</b>−<b>c</b>, showed potent inhibitory activities, with IC<sub>50</sub> values of 1−70 nM. Regarding the effects of 5′-substituents at R<sub>1</sub> position, the CDK2 inhibitory activities increased in the following order: −OCH<sub>3</sub> < −Cl < −H, −CH<sub>3</sub> < −OH, −F. For example, the CDK2 inhibitory activities of the 5′-chloro-substituted-indirubin-3′-oxime compounds <b>4a</b>−<b>d</b> were 10-fold lower (IC<sub>50</sub> = 10−76 nM) than were those of the 5′-fluoro-indirubin-3′-oxime derivatives <b>5a</b>−<b>c</b> (IC<sub>50</sub> = 1−8 nM). Substitution of an electron-donating group, 5′-OCH<sub>3</sub> (<b>16a</b>−<b>c</b>), dramatically reduced CDK2 inhibitory activities with IC<sub>50</sub> values of 2−8 μM, whereas substitution of another electron-donating group, 5′-CH<sub>3</sub> (<b>6a</b>), enhanced inhibitory activity 270-fold compared with <b>16b</b>. Particularly, the most potent CDK2 inhibitors, <b>3a</b>, <b>5a</b>, and <b>5c</b> had IC<sub>50</sub> values against CDK2 of approximately 2 nM, thus demonstrating about a 4-fold greater potency than the 5-nitro-5′-unsubstituted-indirubin-3′-oxime, <b>1</b> (IC<sub>50</sub> = 7 nM). Analysis of the effects of 5-substitution at the R<sub>2</sub> position of indirubin-3′-oxime derivatives showed that nitro or fluoro group generally enhanced CDK2 inhibition, compared with chloro or trifluoromethoxy group substitution. Together, our findings show that indirubin-3′-oxime analogues with combination of substituents providing electronic effects, such as OH or F at the 5′-position and NO<sub>2</sub> or F at the 5-position, displayed potent inhibitory activities against CDK2.</div><div class="NLM_p">We further evaluated the representative potent and selective CDK2 inhibitors <b>3a</b> and <b>4a</b> against a diverse panel of receptor tyrosine kinases, serine/threonine kinases, and lipid kinase (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compound <b>3a</b> showed weak inhibitory activity only against Aurora A (IC<sub>50</sub> = 1 μM), IKKβ (IC<sub>50</sub> = 10 μM), and TrkA (IC<sub>50</sub> = 4 μM), whereas compound <b>4a</b> displayed negligible inhibitory activities against all tested kinases. As the IC<sub>50</sub> values of <b>3a</b> and <b>4a</b> against CDK1 and CDK2 were in the low nanomolar range, the kinase selectivity profiles of these compounds may be significantly favorable for CDK1 and CDK2.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinase panel screening of <b>3a</b>, <b>4a</b>. Compounds <b>3a</b> and <b>4a</b> (10 μM) were tested against more diverse panel of kinases comprising of receptor tyrosine kinases, serine/threonine kinases, and lipid kinase. Results are presented as the mean ± standard error of the mean (SEM) of the % kinase activity. <b>3a</b> showed 9% inhibitory activity against TrkA at 1 μM. IC<sub>50</sub> values of <b>3a</b> against two serine/threonine kinases, Aurora A (1 μM) and IKKβ (10 μM), and a receptor tyrosine kinase, TrkA (4 μM) were calculated from the dose−response curves.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Antiproliferative Activity</h3><div class="NLM_p">We tested the ability of the 5,5′-substituted indirubin-3′-oxime derivatives to inhibit the proliferation of several cancer cell lines, including A549, HT1080, HCT116, K562, SNU638, KB, and MCF-7, using SRB assay, and compared the data with the positive controls 5-nitro-5′-bromo-indirubin-3′-oxime (<b>2</b>) and Roscovitine (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiproliferative Activities of 5,5′-Substituted Indirubin-3′-oxime Derivatives on Different Human Cancer Cell Lines<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0002.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="7" align="center" char=".">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">A549<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">HT1080<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">HCT116<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">K562<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">SNU638<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">KB<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center" char=".">MCF-7<a class="ref internalNav" href="#t2fn8" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.33</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="char" char=".">1.03</td><td class="colsep0 rowsep0" align="char" char=".">1.33</td><td class="colsep0 rowsep0" align="char" char=".">1.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">16.4</td><td class="colsep0 rowsep0" align="char" char=".">2.92</td><td class="colsep0 rowsep0" align="char" char=".">3.51</td><td class="colsep0 rowsep0" align="char" char=".">12.2</td><td class="colsep0 rowsep0" align="char" char=".">5.14</td><td class="colsep0 rowsep0" align="char" char=".">10.2</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">4.09</td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">1.66</td><td class="colsep0 rowsep0" align="char" char=".">1.42</td><td class="colsep0 rowsep0" align="char" char=".">2.11</td><td class="colsep0 rowsep0" align="char" char=".">4.62</td><td class="colsep0 rowsep0" align="char" char=".">2.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">16.9</td><td class="colsep0 rowsep0" align="char" char=".">2.28</td><td class="colsep0 rowsep0" align="char" char=".">2.25</td><td class="colsep0 rowsep0" align="char" char=".">5.91</td><td class="colsep0 rowsep0" align="char" char=".">2.96</td><td class="colsep0 rowsep0" align="char" char=".">5.81</td><td class="colsep0 rowsep0" align="char" char=".">4.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">15.6</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">0.56</td><td class="colsep0 rowsep0" align="char" char=".">1.16</td><td class="colsep0 rowsep0" align="char" char=".">1.11</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">12.2</td><td class="colsep0 rowsep0" align="char" char=".">1.86</td><td class="colsep0 rowsep0" align="char" char=".">17.2</td><td class="colsep0 rowsep0" align="char" char=".">2.57</td><td class="colsep0 rowsep0" align="char" char=".">11.9</td><td class="colsep0 rowsep0" align="char" char=".">6.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">18.9</td><td class="colsep0 rowsep0" align="char" char=".">3.62</td><td class="colsep0 rowsep0" align="char" char=".">1.72</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">2.28</td><td class="colsep0 rowsep0" align="char" char=".">3.62</td><td class="colsep0 rowsep0" align="char" char=".">3.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">17.7</td><td class="colsep0 rowsep0" align="char" char=".">3.79</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">2.71</td><td class="colsep0 rowsep0" align="char" char=".">2.83</td><td class="colsep0 rowsep0" align="char" char=".">4.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.57</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">0.92</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">3.31</td><td class="colsep0 rowsep0" align="char" char=".">7.14</td><td class="colsep0 rowsep0" align="char" char=".">6.32</td><td class="colsep0 rowsep0" align="char" char=".">9.11</td><td class="colsep0 rowsep0" align="char" char=".">7.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">8.62</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td><td class="colsep0 rowsep0" align="char" char=".">15.9</td><td class="colsep0 rowsep0" align="char" char=".">2.23</td><td class="colsep0 rowsep0" align="char" char=".">13.2</td><td class="colsep0 rowsep0" align="char" char=".">6.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">19.9</td><td class="colsep0 rowsep0" align="char" char=".">3.95</td><td class="colsep0 rowsep0" align="char" char=".">1.51</td><td class="colsep0 rowsep0" align="char" char=".">1.53</td><td class="colsep0 rowsep0" align="char" char=".">1.89</td><td class="colsep0 rowsep0" align="char" char=".">3.81</td><td class="colsep0 rowsep0" align="char" char=".">4.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">3.92</td><td class="colsep0 rowsep0" align="char" char=".">1.41</td><td class="colsep0 rowsep0" align="char" char=".">0.81</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td><td class="colsep0 rowsep0" align="char" char=".">2.11</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">18.8</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">12.7</td><td class="colsep0 rowsep0" align="char" char=".">5.18</td><td class="colsep0 rowsep0" align="char" char=".">8.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">11.5</td><td class="colsep0 rowsep0" align="char" char=".">10.6</td><td class="colsep0 rowsep0" align="char" char=".">10.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">8.13</td><td class="colsep0 rowsep0" align="char" char=".">7.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">6.71</td><td class="colsep0 rowsep0" align="char" char=".">4.84</td><td class="colsep0 rowsep0" align="char" char=".">3.59</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">13.6</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">13.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t2fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">16.9</td><td class="colsep0 rowsep0" align="char" char=".">1.45</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">1.14</td><td class="colsep0 rowsep0" align="char" char=".">1.16</td><td class="colsep0 rowsep0" align="char" char=".">0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Roscovitine<a class="ref internalNav" href="#t2fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td><td class="colsep0 rowsep0" align="char" char=".">17.8</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">9.77</td><td class="colsep0 rowsep0" align="char" char=".">30.1</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">A series of indirubin derivatives were tested at five concentrations for their effects on various human cancer cell lines using SRB assay, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. The IC<sub>50</sub> (μM) values were calculated from dose response curves and SD was described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Human lung cancer cell.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Human fibro sarcoma cell.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Human colon cancer cell.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Human leukemia cell.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">Human stomach cancer cell.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Human nasopharyngeal cancer cell.</p></div><div class="footnote" id="t2fn8"><sup>h</sup><p class="last">Human breast cancer cell.</p></div><div class="footnote" id="t2fn9"><sup>i</sup><p class="last">Experiments were also performed with <b>2</b> and Roscovitine as positive control.</p></div></div></div><div class="NLM_p last">We found that the antiproliferative activities of the 5′-hydroxy derivatives <b>3a</b>−<b>d</b> were well correlated with their ability to inhibit CDK2, with activities depending on the substituents at the 5 position, in the order NO<sub>2</sub> > F > Cl, OCF<sub>3</sub>. In particular, the 5-nitro-5′-hydroxy-indirubin-3′-oxime <b>3a</b> showed similar or greater inhibitory activity than did compound <b>2</b>, depending on the cell line tested, with IC<sub>50</sub> values of ∼0.4 μM against the HT1080 and HCT116 cell lines. Among compounds in which the 5′-bromo group of <b>2</b> was replaced by other halogen groups, such as Cl or F, the 5-nitro analogues <b>4a</b> and <b>5a</b> were especially effective against the HCT116 human colon cancer cell line in which cyclin D1 is deregulated,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> with IC<sub>50</sub> values of approximately 0.3 μM. The 5-nitro-5′-fluoro-indirubin-3′-oxime <b>5a</b> showed the broadest spectrum of inhibitory activity against all cancer cell lines, with IC<sub>50</sub> values of 0.28−0.94 μM, and the values correlated with activity against CDK2. Compound <b>5a</b> was the only derivative to show a nanomolar IC<sub>50</sub> value against the A549 human lung cancer cell line, in contrast to the weak antiproliferative activities of most other derivatives. Although the majority of the indirubin-3′-oxime derivatives substituted with electron-donating groups such as 5′-CH<sub>3</sub> or 5′-OCH<sub>3</sub> (<b>6</b> and <b>16</b>) were very weak inhibitors of cancer cell lines, the 5-nitro-5′-methyl-3′-oxime <b>6a</b> had antiproliferative IC<sub>50</sub> values in the range of 0.8−1 μM. Regarding the substitutions at the 5-position (R<sub>2</sub>), the 5-NO<sub>2</sub> group in combination with 5′-OH, Cl, F, or CH<sub>3</sub> showed the most potent antiproliferative activity among the 5,5′-disubsituted derivatives tested. These findings are in good agreement with our previous results<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and are supported by the hypothesized binding mode of <b>2</b> and <b>3a</b>, in which an additional salt bridge may form between the 5-nitro group and Asp145 and Lys33 in the ATP binding site of CDK2. Among the 5′-OCH<sub>3</sub> derivatives, only the 5-F substituted analogue <b>16b</b> displayed moderate antiproliferative activity, indicating that this analogue may have a different mechanism of action. Our combined results suggest that 5′-hydroxyl or halogen groups may enhance the inhibition of CDK and cancer cell growth, possibly by forming additional hydrogen bond or electrostatic interaction at the ATP binding site of CDK2.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vivo Anticancer Activity of <b>3a</b></h3><div class="NLM_p">To assess the in vivo activity of the indirubin analogue, we utilized an animal tumor model in which Sprague−Dawley (SD) rats were subcutaneously transplanted with RK3E-ras rat kidney cells harboring the k-ras and GFP/Luc genes, as published by our group.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The 5-nitro-5′-hydroxy analogue, <b>3a</b>, was selected for in vivo test because the improved water solubility of <b>3a</b> while maintaining the potent CDK inhibitiory and antiproliferative activity compared with other derivatives, which usually precipitated in the bloodstream of animals when administered through tail vein. Five days after transplantation, 5 mg/kg <b>3a</b> was administered iv to each animal every other day with a total of five times and the rats were monitored daily. We found that tumor volume was significantly decreased, by about 84.3%, compared with control rats (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a,b). There was no significant difference in body weight between <b>3a</b>-treated and control rats (data not shown). Bioluminescence images obtained on day 10 after treatment with <b>3a</b> indicated that luminescence intensity, an indicator of tumor growth, was significantly decreased (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>c).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of tumor growth by <b>3a</b>. (a) The SD-rats were injected with RK3E-ras-Luc cells (5 × 10<sup>6</sup>/100 μL). When the tumor reached 5 mm in size, the rats were injected intravenously with <b>3a</b> (5 mg/kg) in nonanesthesia states every other day for a total of five times. The tumor size was measured by caliper as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (b) Representative excised subcutaneous tumor from the control and <b>3a</b> treated rats. (c) In vivo bioluminescence imaging assay from the control and <b>3a</b> treated rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Histological analysis showed that untreated control solid tumors were anaplastic undifferentiated carcinomas, showing many mitotic figures, multifocal necrosis, and hemorrhage. Tumor treatment with <b>3a</b>, however, led to extensive cell death (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a, left) and a 6-fold increase in the number of TUNEL-positive apoptotic cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a, center, and Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). In contrast, the level of expression of PCNA, a cell proliferation marker, was lower in <b>3a</b>-treated animals than in controls (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a, right, and Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>c). In addition, a result of cell cycle analysis using FACS showed that <b>3a</b> inhibited cell cycle progression at the G<sub>0</sub>/G<sub>1</sub> phase in RK3E-ras rat kidney cells (The data of cell cycle distribution is shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, Figure S1).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Histology and immunohistochemistry of tumor tissue. RK3E-ras-Luc cells were inoculated sc on the left flank of rats. <b>3a</b> (5 mg/kg) was injected intravenously into the tumor bearing rats every other day beginning from day 5. The rats were sacrificed on day 11. (a) H&E staining of tumor sections (left), TUNEL assay on paraffin sections from solid tumor (center), and immunohistochemical staining for PCNA (right), (b) positive cells for TUNEL assay, (c) positive cells for PCNA immunostaining. Cells were counted in triplicate. Columns, mean; bars, SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These results indicate that <b>3a</b> suppresses tumor growth in vivo by inhibiting cell proliferation and activating apoptosis. Although the in vitro and in vivo anticancer activity of <b>3a</b> was correlated with the CDK inhibitory activity, a possibility of combined mechanisms of the action could be speculated from several reports of molecular mechanisms of indirubin derivatives in anticancer activity such as inhibition of Notch-1 or Stat3 signaling and promoting caspase activity via a mitochondria-mediated pathway.<a onclick="showRef(event, 'ref27 ref28 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref37 ref38">(27, 28, 37, 38)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we describe here the design and synthesis of several novel 5,5′-substituted-indirubin-3′-oxime compounds as potent inhibitors of CDK1 and CDK2 and with antiproliferative activities against several cancer cell lines. The enhanced inhibitory activities of these 5,5′-substituted derivatives, compared with the 5′-unsubstituted indirubin-3′-oxime <b>1</b>, could be interpreted based on the results of a molecular docking study at the ATP binding site of CDK2, showing that the substituted derivates showed additional projections into the solvent-accessible region and additional interactions with the amino acid residues in the ATP binding pocket, as exemplified by the 5′-hydroxy analogue <b>3a</b>. The most potent CDK2 inhibitors were 5-nitro-5′-hydroxy-indirubin-3′-oxime (<b>3a</b>) and 5-nitro-5′-fluoro-indirubin-3′-oxime (<b>5a</b>), which had IC<sub>50</sub> values of 1.91 and 1.71 nM, respectively, and IC<sub>50</sub> values in the range of 0.2−3.3 μM when tested as antiproliferative agents against several human cancer cell lines. Structure−activity relationship analysis showed that OH and halogen groups were preferred to the electron donating groups such as 5′-CH<sub>3</sub>, 5′-OCH<sub>3</sub> at 5′ position. A representative analogue, 5-nitro-5′-hydroxy-indirubin-3′-oxime (<b>3a</b>), showed greater than 500-fold selectivity for CDK relative to selected kinase panel, and significant in vivo anticancer activity. These findings may contribute to the design and development of CDK inhibitors and facilitate clinical application.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p"><sup>1</sup>H NMR spectra were determined with a JEOL JNM-LA 300WB spectrometer at 300 MHz or JEOL JNM-ECX 400P spectrometer at 400 MHz, and spectra were taken in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> or acetone-<i>d</i><sub>6</sub>. Unless otherwise noted, chemical shifts are expressed as ppm downfield from internal tetramethylsilane, or relative ppm from DMSO (2.5 ppm), acetone (2.04 ppm). Mass spectroscopy was carried out on electrospray and high-resolution mass spectra (<i>m</i>/<i>z</i>) were recorded on a FAB, EI (JEOL: mass range 2600 amu, 10 kV acceleration) and ESI. High-resolution mass analysis was performed at Korea Basic Science Institute (Daegu).</div><div class="NLM_p last">The purity of all final products was determined by HPLC (at least 95% purity unless otherwise noted). The determination of purity was performed on a Shimadzu SCL-10A VP HPLC system using a Shimadzu Shim-pack C18 analytical column (250 mm × 4.6 mm, 5 mm, 100 Å) in linear gradient solvent systems. Solvent system was H<sub>2</sub>O:CH<sub>3</sub>CN = 65:35 to 5:95 over 30 min at a flow rate = 1 mL/min. Peaks were detected by UV absorption using a diode array detector.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure for the Preparation of 5-Substituted indoxyl-<i>N</i>,<i>O</i>-diacetate <b>9a</b>−<b>d</b></h3><div class="NLM_p">To a solution of 5-substituted anthranilic acid (1.0 g, 6.45 mmol) in 50 mL of methanol was added 0.5 mL of acetic acid, followed by ethyl glyoxalate (1 mL, 9.7 mmol) and NaCNBH<sub>3</sub> (609.5 mg, 9.7 mmol). The reaction mixture was stirred for 3 h at room temperature. Then the methanol was removed by evaporation. The residue was taken up in solution of saturated NH<sub>4</sub>Cl in water and extracted with ethyl acetate. The combined extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography (CH<sub>3</sub>Cl:methanol = 30:1) to give ester product (1.4 g, 95%) and then this compound (1.4 g, 5.8 mmol) was hydrolyzed in 25 mL of 1 N NaOH(aq) and 10 mL of methanol. The reaction mixture was stirred for 1 h at room temperature, and the resulting solution was acidified by 1N HCl. The resulting precipitate (1.2 g, 90%) was collected by filtration and washed with water. To the obtained diacid compounds <b>8a</b>−<b>d</b> (1.2 g, 4.97 mmol) was added acetic anhydride (15 mL) and Na<sub>2</sub>CO<sub>3</sub> (1.3 g, 12.4 mmol). The reaction mixture was refluxed for 4 h, and the product was extracted with ethyl acetate and washed with water. The combined extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by silica gel column chromatography (hexane:ethyl acetate =2:1) to give <b>9a</b>−<b>d</b> with 5-acetoxy, chloro, fluoro, and methyl groups, respectively (800 mg, 68%).</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Data for 1-Acetyl-1<i>H</i>-indole-3, 5-diyl Diacetate (<b>9a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz, δ ppm, <i>J</i> in Hz) 8.46 (1H, d, <i>J</i> = 9.3 Hz), 7.76 (1H, s), 7.30 (1H, d, <i>J</i> = 2.4 Hz), 7.11 (1H, dd, <i>J</i> = 9.3, 2.4 Hz), 2.67 (3H, s), 2.36 (3H, s), 2.31 (3H, s). ESI [M − H]<sup>−</sup>: 273.83.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Data for 1-Acetyl-5-chloro-1<i>H</i>-indol-3-yl Acetate (<b>9b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz, δ ppm, <i>J</i> in Hz) 8.40 (1H, d, <i>J</i> = 8.8 Hz), 7.75 (1H, s), 7.53 (1H, d, <i>J</i> = 2 Hz), 7.34 (1H, dd, <i>J</i> = 8.8, 2 Hz), 2.61 (3H, s), 2.39 (3H, s). ESI [M − H]<sup>−</sup>: 249.83.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Data for 1-Acetyl-5-fluoro-1<i>H</i>-indol-3-yl Acetate (<b>9c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz, δ ppm, <i>J</i> in Hz) 8.42 (1H, m), 7.75 (1H, s), 7.19 (1H, dd, <i>J</i> = 8.2, 2.4 Hz), 7.10 (1H, td, <i>J</i> = 8.8, 2.4 Hz), 2.59 (3H, s), 2.37 (3H, s). ESI [M − H]<sup>−</sup>: 233.88.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Data for 1-Acetyl-5-methyl-1<i>H</i>-indol-3-yl Acetate (<b>9d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz, δ ppm, <i>J</i> in Hz) 8.31 (1H, d, <i>J</i> = 7.6 Hz), 7.65 (1H, s), 7.31 (1H, s), 7.19 (1H, d, <i>J</i> = 7.6 Hz), 2.57 (3H, s), 2.44 (3H, s), 2.36 (3H, s). ESI [M − H]<sup>−</sup>: 229.80.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Preparation of 5,5′-Substituted Indirubin-3′-oxime Derivatives <b>3</b>−<b>6</b></h3><div class="NLM_p">To a solution of 5-nitro, chloro, fluoro, and trifluoromethoxy substituted isatin analogues <b>10a</b>−<b>d</b> (77 mg, 0.425 mmol) in methanol (5 mL) were added 5-substituted indoxyl-<i>N</i>,<i>O</i>-diacetate <b>9a</b>−<b>d</b> (100 mg, 0.425 mmol) and the mixture was stirred for 5 min. Anhydrous Na<sub>2</sub>CO<sub>3</sub> (112.5 mg, 1.06 mmol) was added, and the stirring was continued for 3 h at room temperature. The dark precipitate was filtered and washed with cold water and dried under reduced pressure to give derivatives of 5,5′-substituted indirubin (63 mg, 47%), <b>11</b>−<b>14</b>. The indirubin derivative (10 mg, 0.032 mmol) was dissolved in pyridine (0.3 mL), and hydroxylamine hydrochloride (6.6 mg, 0.095 mmol) was added. The reaction mixture was heated under reflux at 120 °C for 2 h. After cooling, the solution was acidified with 1N HCl and the resulting precipitate was filtered and washed with water to afford quantitatively the corresponding 3′-oxime selectively in a (2′<i>Z</i>,3′<i>E</i>) form. The residue was purified by silica gel column chromatography (chloroform:methanol = 20:1) to give <b>3</b>−<b>6</b> (7 mg, 66%).</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Nitro-5′-hydroxy-indirubin-3′-oxime (<b>3a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 300 MHz, δ ppm, <i>J</i> in Hz) 13.87 (1H, s, NOH), 11.78 (1H, s, N-H), 11.35 (1H, s, N′-H), 9.41 (1H, d, <i>J</i> = 2.8 Hz, H-4), 9.32 (1H, s, O-H), 8.05 (1H, dd, <i>J</i> = 11.6, 2.8 Hz, H-6), 7.76 (1H, d, <i>J</i> = 3.2 Hz, H-4′), 7.29 (1H, d, <i>J</i> = 11.6 Hz, H-7), 7.04 (1H, d, <i>J</i> = 11.2 Hz, H-7′), 6.86 (1H, dd, <i>J</i> = 11.2, 3.2 Hz, H-6′). HRMS (EI) [M]<sup>+•</sup> (C<sub>16</sub>H<sub>10</sub>N<sub>4</sub>O<sub>5</sub>): calcd 338.0651, found 338.0648.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Chloro-5′-hydroxy-indirubin-3′-oxime (<b>3b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.71 (1H, s, N-H), 10.78 (1H, s, N′-H), 9.27 (1H, s, O-H), 8.59 (1H, d, <i>J</i> = 2 Hz, H-4), 7.74 (1H, d, <i>J</i> = 2 Hz, H-4′), 7.24 (1H, d, <i>J</i> = 8.4 Hz, H-7), 7.11 (1H, dd, <i>J</i> = 8, 2 Hz, H-6′), 6.87 (1H, d, <i>J</i> = 8.4 Hz, H-6), 6.85 (1H, d, <i>J</i> = 8 Hz, H-7′). HRMS (EI) [M]<sup>+•</sup> (C<sub>16</sub>H<sub>10</sub>ClN<sub>3</sub>O<sub>3</sub>): calcd 327.0411, found 327.0408. Purity 92%.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Fluoro-5′-hydroxy-indirubin-3′-oxime (<b>3c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.69 (1H, s, N-H), 10.66 (1H, s, N′-H), 9.25 (1H, s, O-H), 8.42 (1H, dd, <i>J</i> = 11.4, 2.8 Hz, H-6), 7.73 (1H, d, <i>J</i> = 2.4 Hz, H-4′), 7.24 (1H, d, <i>J</i> = 8.4 Hz, H-6′), 6.81−6.99 (3H, m, H-7′, H-4, H-7). HRMS (EI) [M]<sup>+•</sup> (C<sub>16</sub>H<sub>10</sub>FN<sub>3</sub>O<sub>3</sub>): calcd 311.0706, found 311.0707. Purity 93%.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Trifluoromethoxy-5′-hydroxy-indirubin-3′-oxime (<b>3d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.70 (1H, s, N-H), 10.78 (1H, s, N′-H), 9.22 (1H, s, O-H), 8.50 (1H, s, H-4), 7.70 (1H, d, <i>J</i> = 2 Hz, H-4′), 7.21 (1H, d, <i>J</i> = 8.8 Hz, H-7′), 7.03 (1H, d, <i>J</i> = 8.4 Hz, H-7), 6.88 (1H, d, <i>J</i> = 8.4 Hz, H-6), 6.80 (1H, dd, <i>J</i> = 8.8, 2.4 Hz, H-6′). HRMS (ESI) [M − H]<sup>−</sup> (C<sub>17</sub>H<sub>9</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>): calcd 376.0545, found 376.0546.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Nitro-5′-chloro-indirubin-3′-oxime (<b>4a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.98 (1H, s, N-H), 11.39 (1H, s, N′-H), 9.45 (1H, s, H-4), 8.25 (1H, s, H-4′), 8.08 (1H, d, <i>J</i> = 7.6 Hz, H-6), 7.50 (2H, m, H-6′, H-7), 7.05 (1H, d, <i>J</i> = 8.4 Hz, H-7′). HRMS (ESI) [M − H]<sup>−</sup> (C<sub>16</sub>H<sub>8</sub>ClN<sub>4</sub>O<sub>4</sub>): calcd 355.0234, found 355.0242.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Chloro-5′-chloro-indirubin-3′-oxime (<b>4b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (acetone, 300 MHz, δ ppm, <i>J</i> in Hz) 13.05 (1H, s, NOH), 11.82 (1H, s, N-H), 9.81 (1H, s, N′-H), 8.67 (1H, s, H-4), 8.35 (1H, d, <i>J</i> = 1.8 Hz, H-4′), 7.45 (2H, m, H-6, H-7), 7.16 (1H, d, <i>J</i> = 8.4 Hz, H-6′), 6.97 (1H, d, <i>J</i> = 8.4 Hz, H-7′). HRMS (EI) [M]<sup>+•</sup> (C<sub>16</sub>H<sub>9</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>): calcd 345.0072, found 345.0075.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Fluoro-5′-chloro-indirubin-3′-oxime (<b>4c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (acetone, 300 MHz, δ ppm, <i>J</i> in Hz) 12.96 (1H, s, NOH), 11.78 (1H, s, N-H), 9.71 (1H, s, N′-H), 8.41 (1H, d, <i>J</i> = 11.4 Hz, H-7), 8.32 (1H, s, H-4), 7.40−7.50 (2H, m, H-4′, H-6′), 6.88−6.91 (2H, m, H-6, H-7′). HRMS (ESI) [M − H]<sup>−</sup> (C<sub>16</sub>H<sub>8</sub>ClFN<sub>3</sub>O<sub>2</sub>): calcd 328.0289, found 328.0291.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Trifluoromethoxy-5′-chloro-indirubin-3′-oxime (<b>4d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (acetone, 300 MHz, δ ppm, <i>J</i> in Hz) 13.02 (1H, s, NOH), 11.82 (1H, s, N-H), 9.88 (1H, s, N′-H), 8.63 (1H, s, H-4), 8.34 (1H, d, <i>J</i> = 2.1 Hz, H-4′), 7.47 (2H, m, H-6, H-7), 7.11 (1H, d, <i>J</i> = 8.4 Hz, H-6′), 7.03 (1H, d, <i>J</i> = 8.4 Hz, H-7′). HRMS (ESI) [M − H]<sup>−</sup> (C<sub>17</sub>H<sub>8</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub>): calcd 394.0206, found 394.0215.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Nitro-5′-fluoro-indirubin-3′-oxime (<b>5a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.89 (1H, s, N-H), 11.40 (1H, s, N′-H), 9.43 (1H, d, <i>J</i> = 2 Hz, H-4), 8.08 (1H, dd, <i>J</i> = 8.6, 2 Hz, H-6), 8.00 (1H, dd, <i>J</i> = 8.6, 2 Hz, H-7), 7.51 (1H, m, H-4′), 7.33 (1H, td, <i>J</i> = 9, 2.8 Hz, H-6′), 7.06 (1H, d, <i>J</i> = 8.4 Hz, H-7′). HRMS (EI) [M]<sup>+•</sup> (C<sub>16</sub>H<sub>9</sub>FN<sub>4</sub>O<sub>4</sub>): calcd 340.0608, found 340.0610.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Chloro-5′-fluoro-indirubin-3′-oxime (<b>5b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.81 (1H, s, N-H), 10.85 (1H, s, N′-H), 8.62 (1H, d, <i>J</i> = 2.4 Hz, H-4), 7.97 (1H, dd, <i>J</i> = 8.2, 2.4 Hz, H-6), 7.47 (1H, m, H-4′), 7.31 (1H, m, H-7), 7.15 (1H, dd, <i>J</i> = 8.4, 2 Hz, H-6′), 6.88 (1H, d, <i>J</i> = 8.4 Hz, H-7′). HRMS (ESI) [M − H]<sup>−</sup> (C<sub>16</sub>H<sub>8</sub>ClFN<sub>3</sub>O<sub>2</sub>): calcd 328.0289, found 328.0295.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Fluoro-5′-fluoro-indirubin-3′-oxime (<b>5c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.76 (1H, s, N-H), 10.68 (1H, s, N′-H), 8.41 (1H, dd, <i>J</i> = 11.2, 2.4 Hz, H-4), 7.93 (1H, dd, <i>J</i> = 8.8, 2.4 Hz, H-4′), 7.39 (1H, m, H-7), 7.30 (1H, td, <i>J</i> = 8.8, 2 Hz, H-6), 6.93 (1H, td, <i>J</i> = 9, 2.4 Hz, H-6′), 6.84 (1H, m, H-7′). HRMS (EI) [M]<sup>+•</sup> (C<sub>16</sub>H<sub>9</sub>F<sub>2</sub>N<sub>3</sub>O<sub>2</sub>): calcd 313.0663, found 313.0666. Purity 93%.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Trifluoromethoxy-5′-fluoro-indirubin-3′-oxime (<b>5d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 12.02 (1H, s, N-H), 10.72 (1H, s, N′-H), 8.59 (1H, s, H-4), 8.02 (1H, dd, <i>J</i> = 8.8, 2.4 Hz, H-6), 7.41 (1H, m, H-4′), 7.18 (1H, td, <i>J</i> = 9.2, 2 Hz, H-6), 7.00 (1H, d, <i>J</i> = 8.4 Hz, H-7), 6.9 (1H, d, <i>J</i> = 8.4 Hz, H-7′). HRMS (FAB) (C<sub>17</sub>H<sub>9</sub>O<sub>3</sub>N<sub>3</sub>F<sub>4</sub>): calcd 379.0579, found 379.0580.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Nitro-5′-methyl-indirubin-3′-oxime (<b>6a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.87 (1H, s, N-−H), 11.38 (1H, s, N′-H), 9.46 (1H, d, <i>J</i> = 2.4 Hz, H-4), 8.11 (1H,s, H-4′), 8.07 (1H, dd, <i>J</i> = 8, 2.4 Hz, H-6), 7.37 (1H, d, <i>J</i> = 8 Hz, H-7), 7.26 (1H, d, <i>J</i> = 8.8 Hz, H-6′), 7.05 (1H, d, <i>J</i> = 8.8 Hz, H-7′), 2.32 (3H, s, CH<sub>3</sub>). HRMS (ESI) [M − H]<sup>−</sup> (C<sub>17</sub>H<sub>11</sub>N<sub>4</sub>O<sub>4</sub>): calcd 335.0780, found 335.0787. Purity 93%.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Chloro-5′-methyl-indirubin-3′-oxime (<b>6b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.85 (1H, s, N-H), 10.76 (1H, s, N′-H), 8.64 (1H, s, H-4), 8.10 (1H,s, H-4′), 7.29 (1H, d, <i>J</i> = 8.4 Hz, H-6), 7.20 (1H, d, <i>J</i> = 8.4 Hz, H-7), 7.10 (1H, d, <i>J</i> = 8.2 Hz, H-6′), 6.86 (1H, d, <i>J</i> = 8.4 Hz, H-7′), 2.31 (3H, s, CH<sub>3</sub>). HRMS (EI) [M]<sup>+•</sup> (C<sub>17</sub>H<sub>12</sub>ClN<sub>3</sub>O<sub>2</sub>): calcd 325.0618, found 325.0623.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Fluoro-5′-methyl-indirubin-3′-oxime (<b>6c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.78 (1H, s, N-H), 10.61 (1H, s, N′-H), 8.43 (1H, dd, <i>J</i> = 11.2, 2.4 Hz, H-4), 8.06 (1H,s, H-4′), 7.26 (1H, d, <i>J</i> = 8.4 Hz, H-7), 7.17 (1H, d, <i>J</i> = 8 Hz, H-7′), 6.86 (1H, td, <i>J</i> = 8.4, 2.4 Hz, H-6), 6.80 (1H, d, <i>J</i> = 8 Hz, H-6′), 2.28 (3H, s, CH<sub>3</sub>). HRMS (EI) [M]<sup>+•</sup> (C<sub>17</sub>H<sub>12</sub>FN<sub>3</sub>O<sub>2</sub>): calcd 309.0914, found 309.0912.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Trifluoromethoxy-5′-methyl-indirubin-3′-oxime (<b>6d</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.80 (1H, s, N-H), 10.87 (1H, s, N′-H), 8.59 (1H, d, <i>J</i> = 2 Hz, H-4), 8.09 (1H,s, H-4′), 7.34 (1H, d, <i>J</i> = 8.4 Hz, H-6), 7.25 (1H, d, <i>J</i> = 8 Hz, H-7), 7.10 (1H, d, <i>J</i> = 7.4 Hz, H-6′), 6.94 (1H, d, <i>J</i> = 8.4 Hz, H-7′), 2.33 (3H, s, CH<sub>3</sub>). HRMS (EI) [M]<sup>+•</sup> (C<sub>18</sub>H<sub>12</sub>F<sub>3</sub>N<sub>3</sub>O<sub>3</sub>): calcd 375.0831, found 375.0833.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Procedure for the Preparation of 5-Substituted-5′-methoxy-indirubin-3′-oxime Derivatives <b>16a</b>−<b>c</b></h3><div class="NLM_p">To a solution of 5′-hydroxy-indirubin analogues, <b>11d</b> (10 mg, 0.028 mmol) in acetone (1 mL) were added dropwise methyl iodide (17 μL, 0.276 mmol) and K<sub>2</sub>CO<sub>3</sub> (19 mg, 0.138 mmol). The mixture was stirred for 4 h at room temperature. The dark precipitate was filtered and washed with cold water and dried under reduced pressure to give derivatives of 5-substituted-5′-methoxy-indirubin (6 mg, 60%), <b>15c</b>. The indirubin derivative (6 mg, 0.016 mmol) was dissolved in pyridine (0.3 mL), and hydroxylamine hydrochloride (3.4 mg, 0.048 mmol) was added. The reaction mixture was heated under reflux at 120 °C for 1 h. After cooling, the product was acidified with 1N HCl and the precipitate was filtered and washed with water to afford quantitatively the corresponding 3′-oxime selectively in a (2′<i>Z</i>,3′<i>E</i>) form. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 2:1) to give <b>16a</b>−<b>c</b> (4 mg, 65%).</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Nitro-5′-methoxy-indirubin-3′-oxime (<b>16a</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.82(1H, s, N-H), 9.46 (1H, d, <i>J</i> = 2.4 Hz, H-4), 9.33 (1H, s, N′-H), 8.12 (1H, dd, <i>J</i> = 8.4, 2.4 Hz, H-6), 7.77 (1H, d, <i>J</i> = 2.4 Hz, H-4′), 7.30 (1H, d, <i>J</i> = 8.4 Hz, H-7), 7.24 (1H, d, <i>J</i> = 9.2 Hz, H-7′), 6.85 (1H, dd, <i>J</i> = 7.8, 2.4 Hz, H-6′), 3.39 (3H, s, OCH<sub>3</sub>). HRMS (ESI) [M − H]<sup>−</sup> (C<sub>17</sub>H<sub>11</sub>N<sub>4</sub>O<sub>5</sub>): calcd 351.0729, found 351.0724. Purity 94%.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Fluoro-5′-methoxy-indirubin-3′-oxime (<b>16b</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO, 400 MHz, δ ppm, <i>J</i> in Hz) 11.68 (1H, s, N-H), 9.22 (1H, s, N′-H), 8.44 (1H, m, H-4), 7.70 (1H, d, <i>J</i> = 2.4 Hz, H-4′), 7.21 (1H, d, <i>J</i> = 8.8 Hz, H-6), 6.96 (2H, m, H-7, H-7′), 6.79 (1H, dd, <i>J</i> = 8.6, 2.4 Hz, H-6′), 3.26 (3H, s, OCH<sub>3</sub>). HRMS (EI) [M]<sup>+•</sup> (C<sub>17</sub>H<sub>12</sub>FN<sub>3</sub>O<sub>3</sub>): calcd 325.0863, found 325.0859.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Data for (2′<i>Z</i>,3′<i>E</i>)-5-Trifluoromethoxy-5′-methoxy-indirubin-3′-oxime (<b>16c</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (acetone, 400 MHz, δ ppm, <i>J</i> in Hz) 11.70 (1H, s, N-H), 8.62 (1H, s, H-4), 8.28 (1H, s, N′-H), 7.90 (1H, d, <i>J</i> = 2.4 Hz, H-4′), 7.24 (1H, d, <i>J</i> = 8.4 Hz, H-6), 7.12 (1H, m, H-7′), 7.04 (1H, d, <i>J</i> = 8.4 Hz, H-7), 6.99 (1H, dd, <i>J</i> = 8.4, 2.4 Hz, H-6′), 3.33 (3H, s, OCH<sub>3</sub>). HRMS (EI) [M]<sup>+•</sup> (C<sub>18</sub>H<sub>12</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub>): calcd 391.0780, found 391.0782.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Molecular Docking</h3><div class="NLM_p last">Molecular docking was performed using CDOCKER, a CHARMm-based molecular dynamics docking algorithm on Discovery Studio 2.0 (Accelrys). The CDK2 structure cocrystallized with 5-bromo-indirubin was obtained from the PDB data bank (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHE">2BHE</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A protein clean process and a CHARMm-force field were sequentially applied. The area around 5-bromo-indirubin was chosen as the active site, with a radius set as 8 Å. After removing the ligand from the structure of the complex, a binding sphere in the three axis directions was constructed around the active site. All default parameters were used in the docking process. CHARMm-based molecular dynamics (1000 steps) were used to generate random ligand <b>3a</b> conformations, and the position of any ligand <b>3a</b> was optimized in the binding site using rigid body rotation followed by simulated annealing at 700 K. Final energy minimization was set as the full potential mode. The final binding conformation of <b>3a</b> was determined on the basis of energy. Docking study of ligand <b>2</b> was carried out as described above. The most stable binding mode among the top 10 of docking poses of each compound was presented in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. The other binding modes of compounds <b>2</b>, <b>3a</b> were not identified because of their similar docking poses, and the differences of calculated CDOCKER interaction energy were in the range of 4 kcal/mol.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Biological Methods</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Enzyme Assay</h4><div class="NLM_p">CDK1/cyclin B, CDK2/cyclin E activities were assayed by using radiometric filter binding format.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> CDK1/cyclin B was purchased from Millipore (Billerica, MA). In final reaction volume of 25 μL, CDK1/cyclin B was incubated in buffer (8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM Mg acetate), with 0.1 mg/mL histone H1 and 45 μM [γ-<sup>33</sup>P] ATP (500 cpm/pmol). The reaction was initiated by the addition of the MgATP mix. After incubation for 40 min at 30 °C, the reaction was stopped by the addition of 5 μL of 3% phosphoric acid solution. Ten μL aliquots of supernatant were spotted onto 2.5 cm ×3 cm pieces of Whatman P30 phosphocellulose paper, and 20 s later, the filters were washed three times for 5 min in 75 mM phosphoric acid and once in methanol prior to drying. The wet filters were counted in the presence of 1 mL of ACS (Amersham) scintillation fluid.</div><div class="NLM_p">CDK2/cyclin E was purchased from Millipore (Billerica, MA). The kinase activity was tested in buffer (8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM Mg acetate), with 0.1 mg/mL histone H1, in the presence of 120 μM [γ-<sup>33</sup>P] ATP (500 cpm/pmol) in a final reaction volume of 25 μL. The reaction was initiated by the addition of the MgATP mix. After incubation for 40 min at 30 °C, the reaction was stopped by the addition of 5 μL of 3% phosphoric acid solution. Ten μL aliquots of supernatant were processed as described above.</div><div class="NLM_p">Inhibition of kinase activity against a variety of recombinant kinases (c-Met, Met M1250T, Ron, VEGFR2, EGFR, TrkA, PI3Kγ, IKKβ, Insulin receptor, Aurora A) was determined by measuring the phosphorylation of substrate peptide or lipid in homogeneous time-resolved fluorescence (HTRF) assays.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The inhibition of tyrosine kinases, c-Met, Met M1250T, Ron, VEGF2, EGFR, TrkA, and insulin receptor was determined by measuring the phosphorylation of poly-Glu-Tyr-biotin (pGT-biotin, Cisbio) peptide, HTRF KinEASE kit. Recombinant proteins containing kinase domain were purchased from Millipore (Billerica, MA). Into a black 384-well Costar plate was added 2 μL/well of serially diluted compound with kinase buffer (250 mM HEPES (pH 7.0), 0.5 mM orthovanadate, 0.05% BSA, 0.1% NaN<sub>3</sub>). Next, 2 μL of TK peptide substrate and 1 μL of kinase (10 ng) were added to each well. After 15 min preincubation, the kinase reaction was initiated by the addition of 5 μL of ATP (2× the required final concentration) in reaction buffer, after which the plate was incubated at room temperature for 30 min. The reaction was stopped by the addition of 5 μL of TK-antibody-Eu(K) (Eu-labeled antiphosphotyrosine antibody, Cisbio) in HTRF detection buffer (50 mM HEPES (pH 7.0), 0.05% BSA, 0.1% NaN<sub>3</sub>, and 100 mM EDTA) and 5 μL of streptavidin-XL-665 in HTRF detection buffer. After additional 1 h incubation at room temperature, the plate was read in an EnVision multilabel reader (Perkin-Elmer, Waltham, MA).</div><div class="NLM_p">Recombinant proteins for IKKβ and Aurora A were purchased from Millipore (Billerica, MA). Assay was processed as described above, except for using the STK substrate-biotin-2 peptide (Aurora A), STK substrate-biotin-3 peptide (IKKβ).</div><div class="NLM_p">The followings are ATP and supplement concentration for each enzyme: VEGFR2 (15 μM ATP, 5 mM MgCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, and 1 mM DTT), c-MET and MET M1250T (10 μM ATP, 5 mM MgCl<sub>2</sub>, and 1 mM DTT), Ron (5 μM ATP, 5 mM MgCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, and 1 mM DTT), TrkA (1 μM ATP, 5 mM MgCl<sub>2</sub>, and 1 mM DTT), insulin receptor (20 μM ATP, 5 mM MgCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, and 1 mM DTT), IKKβ (2 μM ATP, 2 mM MnCl<sub>2</sub>, and 1 mM DTT), Aurora A (100 μM ATP, 5 mM MnCl<sub>2</sub>, and 1 mM DTT), and EGFR (2 μM ATP, 5 mM MgCl<sub>2</sub>, 1 mM MnCl<sub>2</sub>, and 1 mM DTT).</div><div class="NLM_p last">Inhibition of PI3Kγ activity was measured by commercial kit from upstate (PI3-kinase (human) HTRF assay, catalogue no. 33-016). PI3K catalyzes the phosphorylation of phosphoinositol 4,5-biphosphate (PIP2) to phosphoinositol 3,4,5-triphosphate (PIP3). The PIP3 product formed by PI3K activity displaces biotin-PIP3 resulting in a loss of energy transfer and thus a decrease in signal. Kinase reaction was performed exactly as described in the manufacturer’s instruction.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Cell Proliferation Assay</h4><div class="NLM_p last">Cells (A549, HT1080, HCT116, K562, SNU638, KB, MCF-7) were counted, diluted to 5 × 10<sup>4</sup> cells/mL with fresh medium (MEME, DMEM, or RPMI containing 10% FBS), and added 190 μL of cell suspension to 96-well plates containing various concentrations of test compounds (10 μL in 10% aq DMSO).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Test plates were incubated for 3 days at 37 °C in CO<sub>2</sub> incubator. For zero day controls, cells were incubated for 30 min at 37 °C in CO<sub>2</sub> incubator. All treatments were performed in triplicate. After the incubation periods, cells were fixed with 50 μL of cold 50% TCA at 4 °C for 30 min, washed 5 times with tap water, and air-dried. The fixed cells were stained with 0.4% SRB solution in 1% aqueous acetic acid at room temperature for 1 h. Free SRB solution was then removed by rinsing 5 times with 1% acetic acid, and air-dried. The bound dye was dissolved with 200 μL of 10 mM Tris-base (pH 10.0), and absorbance was determined at 515 nm using an ELISA microplate reader. Finally, the absorbance values obtained with each of the treatment procedures were averaged, and the average values obtained with the zero day control were subtracted. These results were expressed as a percentage, relative to solvent treated control incubations, and IC<sub>50</sub> values were calculated using nonlinear regression analysis (percent survival versus concentration).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Animal Tumor Model</h4><div class="NLM_p last">The k-ras-transformed rat kidney epithelial cell line (RK3E-ras) were maintained in DMEM supplemented with 10% FCS, 100 units/mL penicillin, and 100 Ag/mL streptomycin. RK3E-ras cells were kindly provided by Dr. Eric Fearon (University of Michigan Medical School, Ann Arbor, MI) and have been described in the previous report.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Male SD rats (6 weeks of age) were used to examine the inhibition of tumor growth in vivo. RK3E-ras-Luc cells (5 × 10<sup>6</sup>) were implanted subcutaneously into the flank of the rats on day 0, and rats were grouped randomly (5 mice/group) on day 5 as previously described.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A solution of <b>3a</b> in a mixture of PEG400, EtOH, and DW (30:33:37, 3 mg/mL, 5 mg/kg) were delivered intravenously in a nonanesthesia state every other day for a total of five times. The animals were sacrificed 48 h after the final administration, and rat weights and tumor volumes were measured. The tumor growth volumes were calculated as follows: <i>V</i> = (<i>ab</i><sup>2</sup>)/2, where, <i>a</i> is the longest diameter and <i>b</i> is the shortest diameter of the tumor.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> All experiments were conducted under protocols approved by the Animal Care and Use Committee at Chosun University School of Dentistry (Gwangju, South Korea).</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Bioluminescence Imaging Assay</h4><div class="NLM_p last">For bioluminescence imaging, the rats received an ip injection of luciferin (Molecular Probes, Palo Alto, CA) with Rompun/ketamine (1:1) anesthesia. The rats were imaged using a LAS-1000 plus imaging System (Fuji film. Tokyo, Japan) to record the bioluminescent signal emitted from the tumor. The LAS-1000 system equipped with a CCD camera was used for acquisition of the emitted light, and Living Image software (Multi Gauge v3.0) was used for data analysis.</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Histology, Immunohistochemistry, and TUNEL Assay</h4><div class="NLM_p last">The excised solid tumors were fixed in 10% buffered formalin and embedded in paraffin. For optical microscopic examinations, 4 μm sectioned tissues were stained with H&E. Immunohistochemical staining was performed with the avidin−biotin complex method using anti-PCNA antibodies. The immune reactions were visualized with 3,3′-diaminobenzidine and counterstained with Mayer’s hematoxylin. A TUNEL assay was performed using an ApopTag Plus peroxidase in situ apoptosis detection kit (Intergen, Purchase, NY) according to the manufacturer’s instructions. Briefly, the slides were deparaffinized and treated with 20 μg/mL proteinase K at 37 °C for 15 min to enhance staining. After immersion in 3% hydrogen peroxide to block the endogenous peroxidase, the slides were incubated with a reaction buffer containing terminal deoxynucleotidyl transferase at 37 °C for 1 h. The slides were then incubated with a peroxidase-conjugated antidigoxigenin antibody for 30 min, and the reaction products were visualized with a 0.03% 3,3′-diaminobenzidine solution containing 2 mM hydrogen peroxide. The slides were counterstained with 0.5% methyl green. The PCNA and TUNEL-positive cells were counted and represented as the average of the five highest areas within a single ×200 field.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/jm100080z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">IC<sub>50</sub> values of antiproliferative activity including mean ± SD, FACS analysis data of <b>3a</b>, analytical data of HPLC analysis of final compounds for purity, solubility data of compound <b>1</b>, <b>2</b>, <b>3a</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100080z/suppl_file/jm100080z_si_001.pdf">jm100080z_si_001.pdf (1.84 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100080z" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong-Chul Kim</span> - <span class="hlFld-Affiliation affiliation">Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Drug Discovery, Anygen Co., Ltd., Gwangju 500-712, Republic of Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#126b7d7c75717a677e52757b61663c73713c7960"><span class="__cf_email__" data-cfemail="790016171e1a110c15391e100a0d57181a57120b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Soo-Jeong Choi</span> - <span class="hlFld-Affiliation affiliation">Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jung-Eun Lee</span> - <span class="hlFld-Affiliation affiliation">Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Soon-Young Jeong</span> - <span class="hlFld-Affiliation affiliation">Division of Drug Discovery, Anygen Co., Ltd., Gwangju 500-712, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isak Im</span> - <span class="hlFld-Affiliation affiliation">Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">So-Deok Lee</span> - <span class="hlFld-Affiliation affiliation">Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eun-Jin Lee</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Ewha Womans University, Seoul 120-759, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sang Kook Lee</span> - <span class="hlFld-Affiliation affiliation">College of Pharmacy, Ewha Womans University, Seoul 120-759, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seong-Min Kwon</span> - <span class="hlFld-Affiliation affiliation">Department of Pathology, School of Dentistry, Chosun University, Gwangju 501-759, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sang-Gun Ahn</span> - <span class="hlFld-Affiliation affiliation">Department of Pathology, School of Dentistry, Chosun University, Gwangju 501-759, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jung-Hoon Yoon</span> - <span class="hlFld-Affiliation affiliation">Department of Pathology, School of Dentistry, Chosun University, Gwangju 501-759, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sun-Young Han</span> - <span class="hlFld-Affiliation affiliation">Pharmacology Research Center, Korea Research Institute of Chemical Technology, Daejon 305-600, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jae-Il Kim</span> - <span class="hlFld-Affiliation affiliation">Department of Life Science, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Drug Discovery, Anygen Co., Ltd., Gwangju 500-712, Republic of Korea</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0720430) and by a grant from the Institute of Medical System Engineering (iMSE) in the GIST, Korea. The work performed by S.-M. Kwon, S.-G. Ahn, and J.-H. Yoon was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST) (no. R13-2008-010-01001-0).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2511</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0001030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2511-2526&author=J.+W.+Harperauthor=P.+D.+Adams&title=Cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcr0001030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0001030%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DCyclin-dependent%2520kinases%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D2511%26epage%3D2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morgan, D. O.</span><span> </span><span class="NLM_article-title">Principles of CDK regulation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1038%2F374131a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=7877684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK2MXkt1yju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=131-134&author=D.+O.+Morgan&title=Principles+of+CDK+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of CDK regulation</span></div><div class="casAuthors">Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">6518</span>),
    <span class="NLM_cas:pages">131-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 77 refs.  As key regulators of the cell cycle, the cyclin-dependent kinases (CDKs) must be tightly regulated by extra- and intracellular signals.  The activity of cyclin-dependent kinases is controlled by four highly conserved biochem. mechanisms, forming a web of regulatory pathways unmatched in its elegance and intricacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrQWC7U9kpj7Vg90H21EOLACvtfcHk0lh0QVHPfx2s9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkt1yju7s%253D&md5=3dafa23aec02e4887757b100abb52d89</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F374131a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F374131a0%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DPrinciples%2520of%2520CDK%2520regulation%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D131%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Dyson, N.</span><span> </span><span class="NLM_article-title">The regulation of E2F by pRB-family proteins</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2245</span><span class="NLM_x">–</span> <span class="NLM_lpage">2262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1101%2Fgad.12.15.2245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=9694791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2245-2262&author=N.+Dyson&title=The+regulation+of+E2F+by+pRB-family+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of E2F by pRB-family proteins</span></div><div class="casAuthors">Dyson, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2245-2262</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics include: Introduction to the families of E2F and DP proteins (free E2F, complexed E2F), E2F-binding sites mediate both transcriptional activation and repression (E2F as a transcriptional activator, E2F-mediated repression), Activation of E2F-dependent transcription (phosphorylation of pRB-family members, phosphorylation of E2F-1, changes in the subcellular localization of specific E2F complexes, synthesis of new E2Fs), Inactivation of E2F (E2F/DP phosphorylation, degrdn. of free E2F, E2F-repressors), Consequences of elevated E2F activity-ectopic S-phase entry and apoptosis, Is E2F required for S-phase entry, What are the key targets of E2F activity, What is the role of pRB in E2F regulation, Is the ability of pRB to bind E2F important for pRB's role as a tumor suppressor, and How can E2F-1 be both an oncogene and a tumor suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeXAl9aLvm5bVg90H21EOLACvtfcHk0lgwjxr9nvnFGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D&md5=755af21d258487f59a09899698e860e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.15.2245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.15.2245%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DN.%26atitle%3DThe%2520regulation%2520of%2520E2F%2520by%2520pRB-family%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2245%26epage%3D2262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The retinoblastoma protein and cell cycle control</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2F0092-8674%2895%2990385-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=7736585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFSrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=323-330&author=R.+A.+Weinberg&title=The+retinoblastoma+protein+and+cell+cycle+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The retinoblastoma protein and cell cycle control</span></div><div class="casAuthors">Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-30</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 84 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCbQVri28wrVg90H21EOLACvtfcHk0lgwjxr9nvnFGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFSrs7k%253D&md5=e91678411f19f45ab0cd434d7112a16a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990385-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990385-2%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520retinoblastoma%2520protein%2520and%2520cell%2520cycle%2520control%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D323%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chen, Y. N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaelin, W. G.,  Jr.</span><span> </span><span class="NLM_article-title">Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4325</span><span class="NLM_x">–</span> <span class="NLM_lpage">4329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4325-4329&author=Y.+N.+P.+Chenauthor=S.+K.+Sharmaauthor=T.+M.+Ramseyauthor=L.+Jiangauthor=M.+S.+Martinauthor=K.+Bakerauthor=P.+D.+Adamsauthor=K.+W.+Bairauthor=W.+G.+Kaelin&title=Selective+killing+of+transformed+cells+by+cyclin%2Fcyclin-dependent+kinase+2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BN.%2BP.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DRamsey%26aufirst%3DT.%2BM.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DM.%2BS.%26aulast%3DBaker%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DSelective%2520killing%2520of%2520transformed%2520cells%2520by%2520cyclin%252Fcyclin-dependent%2520kinase%25202%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4325%26epage%3D4329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span> </span><span class="NLM_article-title">Anticancer drug targets: cell cycle and checkpoint control</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1645</span><span class="NLM_x">–</span> <span class="NLM_lpage">1653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1999&pages=1645-1653&author=G.+I.+Shapiroauthor=J.+W.+Harper&title=Anticancer+drug+targets%3A+cell+cycle+and+checkpoint+control"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26atitle%3DAnticancer%2520drug%2520targets%253A%2520cell%2520cycle%2520and%2520checkpoint%2520control%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1999%26volume%3D104%26spage%3D1645%26epage%3D1653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Van Den Heuvel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlow, E.</span><span> </span><span class="NLM_article-title">Distinct roles for cyclin-dependent kinases in cell cycle control</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">2050</span><span class="NLM_x">–</span> <span class="NLM_lpage">2054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1993&pages=2050-2054&author=S.+Van+Den+Heuvelauthor=E.+Harlow&title=Distinct+roles+for+cyclin-dependent+kinases+in+cell+cycle+control"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDen%2BHeuvel%26aufirst%3DS.%26aulast%3DHarlow%26aufirst%3DE.%26atitle%3DDistinct%2520roles%2520for%2520cyclin-dependent%2520kinases%2520in%2520cell%2520cycle%2520control%26jtitle%3DScience%26date%3D1993%26volume%3D262%26spage%3D2050%26epage%3D2054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Loyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembley, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kidd, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahti, J. M.</span><span> </span><span class="NLM_article-title">Role of CDK/cyclin complexes in transcription and RNA splicing</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2Fj.cellsig.2005.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=15935619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=1033-1051&author=P.+Loyerauthor=J.+H.+Trembleyauthor=R.+Katonaauthor=V.+J.+Kiddauthor=J.+M.+Lahti&title=Role+of+CDK%2Fcyclin+complexes+in+transcription+and+RNA+splicing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CDK/cyclin complexes in transcription and RNA splicing</span></div><div class="casAuthors">Loyer, Pascal; Trembley, Janeen H.; Katona, Robert; Kidd, Vincent J.; Lahti, Jill M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1033-1051</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The prodn. of mRNAs in all living organisms is an extremely complex process that includes multiple catalytic activities such as transcription, capping, splicing, polyadenylation, cleavage and export.  All of these processes are controlled by a large group of proteins which form very dynamic complexes interacting with DNA and pre-mRNAs to coordinate these activities.  Phosphorylations play a central role in regulating formation, activation and inactivation of these complexes.  A growing no. of protein kinases have been identified that are capable of phosphorylating proteins involved in mRNA prodn.  Among them, Cyclin-dependent Kinases (CDKs) represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.  CDK/cyclin complexes were first identified as crucial regulators of cell cycle progression.  More recently, CDK/cyclin complexes have also been implicated in transcription and mRNA processing leading to the concept of an intricate network of CDK/cyclin complexes regulating cell cycle, transcription and mRNA processing via cross-talk between multiple CDKs.  In this review, we discuss the role of CDK/cyclin-dependent phosphorylation in the regulation of transcription and RNA splicing and highlight recent findings that indicate the involvement of CDK/cyclin complexes in connecting transcription and RNA splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQcV5te0YC-bVg90H21EOLACvtfcHk0lgwjxr9nvnFGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWktrc%253D&md5=67633beca40a4ba0f9739dedaadd0bf6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLoyer%26aufirst%3DP.%26aulast%3DTrembley%26aufirst%3DJ.%2BH.%26aulast%3DKatona%26aufirst%3DR.%26aulast%3DKidd%26aufirst%3DV.%2BJ.%26aulast%3DLahti%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520CDK%252Fcyclin%2520complexes%2520in%2520transcription%2520and%2520RNA%2520splicing%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D1033%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbie, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory Matera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlow, E.</span><span> </span><span class="NLM_article-title">NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2283</span><span class="NLM_x">–</span> <span class="NLM_lpage">2297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1101%2Fgad.827700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=10995386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVSksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=2283-2297&author=J.+Zhaoauthor=B.+K.+Kennedyauthor=B.+D.+Lawrenceauthor=D.+A.+Barbieauthor=A.+Gregory+Materaauthor=J.+A.+Fletcherauthor=E.+Harlow&title=NPAT+links+cyclin+E-Cdk2+to+the+regulation+of+replication-dependent+histone+gene+transcription"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription</span></div><div class="casAuthors">Zhao, Jiyong; Kennedy, Brian K.; Lawrence, Brandon D.; Barbie, David A.; Matera, A. Gregory; Fletcher, Jonathan A.; Harlow, Ed</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2283-2297</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In eukaryotic cells, histone gene expression is one of the major events that mark entry into S phase.  While this process is tightly linked to cell cycle position, how it is regulated by the cell cycle machinery is not known.  Here we show that NPAT, a substrate of the cyclin E-Cdk2 complex, is assocd. with human replication-dependent histone gene clusters on both chromosomes 1 and 6 in S phase.  We demonstrate that NPAT activates histone gene transcription and that this activation is dependent on the promoter elements (SSCSs) previously proposed to mediate cell cycle-dependent transcription.  Cyclin E is also assocd. with the histone gene loci, and cyclin E-Cdk2 stimulates the NPAT-mediated activation of histone gene transcription.  Thus, our results both show that NPAT is involved in a key S phase event and provide a link between the cell cycle machinery and activation of histone gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbuObWDETobVg90H21EOLACvtfcHk0lhHN0821tIaLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVSksrw%253D&md5=9fb6bc6ddaf471cfff4ef61a7409e175</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fgad.827700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.827700%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DB.%2BK.%26aulast%3DLawrence%26aufirst%3DB.%2BD.%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26aulast%3DGregory%2BMatera%26aufirst%3DA.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DHarlow%26aufirst%3DE.%26atitle%3DNPAT%2520links%2520cyclin%2520E-Cdk2%2520to%2520the%2520regulation%2520of%2520replication-dependent%2520histone%2520gene%2520transcription%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D2283%26epage%3D2297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">To cycle or not to cycle: a critical decision in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1038%2F35106065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=11902577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=222-231&author=M.+Malumbresauthor=M.+Barbacid&title=To+cycle+or+not+to+cycle%3A+a+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Milestones in cell division: to cycle or not to cycle: a critical decision in cancer</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells undergo uncontrolled proliferation, yet tumors most often originate from adult tissues, in which most cells are quiescent.  So, the proliferative advantage of tumor cells arises from their ability to bypass quiescence.  This can be due to increased mitogenic signaling and/or alterations that lower the threshold required for cell-cycle commitment.  Understanding the mol. mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2EOLFB2ULbVg90H21EOLACvtfcHk0lhHN0821tIaLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D&md5=2bd8961854332a30c814f8ac2f9bd6f4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F35106065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106065%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%2520a%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Porter, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heagerty, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firpo, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daling, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">Expression of cell-cycle regulators p27 (Kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1038%2Fnm0297-222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=9018243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK2sXpsFSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=222-225&author=P.+L.+Porterauthor=K.+E.+Maloneauthor=P.+J.+Heagertyauthor=G.+M.+Alexanderauthor=L.+A.+Gattiauthor=E.+J.+Firpoauthor=J.+R.+Dalingauthor=J.+M.+Roberts&title=Expression+of+cell-cycle+regulators+p27+%28Kip1%29+and+cyclin+E%2C+alone+and+in+combination%2C+correlate+with+survival+in+young+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients</span></div><div class="casAuthors">Porter, Peggy L.; Malone, Kathleen E.; Heagerty, Patrick J.; Alexander, Gail M.; Gatti, Laura A.; Firpo, Eduardo J.; Daling, Janet R.; Roberts, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-225</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Mutations in certain genes that regulate the cell cycle, such as p16 and p53, are frequently found in human cancers.  However, tumor-specific mutations are uncommon in genes encoding cyclin E and the CDK inhibitor p27Kip1, two cell-cycle regulators that are also thought to contribute to tumor progression.  It is now known that levels of both cyclin E and p27 can be controlled by posttranscriptional mechanisms, indicating that expression of these proteins can be altered by means other than simply mutation of their resp. genes.  Thus, changes in p27 and cyclin E protein levels in tumors might be more common than previously anticipated and may be indicators of tumor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruaF7He4NtFbVg90H21EOLACvtfcHk0lhHN0821tIaLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXpsFSlsA%253D%253D&md5=d44e207626ba809dca0002d206e5df4f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm0297-222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0297-222%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DP.%2BL.%26aulast%3DMalone%26aufirst%3DK.%2BE.%26aulast%3DHeagerty%26aufirst%3DP.%2BJ.%26aulast%3DAlexander%26aufirst%3DG.%2BM.%26aulast%3DGatti%26aufirst%3DL.%2BA.%26aulast%3DFirpo%26aufirst%3DE.%2BJ.%26aulast%3DDaling%26aufirst%3DJ.%2BR.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520of%2520cell-cycle%2520regulators%2520p27%2520%2528Kip1%2529%2520and%2520cyclin%2520E%252C%2520alone%2520and%2520in%2520combination%252C%2520correlate%2520with%2520survival%2520in%2520young%2520breast%2520cancer%2520patients%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D222%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Schraml, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kononen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihatsch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirnhofer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, G.</span><span> </span><span class="NLM_article-title">Cyclin E overexpression and amplification in human tumours</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">200</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1002%2Fpath.1356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=12845634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvF2nsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2003&pages=375-382&author=P.+Schramlauthor=C.+Bucherauthor=H.+Bissigauthor=A.+Nocitoauthor=P.+Haasauthor=K.+Wilberauthor=S.+Seeligauthor=J.+Kononenauthor=M.+J.+Mihatschauthor=S.+Dirnhoferauthor=G.+Sauter&title=Cyclin+E+overexpression+and+amplification+in+human+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin E overexpression and amplification in human tumours</span></div><div class="casAuthors">Schraml, Peter; Bucher, Christoph; Bissig, Heidi; Nocito, Antonio; Haas, Philippe; Wilber, Kim; Seelig, Steven; Kononen, Juha; Mihatsch, Michael J.; Dimhofer, Stefan; Sauter, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-382</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Cyclin E amplification and overexpression have recently been described in several tumor types.  However, many tumor entities have never been examd. for cyclin E alterations.  Numerous and time-consuming expts. were previously required to det. the significance of potential oncogenes across different tumor types.  To overcome this problem, tissue microarrays (TMAs) consisting of 3670 primary tumors from 128 different tumor types, 709 metastases, and 354 normal tissues were generated.  Cyclin E alterations were then analyzed by fluorescence in situ hybridization (FISH) and immunohistochem. (IHC).  Cyclin E gene amplification was obsd. in 15 different tumor types and subtypes, ie rhabdomyosarcoma, urinary bladder cancer (three subtypes), ovarian cancer (two subtypes), malignant fibrous histiocytoma, adenocarcinoma of the small intestine, medullary breast cancer, gall bladder adenocarcinoma, phaeochromocytoma, gastric adenocarcinoma, squamous cell carcinoma of the uterine cervix, colonic adenocarcinoma, and endometrial carcinoma.  Cyclin E protein accumulation was found in 48 different tumor types.  The use of TMA technol. has enabled us to expand considerably our knowledge of cyclin E alterations in human tumors.  The occurrence of amplification and overexpression in many different tumor types suggests that cyclin E plays an important role in tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqAhzjv-uQbVg90H21EOLACvtfcHk0lhHN0821tIaLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvF2nsrk%253D&md5=0476c7815a908fff3e508bf16aeca91b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fpath.1356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1356%26sid%3Dliteratum%253Aachs%26aulast%3DSchraml%26aufirst%3DP.%26aulast%3DBucher%26aufirst%3DC.%26aulast%3DBissig%26aufirst%3DH.%26aulast%3DNocito%26aufirst%3DA.%26aulast%3DHaas%26aufirst%3DP.%26aulast%3DWilber%26aufirst%3DK.%26aulast%3DSeelig%26aufirst%3DS.%26aulast%3DKononen%26aufirst%3DJ.%26aulast%3DMihatsch%26aufirst%3DM.%2BJ.%26aulast%3DDirnhofer%26aufirst%3DS.%26aulast%3DSauter%26aufirst%3DG.%26atitle%3DCyclin%2520E%2520overexpression%2520and%2520amplification%2520in%2520human%2520tumours%26jtitle%3DJ.%2520Pathol.%26date%3D2003%26volume%3D200%26spage%3D375%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Soria, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Se Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waun, Ki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span> </span><span class="NLM_article-title">Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4000-4004&author=J.+C.+Soriaauthor=J.+Se+Jinauthor=F.+R.+Khuriauthor=K.+Hassanauthor=D.+Liuauthor=Ki%2C+H.+Waunauthor=L.+Mao&title=Overexpression+of+cyclin+B1+in+early-stage+non-small+cell+lung+cancer+and+its+clinical+implication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26aulast%3DSe%2BJin%26aufirst%3DJ.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DHassan%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWaun%26aufirst%3DKi%252C%2BH.%26aulast%3DMao%26aufirst%3DL.%26atitle%3DOverexpression%2520of%2520cyclin%2520B1%2520in%2520early-stage%2520non-small%2520cell%2520lung%2520cancer%2520and%2520its%2520clinical%2520implication%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4000%26epage%3D4004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Takeno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span> </span><span class="NLM_article-title">Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2874</span><span class="NLM_x">–</span> <span class="NLM_lpage">2881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=2874-2881&author=S.+Takenoauthor=T.+Noguchiauthor=R.+Kikuchiauthor=Y.+Uchidaauthor=S.+Yokoyamaauthor=W.+Muller&title=Prognostic+value+of+cyclin+B1+in+patients+with+esophageal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeno%26aufirst%3DS.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3DUchida%26aufirst%3DY.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DW.%26atitle%3DPrognostic%2520value%2520of%2520cyclin%2520B1%2520in%2520patients%2520with%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%26date%3D2002%26volume%3D94%26spage%3D2874%26epage%3D2881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of cancer cells despite CDK2 inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widlund, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horstmann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. E.</span><span> </span><span class="NLM_article-title">Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=565-576&author=J.+Duauthor=H.+R.+Widlundauthor=M.+A.+Horstmannauthor=S.+Ramaswamyauthor=K.+Rossauthor=W.+E.+Huberauthor=E.+K.+Nishimuraauthor=T.+R.+Golubauthor=D.+E.+Fisher&title=Critical+role+of+CDK2+for+melanoma+growth+linked+to+its+melanocyte-specific+transcriptional+regulation+by+MITF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DWidlund%26aufirst%3DH.%2BR.%26aulast%3DHorstmann%26aufirst%3DM.%2BA.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DW.%2BE.%26aulast%3DNishimura%26aufirst%3DE.%2BK.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26atitle%3DCritical%2520role%2520of%2520CDK2%2520for%2520melanoma%2520growth%2520linked%2520to%2520its%2520melanocyte-specific%2520transcriptional%2520regulation%2520by%2520MITF%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D565%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hanse, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelsen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anttila, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crary, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. H.</span><span> </span><span class="NLM_article-title">Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2802</span><span class="NLM_x">–</span> <span class="NLM_lpage">2809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2802-2809&author=E.+A.+Hanseauthor=C.+J.+Nelsenauthor=M.+M.+Gogginauthor=C.+K.+Anttilaauthor=L.+K.+Mullanyauthor=C.+Berthetauthor=P.+Kaldisauthor=G.+S.+Craryauthor=R.+Kuriyamaauthor=J.+H.+Albrecht&title=Cdk2+plays+a+critical+role+in+hepatocyte+cell+cycle+progression+and+survival+in+the+setting+of+cyclin+D1+expression+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanse%26aufirst%3DE.%2BA.%26aulast%3DNelsen%26aufirst%3DC.%2BJ.%26aulast%3DGoggin%26aufirst%3DM.%2BM.%26aulast%3DAnttila%26aufirst%3DC.%2BK.%26aulast%3DMullany%26aufirst%3DL.%2BK.%26aulast%3DBerthet%26aufirst%3DC.%26aulast%3DKaldis%26aufirst%3DP.%26aulast%3DCrary%26aufirst%3DG.%2BS.%26aulast%3DKuriyama%26aufirst%3DR.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BH.%26atitle%3DCdk2%2520plays%2520a%2520critical%2520role%2520in%2520hepatocyte%2520cell%2520cycle%2520progression%2520and%2520survival%2520in%2520the%2520setting%2520of%2520cyclin%2520D1%2520expression%2520in%2520vivo%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D2802%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">9270</span><span class="NLM_x">–</span> <span class="NLM_lpage">9280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9270-9280&author=D.+Caiauthor=V.+M.+Lathamauthor=X.+Zhangauthor=G.+I.+Shapiro&title=Combined+depletion+of+cell+cycle+and+transcriptional+cyclin-dependent+kinase+activities+induces+apoptosis+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DD.%26aulast%3DLatham%26aufirst%3DV.%2BM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCombined%2520depletion%2520of%2520cell%2520cycle%2520and%2520transcriptional%2520cyclin-dependent%2520kinase%2520activities%2520induces%2520apoptosis%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9270%26epage%3D9280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianella-Borradori, A.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery and development of cyclin-dependent kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1517%2F13543784.14.4.457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=15882121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksl2ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=457-477&author=P.+M.+Fischerauthor=A.+Gianella-Borradori&title=Recent+progress+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery and development of cyclin-dependent kinase inhibitors</span></div><div class="casAuthors">Fischer, Peter M.; Gianella-Borradori, Athos</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-477</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (CDKs) have long been known to be the main facilitators of the cell proliferation cycle.  However, they also play important roles in the regulation of the RNA polymerase II transcription cycle.  Cancer cells display aberrant cell cycle regulation to gain proliferative advantages and they also appear to have an exaggerated dependence on RNA polymerase II transcriptional activity to sustain pro-survival and antiapoptotic signaling.  A picture is now starting to emerge that both the cell-cycle and transcriptional functions of CDKs can be exploited pharmacol. with CDK inhibitors that possess appropriate selectivity profiles.  In this article, recent advances into these mechanistic insights and how they can guide clin. development in terms of choice of indication are reviewed, as well as combinations with existing chemotherapies.  An overview is also given of recent clin. trial results with the lead CDK inhibitor drug candidates seliciclib (CYC202, (R)-roscovitine; Cyclacel) and alvocidib (flavopiridol; Aventis-NCI), as well as the development of other clin. entries and advanced preclin. compds.  The discussion focuses on oncol., but we point out recent results with CDK inhibitors in virol. and nephrol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBpDr_f4OWpLVg90H21EOLACvtfcHk0lhM_w8BtJhRpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksl2ju7Y%253D&md5=9720014650efdc6b8fe7e50edcb2c74f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.4.457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.4.457%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DGianella-Borradori%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D457%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">McClue, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhelev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheleva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)</span> <span class="citation_source-journal">In. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1002%2Fijc.10738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=12432547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVOksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=463-468&author=S.+J.+McClueauthor=D.+Blakeauthor=R.+Clarkeauthor=A.+Cowanauthor=L.+Cummingsauthor=P.+M.+Fischerauthor=M.+MacKenzieauthor=J.+Melvilleauthor=K.+Stewartauthor=S.+Wangauthor=N.+Zhelevauthor=D.+Zhelevaauthor=D.+P.+Lane&title=In+vitro+and+in+vivo+antitumor+properties+of+the+cyclin+dependent+kinase+inhibitor+CYC202+%28R-roscovitine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)</span></div><div class="casAuthors">McClue, Steven J.; Blake, David; Clarke, Rosemary; Cowan, Angela; Cummings, Lorna; Fischer, Peter M.; MacKenzie, Mairi; Melville, Jean; Stewart, Kevin; Wang, Shudong; Zhelev, Nikolai; Zheleva, Daniella; Lane, David P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">CDK2 inhibitors have been proposed as effective anti-cancer therapeutics.  We show here that CYC202 (R-roscovitine) is a potent inhibitor of recombinant CDK2/cyclin E kinase activity (IC50 = 0.10 μM) with an av. cytotoxic IC50 of 15.2 μM in a panel of 19 human tumor cell lines, and we also demonstrate selectivity for rapidly proliferating cells over non-proliferating cells.  A study of the cell cycle effects of CYC202 in Lovo colorectal carcinoma cells showed that the major effect was not the predicted arrest in one part of the cycle, but rather an induction of cell death from all compartments of the cell cycle.  The max. tolerated dose given i.v. to mice was in excess of 20 mg/kg.  Doses up to 2,000 mg/kg were tolerated when administered orally in mice.  Following repeated i.p. administration (3 times daily for 5 days) of 100 mg/kg to nude mice bearing the Lovo human colorectal tumor, CYC202 induced a significant antitumor effect with a 45% redn. in tumor growth compared to controls.  A second expt. using the human uterine xenograft MESSA-DX5 treated with orally administered CYC202 (500 mg/kg 3 times daily for 4 days) also exhibited a significant redn. in the rate of growth of the tumor (62%).  These data, showing enzyme and cellular potency together with antitumor activity, confirm the potential of CDK2 inhibitors such as CYC202 as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekWf0QH861LVg90H21EOLACvtfcHk0liOtiF7GBjVYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVOksL4%253D&md5=bf8ed57667ec566b9cc11c27158f6b8b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fijc.10738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10738%26sid%3Dliteratum%253Aachs%26aulast%3DMcClue%26aufirst%3DS.%2BJ.%26aulast%3DBlake%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DR.%26aulast%3DCowan%26aufirst%3DA.%26aulast%3DCummings%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DMacKenzie%26aufirst%3DM.%26aulast%3DMelville%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhelev%26aufirst%3DN.%26aulast%3DZheleva%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520properties%2520of%2520the%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520CYC202%2520%2528R-roscovitine%2529%26jtitle%3DIn.%2520J.%2520Cancer%26date%3D2002%26volume%3D102%26spage%3D463%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roongta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranadive, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0305568" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1719-1728&author=R.+N.+Misraauthor=H.+Y.+Xiaoauthor=K.+S.+Kimauthor=S.+Luauthor=W.+C.+Hanauthor=S.+A.+Barbosaauthor=J.+T.+Huntauthor=D.+B.+Rawlinsauthor=W.+Shanauthor=S.+Z.+Ahmedauthor=L.+Qianauthor=B.+C.+Chenauthor=R.+Zhaoauthor=M.+S.+Bednarzauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=R.+Batorskyauthor=U.+Roongtaauthor=A.+Kamathauthor=P.+Maratheauthor=S.+A.+Ranadiveauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=N.+P.+Pavletichauthor=F.+Y.+F.+Leeauthor=K.+R.+Websterauthor=S.+D.+Kimball&title=N-%28Cycloalkylamino%29acyl-2-aminothiazole+Inhibitors+of+Cyclin-Dependent+Kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+Highly+Efficacious+and+Selective+Antitumor+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0305568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0305568%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DXiao%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DW.%2BC.%26aulast%3DBarbosa%26aufirst%3DS.%2BA.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DBednarz%26aufirst%3DM.%2BS.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DBatorsky%26aufirst%3DR.%26aulast%3DRoongta%26aufirst%3DU.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DRanadive%26aufirst%3DS.%2BA.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26atitle%3DN-%2528Cycloalkylamino%2529acyl-2-aminothiazole%2520Inhibitors%2520of%2520Cyclin-Dependent%2520Kinase%25202.%2520N-%255B5-%255B%255B%255B5-%25281%252C1-Dimethylethyl%2529-2-oxazolyl%255Dmethyl%255Dthio%255D-2-thiazolyl%255D-4-piperidinecarboxamide%2520%2528BMS-387032%2529%252C%2520a%2520Highly%2520Efficacious%2520and%2520Selective%2520Antitumor%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1719%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0liOtiF7GBjVYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Moon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationships of novel indirubin derivatives as potent antiproliferative agents with CDK2 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=237-246&author=M.+J.+Moonauthor=S.+K.+Leeauthor=J.+W.+Leeauthor=W.+K.+Songauthor=S.+W.+Kimauthor=J.+I.+Kimauthor=C.+Choauthor=S.+J.+Choiauthor=Y.+C.+Kim&title=Synthesis+and+structure%E2%88%92activity+relationships+of+novel+indirubin+derivatives+as+potent+antiproliferative+agents+with+CDK2+inhibitory+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DSong%26aufirst%3DW.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DCho%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520novel%2520indirubin%2520derivatives%2520as%2520potent%2520antiproliferative%2520agents%2520with%2520CDK2%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D237%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Myrianthopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikros, E.</span><span> </span><span class="NLM_article-title">An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4027</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070077z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4027-4037&author=V.+Myrianthopoulosauthor=P.+Magiatisauthor=Y.+Ferandinauthor=A.+L.+Skaltsounisauthor=L.+Meijerauthor=E.+Mikros&title=An+integrated+computational+approach+to+the+phenomenon+of+potent+and+selective+inhibition+of+aurora+kinases+B+and+C+by+a+series+of+7-substituted+indirubins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm070077z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070077z%26sid%3Dliteratum%253Aachs%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DMikros%26aufirst%3DE.%26atitle%3DAn%2520integrated%2520computational%2520approach%2520to%2520the%2520phenomenon%2520of%2520potent%2520and%2520selective%2520inhibition%2520of%2520aurora%2520kinases%2520B%2520and%2520C%2520by%2520a%2520series%2520of%25207-substituted%2520indirubins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4027%26epage%3D4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Vougogiannopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettayeb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myrianthopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Soluble 3′,6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase −3 alter circadian period</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6421</span><span class="NLM_x">–</span> <span class="NLM_lpage">6431</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800648y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6421-6431&author=K.+Vougogiannopoulouauthor=Y.+Ferandinauthor=K.+Bettayebauthor=V.+Myrianthopoulosauthor=O.+Lozachauthor=Y.+Fanauthor=C.+H.+Johnsonauthor=P.+Magiatisauthor=A.+L.+Skaltsounisauthor=E.+Mikrosauthor=L.+Meijer&title=Soluble+3%E2%80%B2%2C6-substituted+indirubins+with+enhanced+selectivity+toward+glycogen+synthase+kinase+%E2%88%923+alter+circadian+period"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800648y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800648y%26sid%3Dliteratum%253Aachs%26aulast%3DVougogiannopoulou%26aufirst%3DK.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DC.%2BH.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26aulast%3DMikros%26aufirst%3DE.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSoluble%25203%25E2%2580%25B2%252C6-substituted%2520indirubins%2520with%2520enhanced%2520selectivity%2520toward%2520glycogen%2520synthase%2520kinase%2520%25E2%2588%25923%2520alter%2520circadian%2520period%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6421%26epage%3D6431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Beauchard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laborie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouillard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guguen-Guillouzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, V.</span><span> </span><span class="NLM_article-title">Synthesis and kinase inhibitory activity of novel substituted indigoids</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6257</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6257-6263&author=A.+Beauchardauthor=H.+Laborieauthor=H.+Rouillardauthor=O.+Lozachauthor=Y.+Ferandinauthor=R.+L.+Guevelauthor=C.+Guguen-Guillouzoauthor=L.+Meijerauthor=T.+Bessonauthor=V.+Thiery&title=Synthesis+and+kinase+inhibitory+activity+of+novel+substituted+indigoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauchard%26aufirst%3DA.%26aulast%3DLaborie%26aufirst%3DH.%26aulast%3DRouillard%26aufirst%3DH.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DGuevel%26aufirst%3DR.%2BL.%26aulast%3DGuguen-Guillouzo%26aufirst%3DC.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DThiery%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520kinase%2520inhibitory%2520activity%2520of%2520novel%2520substituted%2520indigoids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6257%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span> </span><span class="NLM_article-title">Indirubin-3′-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2Fj.canlet.2008.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=18343569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlWhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=2008&pages=215-225&author=M.+J.+Leeauthor=M.+Y.+Kimauthor=J.+S.+Moauthor=E.+J.+Annauthor=M.+S.+Seoauthor=J.+A.+Hongauthor=Y.+C.+Kimauthor=H.+S.+Park&title=Indirubin-3%E2%80%B2-monoxime%2C+a+derivative+of+a+Chinese+anti-leukemia+medicine%2C+inhibits+Notch1+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling</span></div><div class="casAuthors">Lee, Mi-Jee; Kim, Mi-Yeon; Mo, Jung-Soon; Ann, Eun-Jung; Seo, Mi-Sun; Hong, Ji-Ae; Kim, Yong-Chul; Park, Hee-Sae</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Notch proteins perform a crit. function in cell-fate decisions and in differentiation.  In this study, we detd. that indirubin-3'-monoxime reduced Notch1 signaling to a remarkable extent.  Indirubin-3'-monoxime has been shown to inhibit both constitutive active mutants of Notch1 and Notch1-IC-mediated transactivation activity.  However, in such cases, neither the Notch cleavage pattern nor the protein stability of Notch1-IC was detd. to have been significantly altered.  Indirubin-3'-monoxime suppresses Notch1 transcriptional activity via the dissocn. of the Notch1-IC-RBP-Jk complex.  Notably, the transcriptional activity of Notch1-IC was not suppressed significantly in the GSK-3β null cells by indirubin-3'-monoxime as compared to what was obsd. with GSK-3β wild-type cells.  In the previous study, we synthesized a series of indirubin derivs.  Interestingly, some of these indirubin derivs. were characterized as potent inhibitors of Notch1 signaling.  Taken together, the results of this study indicate that indirubin-3'-monoxime downregulated Notch1 signaling in a GSK-3β-dependent and proteosomal degrdn.-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9mgOjx7HfLVg90H21EOLACvtfcHk0lhDZNaH-h6K1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlWhsLY%253D&md5=b99da155860033dc19c809678cbc08a6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DMo%26aufirst%3DJ.%2BS.%26aulast%3DAnn%26aufirst%3DE.%2BJ.%26aulast%3DSeo%26aufirst%3DM.%2BS.%26aulast%3DHong%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DPark%26aufirst%3DH.%2BS.%26atitle%3DIndirubin-3%25E2%2580%25B2-monoxime%252C%2520a%2520derivative%2520of%2520a%2520Chinese%2520anti-leukemia%2520medicine%252C%2520inhibits%2520Notch1%2520signaling%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D265%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Yoon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span> </span><span class="NLM_article-title">5′-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1800</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1800&publication_year=2010&pages=352-358&author=J.+H.+Yoonauthor=S.+A.+Kimauthor=S.+M.+Kwonauthor=J.+H.+Parkauthor=H.+S.+Parkauthor=Y.+C.+Kimauthor=J.+H.+Yoonauthor=S.+G.+Ahn&title=5%E2%80%B2-Nitro-indirubinoxime+induces+G1+cell+cycle+arrest+and+apoptosis+in+salivary+gland+adenocarcinoma+cells+through+the+inhibition+of+Notch-1+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BA.%26aulast%3DKwon%26aufirst%3DS.%2BM.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26atitle%3D5%25E2%2580%25B2-Nitro-indirubinoxime%2520induces%2520G1%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520salivary%2520gland%2520adenocarcinoma%2520cells%2520through%2520the%2520inhibition%2520of%2520Notch-1%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1800%26spage%3D352%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Park, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span> </span><span class="NLM_article-title">Novel small molecule activators of β-catenin-mediated signaling pathway: structure−activity relationships of indirubins</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2282</span><span class="NLM_x">–</span> <span class="NLM_lpage">2284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2282-2284&author=E.+J.+Parkauthor=S.+J.+Choiauthor=Y.+C.+Kimauthor=S.+H.+Leeauthor=S.+W.+Parkauthor=S.+K.+Lee&title=Novel+small+molecule+activators+of+%CE%B2-catenin-mediated+signaling+pathway%3A+structure%E2%88%92activity+relationships+of+indirubins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BK.%26atitle%3DNovel%2520small%2520molecule%2520activators%2520of%2520%25CE%25B2-catenin-mediated%2520signaling%2520pathway%253A%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520indirubins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2282%26epage%3D2284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span> </span><span class="NLM_article-title">Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D<sub>3</sub>- and all-<i>trans</i> retinoic acid-induced differentiation of HL-60 leukemia cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6752-6758&author=S.+H.+Kimauthor=S.+W.+Kimauthor=S.+J.+Choiauthor=Y.+C.+Kimauthor=T.+S.+Kim&title=Enhancing+effect+of+indirubin+derivatives+on+1%2C25-dihydroxyvitamin+D3-+and+all-trans+retinoic+acid-induced+differentiation+of+HL-60+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DT.%2BS.%26atitle%3DEnhancing%2520effect%2520of%2520indirubin%2520derivatives%2520on%25201%252C25-dihydroxyvitamin%2520D3-%2520and%2520all-trans%2520retinoic%2520acid-induced%2520differentiation%2520of%2520HL-60%2520leukemia%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6752%26epage%3D6758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Jautelat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumby, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briem, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucking, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prien, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemeister, G.</span><span> </span><span class="NLM_article-title">From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=531-540&author=R.+Jautelatauthor=T.+Brumbyauthor=M.+Schaferauthor=H.+Briemauthor=G.+Eisenbrandauthor=S.+Schwahnauthor=M.+Krugerauthor=U.+Luckingauthor=O.+Prienauthor=G.+Siemeister&title=From+the+insoluble+dye+indirubin+towards+highly+active%2C+soluble+CDK2-inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJautelat%26aufirst%3DR.%26aulast%3DBrumby%26aufirst%3DT.%26aulast%3DSchafer%26aufirst%3DM.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DSchwahn%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DM.%26aulast%3DLucking%26aufirst%3DU.%26aulast%3DPrien%26aufirst%3DO.%26aulast%3DSiemeister%26aufirst%3DG.%26atitle%3DFrom%2520the%2520insoluble%2520dye%2520indirubin%2520towards%2520highly%2520active%252C%2520soluble%2520CDK2-inhibitors%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D531%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Helen, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, K. C.</span><span> </span><span class="NLM_article-title">Synthesis of bromo-substituted indoxyl esters for cytochemical demonstration of enzyme activity</span> <span class="citation_source-journal">Cytochem. Demon. Enzyme Act.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1960&pages=1187-1189&author=C.+F.+Helenauthor=+Suauthor=K.+C.+Tsou&title=Synthesis+of+bromo-substituted+indoxyl+esters+for+cytochemical+demonstration+of+enzyme+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHelen%26aufirst%3DC.%2BF.%26aulast%3DSu%26aulast%3DTsou%26aufirst%3DK.%2BC.%26atitle%3DSynthesis%2520of%2520bromo-substituted%2520indoxyl%2520esters%2520for%2520cytochemical%2520demonstration%2520of%2520enzyme%2520activity%26jtitle%3DCytochem.%2520Demon.%2520Enzyme%2520Act.%26date%3D1960%26volume%3D82%26spage%3D1187%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J. A.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+A.+Seaversauthor=D.-M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+A.+Woolford&title=Identification+of+N-%284-Piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+Novel+Cyclin+Dependent+Kinase+Inhibitor+Using+Fragment-Based+X-Ray+Crystallography+and+Structure+Based+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%2BA.%26aulast%3DSmith%26aufirst%3DD.-M.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%2BA.%26atitle%3DIdentification%2520of%2520N-%25284-Piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520Novel%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%2520Using%2520Fragment-Based%2520X-Ray%2520Crystallography%2520and%2520Structure%2520Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Beauchard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blairvacq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Synthesis of novel 5-substituted indirubins as protein kinases inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6434</span><span class="NLM_x">–</span> <span class="NLM_lpage">6443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6434-6443&author=A.+Beauchardauthor=Y.+Ferandinauthor=S.+Frereauthor=O.+Lozachauthor=M.+Blairvacqauthor=L.+Meijerauthor=V.+Thieryauthor=T.+Besson&title=Synthesis+of+novel+5-substituted+indirubins+as+protein+kinases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauchard%26aufirst%3DA.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DFrere%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DThiery%26aufirst%3DV.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520novel%25205-substituted%2520indirubins%2520as%2520protein%2520kinases%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6434%26epage%3D6443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Shtutman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhurinsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simcha, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Ze’ev, A.</span><span> </span><span class="NLM_article-title">The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=5522-5527&author=M.+Shtutmanauthor=J.+Zhurinskyauthor=I.+Simchaauthor=C.+Albaneseauthor=M.+D%E2%80%99Amicoauthor=R.+Pestellauthor=A.+Ben-Ze%E2%80%99ev&title=The+cyclin+D1+gene+is+a+target+of+the+%CE%B2-catenin%2FLEF-1+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShtutman%26aufirst%3DM.%26aulast%3DZhurinsky%26aufirst%3DJ.%26aulast%3DSimcha%26aufirst%3DI.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DM.%26aulast%3DPestell%26aufirst%3DR.%26aulast%3DBen-Ze%25E2%2580%2599ev%26aufirst%3DA.%26atitle%3DThe%2520cyclin%2520D1%2520gene%2520is%2520a%2520target%2520of%2520the%2520%25CE%25B2-catenin%252FLEF-1%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D5522%26epage%3D5527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kim, S.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J.-H.</span><span> </span><span class="NLM_article-title">Antitumor Activity of Novel Indirubin Derivatives in Rat Tumor Model</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1158%2F1078-0432.CCR-06-1154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=17200363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=253-259&author=S.-A.+Kimauthor=Y.-C.+Kimauthor=S.-W.+Kimauthor=S.-H.+Leeauthor=J.-J.+Minauthor=S.-G.+Ahnauthor=J.-H.+Yoon&title=Antitumor+Activity+of+Novel+Indirubin+Derivatives+in+Rat+Tumor+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Novel Indirubin Derivatives in Rat Tumor Model</span></div><div class="casAuthors">Kim, Soo-A.; Kim, Yong-Chul; Kim, Si-Wouk; Lee, Sang-Ho; Min, Jung-Joon; Ahn, Sang-Gun; Yoon, Jung-Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-259</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The novel indirubin derivs. 5'-nitro-indirubinoxime, 5'-fluoro-indirubinoxime, and 5'-trimethylacetamino-indirubinoxime were designed and tested for antitumor activity both in vitro and in vivo using rat tumor model.  Exptl. Design: Three-week-old male Sprague-Dawley rats were inoculated s.c. on the left flank with 107 RK3E-ras rat kidney epithelial cells harboring k-ras gene.  Alternatively, 5 × 106 RK3E-ras cells were injected into the oral mucosa.  Indirubin deriv. treatment began on the 3rd or 6th day after oral or s.c. cell injection, resp.  Indirubin derivs. were directly injected into the tumor every other day for a total of five times.  Animals were monitored daily and tumor vol. was measured by caliper.  Results: Indirubin derivs. showed potent antiproliferative activity on various human cancer cells and oncogenic RK3E-ras rat kidney cells, with IC50 ranging from 1 to 12 μM.  Treatment with indirubin derivs. induced the activation of caspase-7 followed by apoptosis in RK3E-ras cells.  Indirubin derivs. showed strong antitumor activity in rat solid and oral tumor models.  Direct injection of indirubin derivs. every other day for 10 days induced significant inhibition of tumor growth in Sprague-Dawley rats bearing RK3E-ras-induced tumors.  Histol., treatment with indirubin derivs. caused significant inhibition of tumor formation with increased apoptosis and decreased tumor cell proliferation.  Conclusions: the authors' data showed that novel indirubin derivs. 5'-nitro-indirubinoxime, 5'-fluoro-indirubinoxime, and 5'-trimethylacetamino-indirubinoxime effectively arrested the tumor growth by inhibiting cell proliferation and inducing apoptosis.  These findings provide the potential value of indirubin derivs. as novel candidates for antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaLzbkgyScK7Vg90H21EOLACvtfcHk0ligh2ADvKyveg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWg&md5=b382a30fead8aeccb54df24da8d7dcea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1154%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.-A.%26aulast%3DKim%26aufirst%3DY.-C.%26aulast%3DKim%26aufirst%3DS.-W.%26aulast%3DLee%26aufirst%3DS.-H.%26aulast%3DMin%26aufirst%3DJ.-J.%26aulast%3DAhn%26aufirst%3DS.-G.%26aulast%3DYoon%26aufirst%3DJ.-H.%26atitle%3DAntitumor%2520Activity%2520of%2520Novel%2520Indirubin%2520Derivatives%2520in%2520Rat%2520Tumor%2520Model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D253%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Nam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muehlbeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vatter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span> </span><span class="NLM_article-title">Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">5998</span><span class="NLM_x">–</span> <span class="NLM_lpage">6003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1073%2Fpnas.0409467102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=15837920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Cmu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=5998-6003&author=S.+Namauthor=R.+Buettnerauthor=J.+Turksonauthor=D.+Kimauthor=J.+Q.+Chengauthor=S.+Muehlbeyerauthor=F.+Hippeauthor=S.+Vatterauthor=K.+H.+Merzauthor=G.+Eisenbrandauthor=R.+Jove&title=Indirubin+derivatives+inhibit+Stat3+signaling+and+induce+apoptosis+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells</span></div><div class="casAuthors">Nam, Sangkil; Buettner, Ralf; Turkson, James; Kim, Donghwa; Cheng, Jin Q.; Muehlbeyer, Stephan; Hippe, Frankie; Vatter, Sandra; Merz, Karl-Heinz; Eisenbrand, Gerhard; Jove, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5998-6003</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Stat3 protein has an important role in oncogenesis and is a promising anticancer target.  Indirubin, the active component of a traditional Chinese herbal medicine, has been shown previously to inhibit cyclin-dependent kinases, resulting in cell cycle arrest.  Here, the authors show that the indirubin derivs. E564, E728, and E804 potently block constitutive Stat3 signaling in human breast and prostate cancer cells.  In addn., E804 directly inhibits Src kinase activity (IC50 = 0.43 μM) in an in vitro kinase assay.  Levels of tyrosyl phosphorylation of c-Src are also reduced in cultured cells 30 min after E804 treatment.  Tyrosyl phosphorylation of Stat3, which is known to be phosphorylated by c-Src, was decreased, and constitutive Stat3 DNA binding-activity was suppressed in cells 30 min after E804 treatment.  The antiapoptotic proteins Mcl-1 and Survivin, which are encoded in target genes of Stat3, were down-regulated by indirubin derivs., followed by induction of apoptosis.  These results demonstrate that E804 directly blocks the Src-Stat3 signaling pathway, suggesting that the antitumor activity of indirubin compds. is at least partially due to inhibition of this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD6CvqDvoUx7Vg90H21EOLACvtfcHk0ligh2ADvKyveg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Cmu78%253D&md5=6e29db4bde679b92bdc0e8e9648781df</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409467102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409467102%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DS.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DMuehlbeyer%26aufirst%3DS.%26aulast%3DHippe%26aufirst%3DF.%26aulast%3DVatter%26aufirst%3DS.%26aulast%3DMerz%26aufirst%3DK.%2BH.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DJove%26aufirst%3DR.%26atitle%3DIndirubin%2520derivatives%2520inhibit%2520Stat3%2520signaling%2520and%2520induce%2520apoptosis%2520in%2520human%2520cancer%2520cells%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D5998%26epage%3D6003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kim, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span> </span><span class="NLM_article-title">5′-Nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2Fj.canlet.2008.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=18926623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2009&pages=72-77&author=S.+A.+Kimauthor=S.+W.+Kimauthor=S.+Changauthor=J.+H.+Yoonauthor=S.+G.+Ahn&title=5%E2%80%B2-Nitro-indirubinoxime+induces+G2%2FM+cell+cycle+arrest+and+apoptosis+in+human+KB+oral+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">5'-nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells</span></div><div class="casAuthors">Kim, Soo-A.; Kim, Si-Wouk; Chang, Sunghoe; Yoon, Jung-Hoon; Ahn, Sang-Gun</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-77</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Our previous study demonstrated that the novel indirubin deriv., 5'-nitro-indirubinoxime (5'-NIO), effectively arrested the tumor growth through the inhibition of cell proliferation and the induction of apoptosis.  However, the precise mol. mechanisms underlying 5'-NIO-induced antitumor activity remain unclear.  Here, we report that 5'-NIO inhibits the proliferation of human KB oral carcinoma cells via the cell cycle arrest in G2/M phase.  5'-NIO reduced the activity of Cdc2/cyclin B complex through the inhibition of the PLK1 expression.  Partially, 5'-NIO also arrested cell cycle in G1/S phase via the redn. of CDK4 and cyclin D1/D3 levels by p16 and induction of the level of p21waf1.  Using flow cytometry anal., we showed that 5'-NIO-induced cell cycle arrest is followed by apoptosis.  We detd. further that 5'-NIO-induced apoptosis is accomplished by the mitochondria-dependent activation of the caspase cascade.  Overall, these observations suggest the potential value of 5'-NIO as a candidate for a therapeutic modality for the treatment of oral cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8UnoqTG8pOLVg90H21EOLACvtfcHk0ligh2ADvKyveg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLvO&md5=a1b74b7204ad1fccfd0a219a5726e586</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26atitle%3D5%25E2%2580%25B2-Nitro-indirubinoxime%2520induces%2520G2%252FM%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520human%2520KB%2520oral%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D274%26spage%3D72%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mclauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+Mclauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lg7UoBoT9YSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Columbus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadari, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kussie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labelle, M.</span><span> </span><span class="NLM_article-title">Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5474</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5474-5477&author=W.+Panauthor=H.+Liuauthor=Y.+J.+Xuauthor=X.+Chenauthor=K.+H.+Kimauthor=D.+L.+Milliganauthor=J.+Columbusauthor=Y.+R.+Hadariauthor=P.+Kussieauthor=W.+C.+Wongauthor=M.+Labelle&title=Pyrimido-oxazepine+as+a+versatile+template+for+the+development+of+inhibitors+of+specific+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMilligan%26aufirst%3DD.%2BL.%26aulast%3DColumbus%26aufirst%3DJ.%26aulast%3DHadari%26aufirst%3DY.%2BR.%26aulast%3DKussie%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DW.%2BC.%26aulast%3DLabelle%26aufirst%3DM.%26atitle%3DPyrimido-oxazepine%2520as%2520a%2520versatile%2520template%2520for%2520the%2520development%2520of%2520inhibitors%2520of%2520specific%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5474%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer+drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lg7UoBoT9YSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer%2520drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 61 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jun Xu, Huiyong Yang, Lei He, Lin Huang, Jiabin Shen, Wanmei Li, <span class="NLM_string-name hlFld-ContribAuthor">Pengfei Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (E)-Quinoxalinone Oximes through a Multicomponent Reaction under Mild Conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     , 195-201. <a href="https://doi.org/10.1021/acs.orglett.0c03918" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03918%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252B%252528E%252529-Quinoxalinone%252BOximes%252Bthrough%252Ba%252BMulticomponent%252BReaction%252Bunder%252BMild%252BConditions%26aulast%3DXu%26aufirst%3DJun%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D26112020%26date%3D23122020%26volume%3D23%26issue%3D1%26spage%3D195%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinlai  Cheng</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Merz</span>, <span class="hlFld-ContribAuthor ">Sandra  Vatter</span>, <span class="hlFld-ContribAuthor ">Jochen  Zeller</span>, <span class="hlFld-ContribAuthor ">Stephan  Muehlbeyer</span>, <span class="hlFld-ContribAuthor ">Andrea  Thommet</span>, <span class="hlFld-ContribAuthor ">Jochen  Christ</span>, <span class="hlFld-ContribAuthor ">Stefan  Wölfl</span>, and <span class="hlFld-ContribAuthor ">Gerhard  Eisenbrand</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 4949-4962. <a href="https://doi.org/10.1021/acs.jmedchem.7b00324" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00324%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BWater-Soluble%252BIndirubin%252BDerivative%252Bas%252BPotent%252BInhibitor%252Bof%252BInsulin-like%252BGrowth%252BFactor%252B1%252BReceptor%252Bthrough%252BStructural%252BModification%252Bof%252Bthe%252BParent%252BNatural%252BMolecule%26aulast%3DCheng%26aufirst%3DXinlai%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D02032017%26date%3D06062017%26date%3D22062017%26date%3D30052017%26volume%3D60%26issue%3D12%26spage%3D4949%26epage%3D4962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud-Kolar</span>, <span class="hlFld-ContribAuthor ">Vasillios  Myrianthopoulos</span>, <span class="hlFld-ContribAuthor ">Konstantina  Vougogiannopoulou</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Gerolymatos</span>, <span class="hlFld-ContribAuthor ">David A.  Horne</span>, <span class="hlFld-ContribAuthor ">Richard  Jove</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Mikros</span>, <span class="hlFld-ContribAuthor ">Sangkil  Nam</span>, and <span class="hlFld-ContribAuthor ">Alexios-Leandros  Skaltsounis</span>  . </span><span class="cited-content_cbyCitation_article-title">Natural-Based Indirubins Display Potent Cytotoxicity toward Wild-Type and T315I-Resistant Leukemia Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2016,</strong> <em>79 </em>
                                    (10)
                                     , 2464-2471. <a href="https://doi.org/10.1021/acs.jnatprod.6b00285" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.6b00285</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.6b00285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.6b00285%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DNatural-Based%252BIndirubins%252BDisplay%252BPotent%252BCytotoxicity%252Btoward%252BWild-Type%252Band%252BT315I-Resistant%252BLeukemia%252BCell%252BLines%26aulast%3DGaboriaud-Kolar%26aufirst%3DNicolas%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01042016%26date%3D11102016%26date%3D28102016%26volume%3D79%26issue%3D10%26spage%3D2464%26epage%3D2471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Sanghapal D.  Sawant</span>, <span class="hlFld-ContribAuthor ">Parvinder Pal  Singh</span>, and <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>  . </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors of Marine Origin. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2013,</strong> <em>113 </em>
                                    (8)
                                     , 6761-6815. <a href="https://doi.org/10.1021/cr300410v" title="DOI URL">https://doi.org/10.1021/cr300410v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr300410v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr300410v%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DKinase%252BInhibitors%252Bof%252BMarine%252BOrigin%26aulast%3DBharate%26aufirst%3DSandip%2BB.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D13102012%26date%3D16052013%26date%3D14082013%26volume%3D113%26issue%3D8%26spage%3D6761%26epage%3D6815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hezhen  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Chunyong  Wei</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Yingshu  Xu</span>, <span class="hlFld-ContribAuthor ">Guohui  Bai</span>, <span class="hlFld-ContribAuthor ">Qizheng  Yao</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongzheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113652. <a href="https://doi.org/10.1016/j.ejmech.2021.113652" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113652%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnticancer%252Bpotential%252Bof%252Bindirubins%252Bin%252Bmedicinal%252Bchemistry%25253A%252BBiological%252Bactivity%25252C%252Bstructural%252Bmodification%25252C%252Band%252Bstructure-activity%252Brelationship%26aulast%3DWang%26aufirst%3DHezhen%26date%3D2021%26volume%3D223%26spage%3D113652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Igor A.  Schepetkin</span>, <span class="hlFld-ContribAuthor ">Mark B.  Plotnikov</span>, <span class="hlFld-ContribAuthor ">Andrei I.  Khlebnikov</span>, <span class="hlFld-ContribAuthor ">Tatiana M.  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Mark T.  Quinn</span>. </span><span class="cited-content_cbyCitation_article-title">Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 777. <a href="https://doi.org/10.3390/biom11060777" title="DOI URL">https://doi.org/10.3390/biom11060777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11060777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11060777%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DOximes%25253A%252BNovel%252BTherapeutics%252Bwith%252BAnticancer%252Band%252BAnti-Inflammatory%252BPotential%26aulast%3DSchepetkin%26aufirst%3DIgor%2BA.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toru  Tanaka</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Saito</span>, <span class="hlFld-ContribAuthor ">Shinichi  Miyairi</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Kobayashi</span>. </span><span class="cited-content_cbyCitation_article-title">7-Hydorxyindirubin is capable of specifically inhibiting anticancer drug-induced YB-1 nuclear translocation without showing cytotoxicity in HepG2 hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2021,</strong> <em>544 </em>, 15-21. <a href="https://doi.org/10.1016/j.bbrc.2021.01.048" title="DOI URL">https://doi.org/10.1016/j.bbrc.2021.01.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2021.01.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2021.01.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3D7-Hydorxyindirubin%252Bis%252Bcapable%252Bof%252Bspecifically%252Binhibiting%252Banticancer%252Bdrug-induced%252BYB-1%252Bnuclear%252Btranslocation%252Bwithout%252Bshowing%252Bcytotoxicity%252Bin%252BHepG2%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DTanaka%26aufirst%3DToru%26date%3D2021%26volume%3D544%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raphael Enoque  Ferraz de Paiva</span>, <span class="hlFld-ContribAuthor ">Eduardo Guimarães  Vieira</span>, <span class="hlFld-ContribAuthor ">Daniel  Rodrigues da Silva</span>, <span class="hlFld-ContribAuthor ">Camila Anchau  Wegermann</span>, <span class="hlFld-ContribAuthor ">Ana Maria  Costa Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2021,</strong> <em>7 </em><a href="https://doi.org/10.3389/fmolb.2020.627272" title="DOI URL">https://doi.org/10.3389/fmolb.2020.627272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2020.627272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2020.627272%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DAnticancer%252BCompounds%252BBased%252Bon%252BIsatin-Derivatives%25253A%252BStrategies%252Bto%252BAmeliorate%252BSelectivity%252Band%252BEfficiency%26aulast%3DFerraz%2Bde%2BPaiva%26aufirst%3DRaphael%2BEnoque%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang-liang  Yao</span>, <span class="hlFld-ContribAuthor ">Jian-qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia-yuan  Li</span>, <span class="hlFld-ContribAuthor ">Wen-long  Wei</span>, <span class="hlFld-ContribAuthor ">Shi-fei  Wu</span>, <span class="hlFld-ContribAuthor ">De-an  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Traditional Chinese medicine (TCM) as a source of new anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2021,</strong> <em>68 </em><a href="https://doi.org/10.1039/D0NP00057D" title="DOI URL">https://doi.org/10.1039/D0NP00057D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NP00057D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NP00057D%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DTraditional%252BChinese%252Bmedicine%252B%252528TCM%252529%252Bas%252Ba%252Bsource%252Bof%252Bnew%252Banticancer%252Bdrugs%26aulast%3DYao%26aufirst%3DChang-liang%26date%3D2021%26date%3D2021%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyo Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">Pyeonghwa  Jeong</span>, <span class="hlFld-ContribAuthor ">Yeongyu  Moon</span>, <span class="hlFld-ContribAuthor ">Jungil  Choi</span>, <span class="hlFld-ContribAuthor ">Jeong Doo  Heo</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Sun-Young  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of LDD-2633 as a Novel RET Kinase Inhibitor with Anti-Tumor Effects in Thyroid Cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     , 38. <a href="https://doi.org/10.3390/ph14010038" title="DOI URL">https://doi.org/10.3390/ph14010038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14010038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14010038%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DCharacterization%252Bof%252BLDD-2633%252Bas%252Ba%252BNovel%252BRET%252BKinase%252BInhibitor%252Bwith%252BAnti-Tumor%252BEffects%252Bin%252BThyroid%252BCancer%26aulast%3DLee%26aufirst%3DHyo%2BJeong%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1%26spage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoj Kumar  Shrivash</span>, <span class="hlFld-ContribAuthor ">Shilipi  Singh</span>, <span class="hlFld-ContribAuthor ">Akhilesh Kumar  Shukla</span>, <span class="hlFld-ContribAuthor ">Suaib  Luqman</span>, <span class="hlFld-ContribAuthor ">Jyoti  Pandey</span>, <span class="hlFld-ContribAuthor ">Krishna  Misra</span>. </span><span class="cited-content_cbyCitation_article-title">Water mediated procedure for preparation of stereoselective oximes as inhibitors of MRCK kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1220 </em>, 128699. <a href="https://doi.org/10.1016/j.molstruc.2020.128699" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.128699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.128699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.128699%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DWater%252Bmediated%252Bprocedure%252Bfor%252Bpreparation%252Bof%252Bstereoselective%252Boximes%252Bas%252Binhibitors%252Bof%252BMRCK%252Bkinase%26aulast%3DShrivash%26aufirst%3DManoj%2BKumar%26date%3D2020%26volume%3D1220%26spage%3D128699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Fu</span>, <span class="hlFld-ContribAuthor ">Guorui  Yin</span>, <span class="hlFld-ContribAuthor ">Ke  Song</span>, <span class="hlFld-ContribAuthor ">Xiurui  Mu</span>, <span class="hlFld-ContribAuthor ">Bo  Xu</span>, <span class="hlFld-ContribAuthor ">Xubin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin-3′-Oxime (IDR3O) Inhibits Proliferation of Osteosarcoma Cells in vitro and Tumor Growth in vivo Through AMPK-Activation and PGC-1α/TFAM Up-Regulation. </span><span class="cited-content_cbyCitation_journal-name">Doklady Biochemistry and Biophysics</span><span> <strong>2020,</strong> <em>495 </em>
                                    (1)
                                     , 354-360. <a href="https://doi.org/10.1134/S1607672920060022" title="DOI URL">https://doi.org/10.1134/S1607672920060022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1607672920060022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1607672920060022%26sid%3Dliteratum%253Aachs%26jtitle%3DDoklady%2520Biochemistry%2520and%2520Biophysics%26atitle%3DIndirubin-3%2525E2%252580%2525B2-Oxime%252B%252528IDR3O%252529%252BInhibits%252BProliferation%252Bof%252BOsteosarcoma%252BCells%252Bin%252Bvitro%252Band%252BTumor%252BGrowth%252Bin%252Bvivo%252BThrough%252BAMPK-Activation%252Band%252BPGC-1%2525CE%2525B1%25252FTFAM%252BUp-Regulation%26aulast%3DFu%26aufirst%3DBing%26date%3D2020%26date%3D2020%26volume%3D495%26issue%3D1%26spage%3D354%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mudasir Nabi  Peerzada</span>, <span class="hlFld-ContribAuthor ">Parvez  Khan</span>, <span class="hlFld-ContribAuthor ">Nashrah Sharif  Khan</span>, <span class="hlFld-ContribAuthor ">Aysha  Gaur</span>, <span class="hlFld-ContribAuthor ">Fernando  Avecilla</span>, <span class="hlFld-ContribAuthor ">Md. Imtaiyaz  Hassan</span>, <span class="hlFld-ContribAuthor ">Amir  Azam</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (38)
                                     , 16626-16637. <a href="https://doi.org/10.1039/D0NJ03474F" title="DOI URL">https://doi.org/10.1039/D0NJ03474F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ03474F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ03474F%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DIdentification%252Bof%252Bmorpholine%252Bbased%252Bhydroxylamine%252Banalogues%25253A%252Bselective%252Binhibitors%252Bof%252BMARK4%25252FPar-1d%252Bcausing%252Bcancer%252Bcell%252Bdeath%252Bthrough%252Bapoptosis%26aulast%3DPeerzada%26aufirst%3DMudasir%2BNabi%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D38%26spage%3D16626%26epage%3D16637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pyeonghwa  Jeong</span>, <span class="hlFld-ContribAuthor ">Yeongyu  Moon</span>, <span class="hlFld-ContribAuthor ">Je-Heon  Lee</span>, <span class="hlFld-ContribAuthor ">So-Deok  Lee</span>, <span class="hlFld-ContribAuthor ">Jiyeon  Park</span>, <span class="hlFld-ContribAuthor ">Jungeun  Lee</span>, <span class="hlFld-ContribAuthor ">Jiheon  Kim</span>, <span class="hlFld-ContribAuthor ">Hyo Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">Na Yoon  Kim</span>, <span class="hlFld-ContribAuthor ">Jungil  Choi</span>, <span class="hlFld-ContribAuthor ">Jeong Doo  Heo</span>, <span class="hlFld-ContribAuthor ">Ji Eun  Shin</span>, <span class="hlFld-ContribAuthor ">Hyun Woo  Park</span>, <span class="hlFld-ContribAuthor ">Yoon-Gyoon  Kim</span>, <span class="hlFld-ContribAuthor ">Sun-Young  Han</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112205. <a href="https://doi.org/10.1016/j.ejmech.2020.112205" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112205%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Borally%252Bactive%252Bindirubin-3%2525E2%252580%2525B2-oxime%252Bderivatives%252Bas%252Bpotent%252Btype%252B1%252BFLT3%252Binhibitors%252Bfor%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DJeong%26aufirst%3DPyeonghwa%26date%3D2020%26volume%3D195%26spage%3D112205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya‐Zhou  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong‐Zhi  Du</span>, <span class="hlFld-ContribAuthor ">Hai‐Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Qian‐Song  He</span>, <span class="hlFld-ContribAuthor ">Zhi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Isatin dimers and their biological activities. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (3)
                                     , 1900299. <a href="https://doi.org/10.1002/ardp.201900299" title="DOI URL">https://doi.org/10.1002/ardp.201900299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900299%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DIsatin%252Bdimers%252Band%252Btheir%252Bbiological%252Bactivities%26aulast%3DZhang%26aufirst%3DYa%25E2%2580%2590Zhou%26date%3D2020%26date%3D2020%26volume%3D353%26issue%3D3%26spage%3D1900299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilesh  Kahar</span>, <span class="hlFld-ContribAuthor ">Pankaj  Jadhav</span>, <span class="hlFld-ContribAuthor ">R. V. Ramana  Reddy</span>, <span class="hlFld-ContribAuthor ">Sudam  Dawande</span>. </span><span class="cited-content_cbyCitation_article-title">A rhodium(
              ii
              ) catalysed domino synthesis of azepino fused diindoles from isatin tethered
              N
              -sulfonyl-1,2,3-triazoles and indoles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (8)
                                     , 1207-1210. <a href="https://doi.org/10.1039/C9CC08377D" title="DOI URL">https://doi.org/10.1039/C9CC08377D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC08377D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC08377D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Brhodium%252528%252Bii%252B%252529%252Bcatalysed%252Bdomino%252Bsynthesis%252Bof%252Bazepino%252Bfused%252Bdiindoles%252Bfrom%252Bisatin%252Btethered%252BN%252B-sulfonyl-1%25252C2%25252C3-triazoles%252Band%252Bindoles%26aulast%3DKahar%26aufirst%3DNilesh%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D8%26spage%3D1207%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshimi  Ichimaru</span>, <span class="hlFld-ContribAuthor ">Makoto  Sano</span>, <span class="hlFld-ContribAuthor ">Ichie  Kajiwara</span>, <span class="hlFld-ContribAuthor ">Takao  Tobe</span>, <span class="hlFld-ContribAuthor ">Hiroki  Yoshioka</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Hayashi</span>, <span class="hlFld-ContribAuthor ">Hideaki  Ijichi</span>, <span class="hlFld-ContribAuthor ">Shinichi  Miyairi</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin 3′-Oxime Inhibits Migration, Invasion, and Metastasis     in Mice Bearing Spontaneously Occurring Pancreatic Cancer via Blocking the RAF/ERK, AKT, and SAPK/JNK Pathways. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (12)
                                     , 1574-1582. <a href="https://doi.org/10.1016/j.tranon.2019.08.010" title="DOI URL">https://doi.org/10.1016/j.tranon.2019.08.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tranon.2019.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tranon.2019.08.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DIndirubin%252B3%2525E2%252580%2525B2-Oxime%252BInhibits%252BMigration%25252C%252BInvasion%25252C%252Band%252BMetastasis%252Bin%252BMice%252BBearing%252BSpontaneously%252BOccurring%252BPancreatic%252BCancer%252Bvia%252BBlocking%252Bthe%252BRAF%25252FERK%25252C%252BAKT%25252C%252Band%252BSAPK%25252FJNK%252BPathways%26aulast%3DIchimaru%26aufirst%3DYoshimi%26date%3D2019%26volume%3D12%26issue%3D12%26spage%3D1574%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Woong-Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Pyeonghwa  Jeong</span>, <span class="hlFld-ContribAuthor ">Seon-Wook  Kim</span>, <span class="hlFld-ContribAuthor ">Haaglim  Cho</span>, <span class="hlFld-ContribAuthor ">Jeong-min  Lee</span>, <span class="hlFld-ContribAuthor ">Shinae  Seo</span>, <span class="hlFld-ContribAuthor ">Haihong  Shen</span>, <span class="hlFld-ContribAuthor ">Youngkeun  Ahn</span>, <span class="hlFld-ContribAuthor ">Da-Woon  Jung</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Darren R.  Williams</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical characterization and biological activity data for a novel indirubin derivative, LDD-1819. </span><span class="cited-content_cbyCitation_journal-name">Data in Brief</span><span> <strong>2019,</strong> <em>25 </em>, 104373. <a href="https://doi.org/10.1016/j.dib.2019.104373" title="DOI URL">https://doi.org/10.1016/j.dib.2019.104373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dib.2019.104373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dib.2019.104373%26sid%3Dliteratum%253Aachs%26jtitle%3DData%2520in%2520Brief%26atitle%3DChemical%252Bcharacterization%252Band%252Bbiological%252Bactivity%252Bdata%252Bfor%252Ba%252Bnovel%252Bindirubin%252Bderivative%25252C%252BLDD-1819%26aulast%3DKim%26aufirst%3DWoong-Hee%26date%3D2019%26volume%3D25%26spage%3D104373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Hisham</span>, <span class="hlFld-ContribAuthor ">Bahaa G.M.  Youssif</span>, <span class="hlFld-ContribAuthor ">Essam Eldin A.  Osman</span>, <span class="hlFld-ContribAuthor ">Alaa M.  Hayallah</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abdel-Aziz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 117-128. <a href="https://doi.org/10.1016/j.ejmech.2019.05.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bxanthine%252Bderivatives%252Bas%252Bpotential%252Bapoptotic%252Bantitumor%252Bagents%26aulast%3DHisham%26aufirst%3DMohamed%26date%3D2019%26volume%3D176%26spage%3D117%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liliana  Pacureanu</span>, <span class="hlFld-ContribAuthor ">Sorin  Avram</span>, <span class="hlFld-ContribAuthor ">Alina  Bora</span>, <span class="hlFld-ContribAuthor ">Ludovic  Kurunczi</span>, <span class="hlFld-ContribAuthor ">Luminita  Crisan</span>. </span><span class="cited-content_cbyCitation_article-title">Portraying the selectivity of GSK-3 inhibitors towards CDK-2 by 3D similarity and molecular docking. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (3)
                                     , 911-923. <a href="https://doi.org/10.1007/s11224-018-1224-z" title="DOI URL">https://doi.org/10.1007/s11224-018-1224-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-018-1224-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-018-1224-z%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DPortraying%252Bthe%252Bselectivity%252Bof%252BGSK-3%252Binhibitors%252Btowards%252BCDK-2%252Bby%252B3D%252Bsimilarity%252Band%252Bmolecular%252Bdocking%26aulast%3DPacureanu%26aufirst%3DLiliana%26date%3D2019%26date%3D2018%26volume%3D30%26issue%3D3%26spage%3D911%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gladys  Asong</span>, <span class="hlFld-ContribAuthor ">Xue Y.  Zhu</span>, <span class="hlFld-ContribAuthor ">Barbara  Bricker</span>, <span class="hlFld-ContribAuthor ">Terrick  Andey</span>, <span class="hlFld-ContribAuthor ">Felix  Amissah</span>, <span class="hlFld-ContribAuthor ">Nazarius  Lamango</span>, <span class="hlFld-ContribAuthor ">Seth Y.  Ablordeppey</span>. </span><span class="cited-content_cbyCitation_article-title">New analogs of SYA013 as sigma-2 ligands with anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (12)
                                     , 2629-2636. <a href="https://doi.org/10.1016/j.bmc.2019.04.012" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.04.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.04.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNew%252Banalogs%252Bof%252BSYA013%252Bas%252Bsigma-2%252Bligands%252Bwith%252Banticancer%252Bactivity%26aulast%3DAsong%26aufirst%3DGladys%26date%3D2019%26volume%3D27%26issue%3D12%26spage%3D2629%26epage%3D2636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yinqiu  Xu</span>, <span class="hlFld-ContribAuthor ">Pingping  Chen</span>, <span class="hlFld-ContribAuthor ">Xinhao  Lin</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of CDK4 inhibitors by convolutional neural networks. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (3)
                                     , 165-177. <a href="https://doi.org/10.4155/fmc-2018-0478" title="DOI URL">https://doi.org/10.4155/fmc-2018-0478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0478%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BCDK4%2525C2%2525A0inhibitors%252Bby%252Bconvolutional%252Bneural%252Bnetworks%26aulast%3DXu%26aufirst%3DYinqiu%26date%3D2019%26volume%3D11%26issue%3D3%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonia  Efstathiou</span>, <span class="hlFld-ContribAuthor ">Cássio Santana  Meira</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud-Kolar</span>, <span class="hlFld-ContribAuthor ">Tanira Matutino  Bastos</span>, <span class="hlFld-ContribAuthor ">Vinícius Pinto Costa  Rocha</span>, <span class="hlFld-ContribAuthor ">Konstantina  Vougogiannopoulou</span>, <span class="hlFld-ContribAuthor ">Alexios-Leandros  Skaltsounis</span>, <span class="hlFld-ContribAuthor ">Despina  Smirlis</span>, <span class="hlFld-ContribAuthor ">Milena Botelho Pereira  Soares</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin derivatives are potent and selective anti-
              Trypanosoma cruzi
              agents. </span><span class="cited-content_cbyCitation_journal-name">Virulence</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     , 1658-1668. <a href="https://doi.org/10.1080/21505594.2018.1532242" title="DOI URL">https://doi.org/10.1080/21505594.2018.1532242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/21505594.2018.1532242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F21505594.2018.1532242%26sid%3Dliteratum%253Aachs%26jtitle%3DVirulence%26atitle%3DIndirubin%252Bderivatives%252Bare%252Bpotent%252Band%252Bselective%252Banti-%252BTrypanosoma%252Bcruzi%252Bagents%26aulast%3DEfstathiou%26aufirst%3DAntonia%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D1658%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahmoud S.  Abdelbaset</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Gamal El-Din A.  Abuo-Rahma</span>, <span class="hlFld-ContribAuthor ">Mostafa H.  Abdelrahman</span>, <span class="hlFld-ContribAuthor ">Mohamed  Ramadan</span>, <span class="hlFld-ContribAuthor ">Bahaa G. M.  Youssif</span>. </span><span class="cited-content_cbyCitation_article-title">Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>6 </em>, 1800270. <a href="https://doi.org/10.1002/ardp.201800270" title="DOI URL">https://doi.org/10.1002/ardp.201800270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800270%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DNovel%252Bquinoline%252Bderivatives%252Bcarrying%252Bnitrones%25252Foximes%252Bnitric%252Boxide%252Bdonors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bantiproliferative%252Band%252Bcaspase-3%252Bactivation%252Bactivities%26aulast%3DAbdelbaset%26aufirst%3DMahmoud%2BS.%26date%3D2018%26date%3D2018%26volume%3D6%26spage%3D1800270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toru  Tanaka</span>, <span class="hlFld-ContribAuthor ">Misaki  Kasai</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Kobayashi</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism responsible for inhibitory effect of indirubin 3′-oxime on anticancer agent-induced YB-1 nuclear translocation in HepG2 human hepatocellular carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Experimental Cell Research</span><span> <strong>2018,</strong> <em>370 </em>
                                    (2)
                                     , 454-460. <a href="https://doi.org/10.1016/j.yexcr.2018.07.009" title="DOI URL">https://doi.org/10.1016/j.yexcr.2018.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yexcr.2018.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yexcr.2018.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Cell%2520Research%26atitle%3DMechanism%252Bresponsible%252Bfor%252Binhibitory%252Beffect%252Bof%252Bindirubin%252B3%2525E2%252580%2525B2-oxime%252Bon%252Banticancer%252Bagent-induced%252BYB-1%252Bnuclear%252Btranslocation%252Bin%252BHepG2%252Bhuman%252Bhepatocellular%252Bcarcinoma%252Bcells%26aulast%3DTanaka%26aufirst%3DToru%26date%3D2018%26volume%3D370%26issue%3D2%26spage%3D454%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajeena  Pathoor</span>, <span class="hlFld-ContribAuthor ">D.  Bahulayan</span>. </span><span class="cited-content_cbyCitation_article-title">MCR-click synthesis, molecular docking and cytotoxicity evaluation of a new series of indole–triazole–coumarin hybrid peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2018,</strong> <em>42 </em>
                                    (9)
                                     , 6810-6816. <a href="https://doi.org/10.1039/C8NJ00032H" title="DOI URL">https://doi.org/10.1039/C8NJ00032H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8NJ00032H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8NJ00032H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DMCR-click%252Bsynthesis%25252C%252Bmolecular%252Bdocking%252Band%252Bcytotoxicity%252Bevaluation%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Bindole%2525E2%252580%252593triazole%2525E2%252580%252593coumarin%252Bhybrid%252Bpeptidomimetics%26aulast%3DPathoor%26aufirst%3DRajeena%26date%3D2018%26date%3D2018%26volume%3D42%26issue%3D9%26spage%3D6810%26epage%3D6816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan-Su  Park</span>, <span class="hlFld-ContribAuthor ">Gab-jin  Park</span>, <span class="hlFld-ContribAuthor ">Seunghoon  Han</span>, <span class="hlFld-ContribAuthor ">Sooho  Ban</span>, <span class="hlFld-ContribAuthor ">Moon-Young  Park</span>, <span class="hlFld-ContribAuthor ">San-ho  Kim</span>, <span class="hlFld-ContribAuthor ">Seon-Myung  Kim</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Hyung Sik  Kim</span>, <span class="hlFld-ContribAuthor ">Young G.  Shin</span>, <span class="hlFld-ContribAuthor ">Dong-Seok  Yim</span>. </span><span class="cited-content_cbyCitation_article-title">Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2017,</strong> <em>80 </em>
                                    (2)
                                     , 363-369. <a href="https://doi.org/10.1007/s00280-017-3373-y" title="DOI URL">https://doi.org/10.1007/s00280-017-3373-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-017-3373-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-017-3373-y%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DHuman%252Bmicrodosing%252Band%252Bmice%252Bxenograft%252Bdata%252Bof%252BAGM-130%252Bapplied%252Bto%252Bestimate%252Befficacious%252Bdoses%252Bin%252Bpatients%26aulast%3DPark%26aufirst%3DWan-Su%26date%3D2017%26date%3D2017%26volume%3D80%26issue%3D2%26spage%3D363%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Makoto  Sano</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Ichimaru</span>, <span class="hlFld-ContribAuthor ">Masahiro  Kurita</span>, <span class="hlFld-ContribAuthor ">Emiko  Hayashi</span>, <span class="hlFld-ContribAuthor ">Taku  Homma</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Saito</span>, <span class="hlFld-ContribAuthor ">Shinobu  Masuda</span>, <span class="hlFld-ContribAuthor ">Norimichi  Nemoto</span>, <span class="hlFld-ContribAuthor ">Akihiro  Hemmi</span>, <span class="hlFld-ContribAuthor ">Takashi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shinichi  Miyairi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3′-oxime and 5-methoxyindirubin 3′-oxime in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2017,</strong> <em>397 </em>, 72-82. <a href="https://doi.org/10.1016/j.canlet.2017.03.031" title="DOI URL">https://doi.org/10.1016/j.canlet.2017.03.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2017.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2017.03.031%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DInduction%252Bof%252Bcell%252Bdeath%252Bin%252Bpancreatic%252Bductal%252Badenocarcinoma%252Bby%252Bindirubin%252B3%2525E2%252580%2525B2-oxime%252Band%252B5-methoxyindirubin%252B3%2525E2%252580%2525B2-oxime%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DSano%26aufirst%3DMakoto%26date%3D2017%26volume%3D397%26spage%3D72%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cuiling  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaxu  Yan</span>, <span class="hlFld-ContribAuthor ">Mo  Du</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Burlison</span>, <span class="hlFld-ContribAuthor ">Chi  Li</span>, <span class="hlFld-ContribAuthor ">Yanni  Sun</span>, <span class="hlFld-ContribAuthor ">Danqing  Zhao</span>, <span class="hlFld-ContribAuthor ">Jianli  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">One step synthesis of indirubins by reductive coupling of isatins with KBH 4. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (19)
                                     , 2780-2785. <a href="https://doi.org/10.1016/j.tet.2017.03.077" title="DOI URL">https://doi.org/10.1016/j.tet.2017.03.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.03.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.03.077%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DOne%252Bstep%252Bsynthesis%252Bof%252Bindirubins%252Bby%252Breductive%252Bcoupling%252Bof%252Bisatins%252Bwith%252BKBH%252B4%26aulast%3DWang%26aufirst%3DCuiling%26date%3D2017%26volume%3D73%26issue%3D19%26spage%3D2780%26epage%3D2785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandra Sekhar  Kuruva</span>, <span class="hlFld-ContribAuthor ">P. Hemachandra  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (2)
                                     , 223-233. <a href="https://doi.org/10.1016/j.drudis.2016.10.010" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAmyloid%252Bbeta%252Bmodulators%252Band%252Bneuroprotection%252Bin%252BAlzheimer%252527s%252Bdisease%25253A%252Ba%252Bcritical%252Bappraisal%26aulast%3DKuruva%26aufirst%3DChandra%2BSekhar%26date%3D2017%26volume%3D22%26issue%3D2%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Yin</span>, <span class="hlFld-ContribAuthor ">Panpan  Huang</span>, <span class="hlFld-ContribAuthor ">Yingbing  Lu</span>, <span class="hlFld-ContribAuthor ">Liangxian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">TEMPO-catalyzed oxidative homocoupling route to 3,2′-biindolin-2-ones via an indolin-3-one intermediate. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (2)
                                     , 606-610. <a href="https://doi.org/10.1039/C6RA24834A" title="DOI URL">https://doi.org/10.1039/C6RA24834A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA24834A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA24834A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DTEMPO-catalyzed%252Boxidative%252Bhomocoupling%252Broute%252Bto%252B3%25252C2%2525E2%252580%2525B2-biindolin-2-ones%252Bvia%252Ban%252Bindolin-3-one%252Bintermediate%26aulast%3DYin%26aufirst%3DBo%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D2%26spage%3D606%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoela Viar  Fogaça</span>, <span class="hlFld-ContribAuthor ">Priscila de Matos  Cândido-Bacani</span>, <span class="hlFld-ContribAuthor ">Lucas Milanez  Benicio</span>, <span class="hlFld-ContribAuthor ">Lara Martinelli  Zapata</span>, <span class="hlFld-ContribAuthor ">Priscilla de Freitas  Cardoso</span>, <span class="hlFld-ContribAuthor ">Marcelo Tempesta  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Tamara Regina  Calvo</span>, <span class="hlFld-ContribAuthor ">Eliana Aparecida  Varanda</span>, <span class="hlFld-ContribAuthor ">Wagner  Vilegas</span>, <span class="hlFld-ContribAuthor ">Ilce Mara  de Syllos Cólus</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Biology</span><span> <strong>2017,</strong> <em>55 </em>
                                    (1)
                                     , 2005-2014. <a href="https://doi.org/10.1080/13880209.2017.1354387" title="DOI URL">https://doi.org/10.1080/13880209.2017.1354387</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13880209.2017.1354387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13880209.2017.1354387%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Biology%26atitle%3DEffects%252Bof%252Bindirubin%252Band%252Bisatin%252Bon%252Bcell%252Bviability%25252C%252Bmutagenicity%25252C%252Bgenotoxicity%252Band%252BBAX%25252FERCC1%252Bgene%252Bexpression%26aulast%3DFoga%25C3%25A7a%26aufirst%3DManoela%2BViar%26date%3D2017%26date%3D2017%26volume%3D55%26issue%3D1%26spage%3D2005%26epage%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Anticancer Potentials of Antipyretic Herbs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 17-192. <a href="https://doi.org/10.1201/9781315366753-3" title="DOI URL">https://doi.org/10.1201/9781315366753-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/9781315366753-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2F9781315366753-3%26sid%3Dliteratum%253Aachs%26atitle%3DAnticancer%252BPotentials%252Bof%252BAntipyretic%252BHerbs%26date%3D2016%26date%3D2016%26spage%3D17%26epage%3D192%26pub%3DCRC%2520Press%26atitle%3DCancer%252BInhibitors%252Bfrom%252BChinese%252BNatural%252BMedicines%26aulast%3DJun%26aufirst%3DXu%26date%3D2016%26date%3D2016%26volume%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myoung Eun  Jung</span>, <span class="hlFld-ContribAuthor ">Byung Jin  Byun</span>, <span class="hlFld-ContribAuthor ">Hye-Mi  Kim</span>, <span class="hlFld-ContribAuthor ">Joo Yun  Lee</span>, <span class="hlFld-ContribAuthor ">Jin-Hee  Park</span>, <span class="hlFld-ContribAuthor ">Nari  Lee</span>, <span class="hlFld-ContribAuthor ">You Hwa  Son</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>, <span class="hlFld-ContribAuthor ">Kyung-Min  Yang</span>, <span class="hlFld-ContribAuthor ">Seong-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Gildon  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2719-2723. <a href="https://doi.org/10.1016/j.bmcl.2016.03.111" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.111%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bindirubin%252Bderivatives%252Bas%252Bnew%252Bclass%252Bof%252BDRAK2%252Binhibitors%252Bfrom%252Bhigh%252Bthroughput%252Bscreening%26aulast%3DJung%26aufirst%3DMyoung%2BEun%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2719%26epage%3D2723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Ho  Park</span>, <span class="hlFld-ContribAuthor ">Yun Young  Lee</span>, <span class="hlFld-ContribAuthor ">Kyung Hee  Cho</span>, <span class="hlFld-ContribAuthor ">Sookie  La</span>, <span class="hlFld-ContribAuthor ">Hee Joo  Lee</span>, <span class="hlFld-ContribAuthor ">Dong-Seok  Yim</span>, <span class="hlFld-ContribAuthor ">Sooho  Ban</span>, <span class="hlFld-ContribAuthor ">Moon-Young  Park</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon-Gyoon  Kim</span>, <span class="hlFld-ContribAuthor ">Young G.  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Validation of a liquid chromatography-triple quadrupole mass spectrometric method for the determination of 5-nitro-5′-hydroxy-indirubin-3′-oxime (AGM-130) in human plasma and its application to microdose clinical trial. </span><span class="cited-content_cbyCitation_journal-name">Biomedical Chromatography</span><span> <strong>2016,</strong> <em>30 </em>
                                    (3)
                                     , 323-329. <a href="https://doi.org/10.1002/bmc.3551" title="DOI URL">https://doi.org/10.1002/bmc.3551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bmc.3551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbmc.3551%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520Chromatography%26atitle%3DValidation%252Bof%252Ba%252Bliquid%252Bchromatography-triple%252Bquadrupole%252Bmass%252Bspectrometric%252Bmethod%252Bfor%252Bthe%252Bdetermination%252Bof%252B5-nitro-5%2525E2%252580%2525B2-hydroxy-indirubin-3%2525E2%252580%2525B2-oxime%252B%252528AGM-130%252529%252Bin%252Bhuman%252Bplasma%252Band%252Bits%252Bapplication%252Bto%252Bmicrodose%252Bclinical%252Btrial%26aulast%3DPark%26aufirst%3DMin-Ho%26date%3D2016%26date%3D2015%26volume%3D30%26issue%3D3%26spage%3D323%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinlai  Cheng</span>, <span class="hlFld-ContribAuthor ">Karl-Heinz  Merz</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Indirubins in Inflammation and Associated Tumorigenesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 269-290. <a href="https://doi.org/10.1007/978-3-319-41342-6_12" title="DOI URL">https://doi.org/10.1007/978-3-319-41342-6_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-41342-6_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-41342-6_12%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Bof%252BIndirubins%252Bin%252BInflammation%252Band%252BAssociated%252BTumorigenesis%26aulast%3DCheng%26aufirst%3DXinlai%26date%3D2016%26date%3D2016%26spage%3D269%26epage%3D290%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDrug%252BDiscovery%252Bfrom%252BMother%252BNature%26aulast%3DGupta%26aufirst%3DSubash%2BChandra%26date%3D2016%26volume%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mudasir  Maqbool</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mobashir</span>, <span class="hlFld-ContribAuthor ">Nasimul  Hoda</span>. </span><span class="cited-content_cbyCitation_article-title">Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>107 </em>, 63-81. <a href="https://doi.org/10.1016/j.ejmech.2015.10.018" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.018%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPivotal%252Brole%252Bof%252Bglycogen%252Bsynthase%252Bkinase-3%25253A%252BA%252Btherapeutic%252Btarget%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DMaqbool%26aufirst%3DMudasir%26date%3D2016%26volume%3D107%26spage%3D63%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaochao  Huang</span>, <span class="hlFld-ContribAuthor ">Rizheng  Huang</span>, <span class="hlFld-ContribAuthor ">Zhixin  Liao</span>, <span class="hlFld-ContribAuthor ">Yingming  Pan</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>, <span class="hlFld-ContribAuthor ">Hengshan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 381-391. <a href="https://doi.org/10.1016/j.ejmech.2015.12.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bdehydroabietic%252Bacid%252Bthiourea%252Bderivatives%252Bcontaining%252Bbisphosphonate%252Bmoiety%252Bas%252Ban%252Binducer%252Bof%252Bapoptosis%26aulast%3DHuang%26aufirst%3DXiaochao%26date%3D2016%26volume%3D108%26spage%3D381%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seok-Ho  Shin</span>, <span class="hlFld-ContribAuthor ">Min-Ho  Park</span>, <span class="hlFld-ContribAuthor ">Jin-Ju  Byeon</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Young Geun  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">A Highly Sensitive Liquid Chromatography–Electrospray Ionization–Time of Flight/Mass Spectrometric Assay for the Quantitation of 4-Beta-Hydroxycholesterol and Its Application to
              in vivo
              Cytochrome P450 3a Induction by AGM-130. </span><span class="cited-content_cbyCitation_journal-name">Journal of Liquid Chromatography & Related Technologies</span><span> <strong>2015,</strong> <em>38 </em>
                                    (18)
                                     , 1675-1680. <a href="https://doi.org/10.1080/10826076.2015.1091009" title="DOI URL">https://doi.org/10.1080/10826076.2015.1091009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10826076.2015.1091009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10826076.2015.1091009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Liquid%2520Chromatography%2520%2526%2520Related%2520Technologies%26atitle%3DA%252BHighly%252BSensitive%252BLiquid%252BChromatography%2525E2%252580%252593Electrospray%252BIonization%2525E2%252580%252593Time%252Bof%252BFlight%25252FMass%252BSpectrometric%252BAssay%252Bfor%252Bthe%252BQuantitation%252Bof%252B4-Beta-Hydroxycholesterol%252Band%252BIts%252BApplication%252Bto%252Bin%252Bvivo%252BCytochrome%252BP450%252B3a%252BInduction%252Bby%252BAGM-130%26aulast%3DShin%26aufirst%3DSeok-Ho%26date%3D2015%26date%3D2015%26volume%3D38%26issue%3D18%26spage%3D1675%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhaoxiao  Du</span>, <span class="hlFld-ContribAuthor ">Zirong  Zhuang</span>, <span class="hlFld-ContribAuthor ">Yanjun  Wang</span>, <span class="hlFld-ContribAuthor ">Fen  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai  Liu</span>, <span class="hlFld-ContribAuthor ">Han  Wang</span>, <span class="hlFld-ContribAuthor ">Hairong  Feng</span>, <span class="hlFld-ContribAuthor ">Haoyuan  Li</span>, <span class="hlFld-ContribAuthor ">Liyan  Wang</span>, <span class="hlFld-ContribAuthor ">Xianghong  Zhang</span>, <span class="hlFld-ContribAuthor ">Aijun  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">E804 induces growth arrest, differentiation and apoptosis of glioblastoma cells by blocking Stat3 signaling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuro-Oncology</span><span> <strong>2015,</strong> <em>125 </em>
                                    (2)
                                     , 265-275. <a href="https://doi.org/10.1007/s11060-015-1917-8" title="DOI URL">https://doi.org/10.1007/s11060-015-1917-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11060-015-1917-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11060-015-1917-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuro-Oncology%26atitle%3DE804%252Binduces%252Bgrowth%252Barrest%25252C%252Bdifferentiation%252Band%252Bapoptosis%252Bof%252Bglioblastoma%252Bcells%252Bby%252Bblocking%252BStat3%252Bsignaling%26aulast%3DZhang%26aufirst%3DYanmin%26date%3D2015%26date%3D2015%26volume%3D125%26issue%3D2%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mee-Young  Ahn</span>, <span class="hlFld-ContribAuthor ">Tae-Hyung  Kim</span>, <span class="hlFld-ContribAuthor ">Seong-Min  Kwon</span>, <span class="hlFld-ContribAuthor ">Hyo-Eun  Yoon</span>, <span class="hlFld-ContribAuthor ">Hyung-Sik  Kim</span>, <span class="hlFld-ContribAuthor ">Jae-Il  Kim</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Keon-Wook  Kang</span>, <span class="hlFld-ContribAuthor ">Sang-Gun  Ahn</span>, <span class="hlFld-ContribAuthor ">Jung-Hoon  Yoon</span>. </span><span class="cited-content_cbyCitation_article-title">5-Nitro-5′-hydroxy-indirubin-3′-oxime (AGM130), an indirubin-3′-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2015,</strong> <em>79 </em>, 122-131. <a href="https://doi.org/10.1016/j.ejps.2015.08.015" title="DOI URL">https://doi.org/10.1016/j.ejps.2015.08.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2015.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2015.08.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3D5-Nitro-5%2525E2%252580%2525B2-hydroxy-indirubin-3%2525E2%252580%2525B2-oxime%252B%252528AGM130%252529%25252C%252Ban%252Bindirubin-3%2525E2%252580%2525B2-oxime%252Bderivative%25252C%252Binhibits%252Btumor%252Bgrowth%252Bby%252Binducing%252Bapoptosis%252Bagainst%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DAhn%26aufirst%3DMee-Young%26date%3D2015%26volume%3D79%26spage%3D122%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander M.  Sele</span>, <span class="hlFld-ContribAuthor ">John B.  Bremner</span>, <span class="hlFld-ContribAuthor ">Anthony C.  Willis</span>, <span class="hlFld-ContribAuthor ">Rachada  Haritakun</span>, <span class="hlFld-ContribAuthor ">Renate  Griffith</span>, <span class="hlFld-ContribAuthor ">Paul A.  Keller</span>. </span><span class="cited-content_cbyCitation_article-title">A cascade synthetic route to new bioactive spiroindolinepyrido[1,2-a]indolediones from indirubin. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (43)
                                     , 8357-8367. <a href="https://doi.org/10.1016/j.tet.2015.08.012" title="DOI URL">https://doi.org/10.1016/j.tet.2015.08.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.08.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DA%252Bcascade%252Bsynthetic%252Broute%252Bto%252Bnew%252Bbioactive%252Bspiroindolinepyrido%25255B1%25252C2-a%25255Dindolediones%252Bfrom%252Bindirubin%26aulast%3DSele%26aufirst%3DAlexander%2BM.%26date%3D2015%26volume%3D71%26issue%3D43%26spage%3D8357%26epage%3D8367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Yan</span>, <span class="hlFld-ContribAuthor ">Fangfang  Lai</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (11)
                                     , 2447-2451. <a href="https://doi.org/10.1016/j.bmcl.2015.03.066" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bindirubin-3%2525E2%252580%2525B2-monoxime%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bagainst%252BCDK2%252Band%252BCDK9%26aulast%3DYan%26aufirst%3DLei%26date%3D2015%26volume%3D25%26issue%3D11%26spage%3D2447%26epage%3D2451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongliang  Li</span>, <span class="hlFld-ContribAuthor ">Zhijie  Fang</span>, <span class="hlFld-ContribAuthor ">Huanran  Dai</span>, <span class="hlFld-ContribAuthor ">Hengrui  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Novel Oxime Analogues of the Hormone 1α, 25-Dihydroxyvitamin D
              3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2015,</strong> <em>39 </em>
                                    (6)
                                     , 368-372. <a href="https://doi.org/10.3184/174751915X14352521285949" title="DOI URL">https://doi.org/10.3184/174751915X14352521285949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751915X14352521285949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751915X14352521285949%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DEfficient%252BSynthesis%252Bof%252BNovel%252BOxime%252BAnalogues%252Bof%252Bthe%252BHormone%252B1%2525CE%2525B1%25252C%252B25-Dihydroxyvitamin%252BD%252B3%26aulast%3DLi%26aufirst%3DHongliang%26date%3D2015%26date%3D2019%26volume%3D39%26issue%3D6%26spage%3D368%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud-Kolar</span>, <span class="hlFld-ContribAuthor ">Konstantina  Vougogiannopoulou</span>, <span class="hlFld-ContribAuthor ">Alexios-Leandros  Skaltsounis</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin derivatives: a patent review (2010 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (5)
                                     , 583-593. <a href="https://doi.org/10.1517/13543776.2015.1019865" title="DOI URL">https://doi.org/10.1517/13543776.2015.1019865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1019865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1019865%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DIndirubin%252Bderivatives%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DGaboriaud-Kolar%26aufirst%3DNicolas%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D583%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-En  Qu</span>, <span class="hlFld-ContribAuthor ">Ri-Zhen  Huang</span>, <span class="hlFld-ContribAuthor ">Gui-Yang  Yao</span>, <span class="hlFld-ContribAuthor ">Jiu-Ling  Li</span>, <span class="hlFld-ContribAuthor ">Man-Yi  Ye</span>, <span class="hlFld-ContribAuthor ">Heng-Shan  Wang</span>, <span class="hlFld-ContribAuthor ">Liangxian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: Identification of novel proapoptotic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>95 </em>, 400-415. <a href="https://doi.org/10.1016/j.ejmech.2015.03.058" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.03.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.03.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.03.058%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bnovel%252Bbisindole%252Bderivatives%252Bbearing%252Boximes%252Bmoiety%25253A%252BIdentification%252Bof%252Bnovel%252Bproapoptotic%252Bagents%26aulast%3DQu%26aufirst%3DHong-En%26date%3D2015%26volume%3D95%26spage%3D400%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">LING  WANG</span>, <span class="hlFld-ContribAuthor ">XIANGLU  LI</span>, <span class="hlFld-ContribAuthor ">XINYU  LIU</span>, <span class="hlFld-ContribAuthor ">KANG  LU</span>, <span class="hlFld-ContribAuthor ">NA  CHEN</span>, <span class="hlFld-ContribAuthor ">PEIPEI  LI</span>, <span class="hlFld-ContribAuthor ">XIAO  LV</span>, <span class="hlFld-ContribAuthor ">XIN  WANG</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing effects of indirubin on the arsenic disulfide-induced apoptosis of human diffuse large B-cell lymphoma cells. </span><span class="cited-content_cbyCitation_journal-name">Oncology Letters</span><span> <strong>2015,</strong> <em>9 </em>
                                    (4)
                                     , 1940-1946. <a href="https://doi.org/10.3892/ol.2015.2941" title="DOI URL">https://doi.org/10.3892/ol.2015.2941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ol.2015.2941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fol.2015.2941%26sid%3Dliteratum%253Aachs%26jtitle%3DOncology%2520Letters%26atitle%3DEnhancing%252Beffects%252Bof%252Bindirubin%252Bon%252Bthe%252Barsenic%252Bdisulfide-induced%252Bapoptosis%252Bof%252Bhuman%252Bdiffuse%252Blarge%252BB-cell%252Blymphoma%252Bcells%26aulast%3DWANG%26aufirst%3DLING%26date%3D2015%26date%3D2015%26volume%3D9%26issue%3D4%26spage%3D1940%26epage%3D1946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshimi  Ichimaru</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Saito</span>, <span class="hlFld-ContribAuthor ">Taketo  Uchiyama</span>, <span class="hlFld-ContribAuthor ">Koichi  Metori</span>, <span class="hlFld-ContribAuthor ">Keiichi  Tabata</span>, <span class="hlFld-ContribAuthor ">Takashi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shinichi  Miyairi</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin 3′-(O-oxiran-2-ylmethyl)oxime: A novel anticancer agent. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 1403-1406. <a href="https://doi.org/10.1016/j.bmcl.2015.02.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.02.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.02.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.02.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIndirubin%252B3%2525E2%252580%2525B2-%252528O-oxiran-2-ylmethyl%252529oxime%25253A%252BA%252Bnovel%252Banticancer%252Bagent%26aulast%3DIchimaru%26aufirst%3DYoshimi%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D1403%26epage%3D1406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasat  Kittakoop</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Drugs and Potential Anticancer Leads Inspired by Natural Products. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 251-307. <a href="https://doi.org/10.1016/B978-0-444-63460-3.00005-5" title="DOI URL">https://doi.org/10.1016/B978-0-444-63460-3.00005-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63460-3.00005-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63460-3.00005-5%26sid%3Dliteratum%253Aachs%26atitle%3DAnticancer%252BDrugs%252Band%252BPotential%252BAnticancer%252BLeads%252BInspired%252Bby%252BNatural%252BProducts%26aulast%3DKittakoop%26aufirst%3DPrasat%26date%3D2015%26spage%3D251%26epage%3D307%26pub%3DElsevier%26date%3D2015%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Le  Jin</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Dong  Liang</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Ye  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying-Ming  Pan</span>, <span class="hlFld-ContribAuthor ">Heng-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 370-385. <a href="https://doi.org/10.1016/j.ejmech.2014.10.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%2525C2%2525A0vitro%252Bevaluation%252Bof%252Bnovel%252Bdehydroabietic%252Bacid%252Bderivatives%252Bcontaining%252Ba%252Bdipeptide%252Bmoiety%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DHuang%26aufirst%3DXiao-Chao%26date%3D2015%26volume%3D89%26spage%3D370%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Da-Woon  Jung</span>, <span class="hlFld-ContribAuthor ">Young J.  Hong</span>, <span class="hlFld-ContribAuthor ">Soo-Yeon  Kim</span>, <span class="hlFld-ContribAuthor ">Woong-Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Shinae  Seo</span>, <span class="hlFld-ContribAuthor ">Jung-Eun  Lee</span>, <span class="hlFld-ContribAuthor ">Haihong  Shen</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Darren R.  Williams</span>. </span><span class="cited-content_cbyCitation_article-title">5-Nitro-5′hydroxy-indirubin-3′oxime Is a Novel Inducer of Somatic Cell Transdifferentiation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2014,</strong> <em>347 </em>
                                    (11)
                                     , 806-818. <a href="https://doi.org/10.1002/ardp.201400223" title="DOI URL">https://doi.org/10.1002/ardp.201400223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400223%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3D5-Nitro-5%2525E2%252580%2525B2hydroxy-indirubin-3%2525E2%252580%2525B2oxime%252BIs%252Ba%252BNovel%252BInducer%252Bof%252BSomatic%252BCell%252BTransdifferentiation%26aulast%3DJung%26aufirst%3DDa-Woon%26date%3D2014%26date%3D2014%26volume%3D347%26issue%3D11%26spage%3D806%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaiprakash N.  Sangshetti</span>, <span class="hlFld-ContribAuthor ">Deepak K.  Lokwani</span>, <span class="hlFld-ContribAuthor ">Rashmi S.  Chouthe</span>, <span class="hlFld-ContribAuthor ">Ashok  Ganure</span>, <span class="hlFld-ContribAuthor ">Bhuvan  Raval</span>, <span class="hlFld-ContribAuthor ">Firoz A. Kalam  Khan</span>, <span class="hlFld-ContribAuthor ">Devanand B.  Shinde</span>. </span><span class="cited-content_cbyCitation_article-title">Green synthesis and biological evaluation of some new benzothiazolo [2,3-b] quinazolin-1-ones as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (11)
                                     , 4893-4900. <a href="https://doi.org/10.1007/s00044-014-1044-7" title="DOI URL">https://doi.org/10.1007/s00044-014-1044-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1044-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1044-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DGreen%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252Bnew%252Bbenzothiazolo%252B%25255B2%25252C3-b%25255D%252Bquinazolin-1-ones%252Bas%252Banticancer%252Bagents%26aulast%3DSangshetti%26aufirst%3DJaiprakash%2BN.%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D11%26spage%3D4893%26epage%3D4900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toru  Tanaka</span>, <span class="hlFld-ContribAuthor ">Sachiyo  Ohashi</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Saito</span>, <span class="hlFld-ContribAuthor ">Takashi  Higuchi</span>, <span class="hlFld-ContribAuthor ">Keiichi  Tabata</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Kosuge</span>, <span class="hlFld-ContribAuthor ">Takashi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shinichi  Miyairi</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Kobayashi</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin derivatives alter DNA binding activity of the transcription factor NF-Y and inhibit MDR1 gene promoter. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2014,</strong> <em>741 </em>, 83-89. <a href="https://doi.org/10.1016/j.ejphar.2014.07.035" title="DOI URL">https://doi.org/10.1016/j.ejphar.2014.07.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2014.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2014.07.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DIndirubin%252Bderivatives%252Balter%252BDNA%252Bbinding%252Bactivity%252Bof%252Bthe%252Btranscription%252Bfactor%252BNF-Y%252Band%252Binhibit%252BMDR1%252Bgene%252Bpromoter%26aulast%3DTanaka%26aufirst%3DToru%26date%3D2014%26volume%3D741%26spage%3D83%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucy  Liu</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud</span>, <span class="hlFld-ContribAuthor ">Konstantina  Vougogianopoulou</span>, <span class="hlFld-ContribAuthor ">Yan  Tian</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Wei  Wen</span>, <span class="hlFld-ContribAuthor ">Leandros  Skaltsounis</span>, <span class="hlFld-ContribAuthor ">Richard  Jove</span>. </span><span class="cited-content_cbyCitation_article-title">MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2014,</strong> <em>15 </em>
                                    (2)
                                     , 178-184. <a href="https://doi.org/10.4161/cbt.26721" title="DOI URL">https://doi.org/10.4161/cbt.26721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/cbt.26721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fcbt.26721%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DMLS-2384%25252C%252Ba%252Bnew%252B6-bromoindirubin%252Bderivative%252Bwith%252Bdual%252BJAK%25252FSrc%252Bkinase%252Binhibitory%252Bactivity%25252C%252Bsuppresses%252Bgrowth%252Bof%252Bdiverse%252Bcancer%252Bcells%26aulast%3DLiu%26aufirst%3DLucy%26date%3D2014%26date%3D2013%26volume%3D15%26issue%3D2%26spage%3D178%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Bergman</span>, <span class="hlFld-ContribAuthor ">Birgitta  Stensland</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclization of Cyanoethylated Ketones as a Route to 6-Substituted Indole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2014,</strong> <em>51 </em>
                                    (1)
                                     , 1-10. <a href="https://doi.org/10.1002/jhet.2048" title="DOI URL">https://doi.org/10.1002/jhet.2048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2048%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DCyclization%252Bof%252BCyanoethylated%252BKetones%252Bas%252Ba%252BRoute%252Bto%252B6-Substituted%252BIndole%252BDerivatives%26aulast%3DBergman%26aufirst%3DJan%26date%3D2014%26date%3D2013%26volume%3D51%26issue%3D1%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud-Kolar</span>, <span class="hlFld-ContribAuthor ">Sangkil  Nam</span>, <span class="hlFld-ContribAuthor ">Alexios-Leandros  Skaltsounis</span>. </span><span class="cited-content_cbyCitation_article-title">A Colorful History: The Evolution of Indigoids. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 69-145. <a href="https://doi.org/10.1007/978-3-319-04900-7_2" title="DOI URL">https://doi.org/10.1007/978-3-319-04900-7_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-04900-7_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-04900-7_2%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BColorful%252BHistory%25253A%252BThe%252BEvolution%252Bof%252BIndigoids%26aulast%3DGaboriaud-Kolar%26aufirst%3DNicolas%26date%3D2014%26date%3D2014%26spage%3D69%26epage%3D145%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProgress%252Bin%252Bthe%252BChemistry%252Bof%252BOrganic%252BNatural%252BProducts%252B99%26aulast%3DKinghorn%26aufirst%3DA.%2BD.%26date%3D2014%26volume%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun-Kyung  Shin</span>, <span class="hlFld-ContribAuthor ">Jin-Kyung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Indirubin derivative E804 inhibits angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2012,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1471-2407-12-164" title="DOI URL">https://doi.org/10.1186/1471-2407-12-164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1471-2407-12-164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1471-2407-12-164%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DIndirubin%252Bderivative%252BE804%252Binhibits%252Bangiogenesis%26aulast%3DShin%26aufirst%3DEun-Kyung%26date%3D2012%26date%3D2012%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucy  Liu</span>, <span class="hlFld-ContribAuthor ">Marina  Kritsanida</span>, <span class="hlFld-ContribAuthor ">Prokopios  Magiatis</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Ralf  Buettner</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Sangkil  Nam</span>, <span class="hlFld-ContribAuthor ">Leandros  Skaltsounis</span>, <span class="hlFld-ContribAuthor ">Richard  Jove</span>. </span><span class="cited-content_cbyCitation_article-title">A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biology & Therapy</span><span> <strong>2012,</strong> <em>13 </em>
                                    (13)
                                     , 1255-1261. <a href="https://doi.org/10.4161/cbt.21781" title="DOI URL">https://doi.org/10.4161/cbt.21781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/cbt.21781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fcbt.21781%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biology%2520%2526%2520Therapy%26atitle%3DA%252Bnovel%252B7-bromoindirubin%252Bwith%252Bpotent%252Banticancer%252Bactivity%252Bsuppresses%252Bsurvival%252Bof%252Bhuman%252Bmelanoma%252Bcells%252Bassociated%252Bwith%252Binhibition%252Bof%252BSTAT3%252Band%252BAkt%252Bsignaling%26aulast%3DLiu%26aufirst%3DLucy%26date%3D2012%26date%3D2012%26volume%3D13%26issue%3D13%26spage%3D1255%26epage%3D1261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margarita  Maurer</span>, <span class="hlFld-ContribAuthor ">Oxana  Komina</span>, <span class="hlFld-ContribAuthor ">Józefa  Węsierska-Gądek</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Compounds as Specific Inhibitors of Cyclin-Dependent Kinases – Past, Present and Future. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 347-371. <a href="https://doi.org/10.1007/978-94-007-4575-9_14" title="DOI URL">https://doi.org/10.1007/978-94-007-4575-9_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-94-007-4575-9_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-94-007-4575-9_14%26sid%3Dliteratum%253Aachs%26atitle%3DNatural%252BCompounds%252Bas%252BSpecific%252BInhibitors%252Bof%252BCyclin-Dependent%252BKinases%252B%2525E2%252580%252593%252BPast%25252C%252BPresent%252Band%252BFuture%26aulast%3DMaurer%26aufirst%3DMargarita%26date%3D2012%26date%3D2012%26spage%3D347%26epage%3D371%26pub%3DSpringer%2520Netherlands%26atitle%3DNatural%252Bcompounds%252Bas%252Binducers%252Bof%252Bcell%252Bdeath%26aulast%3DDiederich%26aufirst%3DMarc%26date%3D2012%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroaki  Saito</span>, <span class="hlFld-ContribAuthor ">Keiichi  Tabata</span>, <span class="hlFld-ContribAuthor ">Satoshi  Hanada</span>, <span class="hlFld-ContribAuthor ">Yuko  Kanda</span>, <span class="hlFld-ContribAuthor ">Takashi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shinichi  Miyairi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of methoxy- and bromo-substituted indirubins and their activities on apoptosis induction in human neuroblastoma cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (18)
                                     , 5370-5373. <a href="https://doi.org/10.1016/j.bmcl.2011.07.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bmethoxy-%252Band%252Bbromo-substituted%252Bindirubins%252Band%252Btheir%252Bactivities%252Bon%252Bapoptosis%252Binduction%252Bin%252Bhuman%252Bneuroblastoma%252Bcells%26aulast%3DSaito%26aufirst%3DHiroaki%26date%3D2011%26volume%3D21%26issue%3D18%26spage%3D5370%26epage%3D5373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  Lan</span>, <span class="hlFld-ContribAuthor ">Wan-Na  Chen</span>, <span class="hlFld-ContribAuthor ">Gao-Keng  Xiao</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (22)
                                     , 6764-6772. <a href="https://doi.org/10.1016/j.bmcl.2010.08.131" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.08.131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.08.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.08.131%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudies%252Bon%252Bpyrazolo%25255B4%25252C3-h%25255Dqinazoline-3-carboxamides%252Bas%252Bcyclin-dependent%252Bkinase%252B2%252B%252528CDK2%252529%252Binhibitors%26aulast%3DLan%26aufirst%3DPing%26date%3D2010%26volume%3D20%26issue%3D22%26spage%3D6764%26epage%3D6772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of indirubin derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding mode of <b>2</b> and <b>3a</b> in the ATP binding site of CDK2. (a) Network of hydrogen bonds (green dashed lines) between <b>2</b> and the backbone amino acids in the ATP binding pocket of CDK2. Binding mode of <b>2</b> with CDK2 displays three hydrogen bonds between two nitrogen of <b>2</b> and Leu83 and Glu81 in the CDK2 hinge region, additional hydrogen bond between the oxime moiety and carbonyl oxygen of Gln131, and a salt bridge formed between 5-nitro group and the side chains of Lys33, Asp145. (b) van der Waals surface of CDK2 with <b>2</b> in CPK representation. 5′-Bromo group is projected toward the outer aqueous space of ATP binding pocket that presents a positively charged amino acid residue, Lys89. (c) Network of hydrogen bonds (green dashed lines) between <b>3a</b> and the backbone amino acids in the ATP binding pocket of CDK2. <b>3a</b> forms an additional hydrogen bond between the 5′-hydroxy group and the carboxylic acid of Asp86. This may further improve CDK2 inhibitory activity. (d) Molecular surface representation of CDK2 with <b>3a</b> bound in the ATP binding site. Some important amino acids lying within binding surface are displayed. The 5′-hydroxy group is pointing out of the pocket toward the solvent.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 5-Substituted Indoxyl-<i>N</i>,<i>O</i>-diacetate<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (i) ethyl glyoxalate, NaCNBH<sub>3</sub>, 1% acetic acid, methanol, room temp, 3 h, 85−95%; (ii) 1N NaOH (aq), methanol, room temp, 1 h, 90%; (iii) acetic anhydride, Na<sub>2</sub>CO<sub>3</sub>, reflux, 4 h, 65−72%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5,5′-Substituted Indirubin-3′-oxime Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (i) Na<sub>2</sub>CO<sub>3</sub>, methanol or methanol: water (2:1), room temp, 2−3 h, 35−65%; (ii) H<sub>2</sub>NOH·HCl, pyridine, reflux, 0.5−3 h, 65−70%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 5-Substituted-5′-methoxy-indirubin-3′-oxime Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (i) CH<sub>3</sub>I, K<sub>2</sub>CO<sub>3</sub>, acetone, room temp, 4 h, 58−65%; (ii) H<sub>2</sub>NOH·HCl, pyridine, reflux, 0.5−3 h, 65−70%.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. CDK1 and CDK2 % activity in the presence of 1 μM of 5,5′-substituted indirubin-3′-oxime derivatives. New indirubin derivatives (1 μM) were tested for their inhibitory effects in the kinase activity of CDK1/cyclin B and CDK2/cyclin E. 5-Nitroindirubin-3′-oxime (<b>1</b>) was also tested for comparison. Results are presented as the mean ± standard error of the mean (SEM) of the % kinase activity of CDK1 and CDK2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinase panel screening of <b>3a</b>, <b>4a</b>. Compounds <b>3a</b> and <b>4a</b> (10 μM) were tested against more diverse panel of kinases comprising of receptor tyrosine kinases, serine/threonine kinases, and lipid kinase. Results are presented as the mean ± standard error of the mean (SEM) of the % kinase activity. <b>3a</b> showed 9% inhibitory activity against TrkA at 1 μM. IC<sub>50</sub> values of <b>3a</b> against two serine/threonine kinases, Aurora A (1 μM) and IKKβ (10 μM), and a receptor tyrosine kinase, TrkA (4 μM) were calculated from the dose−response curves.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of tumor growth by <b>3a</b>. (a) The SD-rats were injected with RK3E-ras-Luc cells (5 × 10<sup>6</sup>/100 μL). When the tumor reached 5 mm in size, the rats were injected intravenously with <b>3a</b> (5 mg/kg) in nonanesthesia states every other day for a total of five times. The tumor size was measured by caliper as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (b) Representative excised subcutaneous tumor from the control and <b>3a</b> treated rats. (c) In vivo bioluminescence imaging assay from the control and <b>3a</b> treated rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/medium/jm-2010-00080z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Histology and immunohistochemistry of tumor tissue. RK3E-ras-Luc cells were inoculated sc on the left flank of rats. <b>3a</b> (5 mg/kg) was injected intravenously into the tumor bearing rats every other day beginning from day 5. The rats were sacrificed on day 11. (a) H&E staining of tumor sections (left), TUNEL assay on paraffin sections from solid tumor (center), and immunohistochemical staining for PCNA (right), (b) positive cells for TUNEL assay, (c) positive cells for PCNA immunostaining. Cells were counted in triplicate. Columns, mean; bars, SD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-9/jm100080z/production/images/large/jm-2010-00080z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100080z&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Harper, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span> </span><span class="NLM_article-title">Cyclin-dependent kinases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">2511</span><span class="NLM_x">–</span> <span class="NLM_lpage">2526</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0001030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2511-2526&author=J.+W.+Harperauthor=P.+D.+Adams&title=Cyclin-dependent+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fcr0001030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0001030%26sid%3Dliteratum%253Aachs%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DCyclin-dependent%2520kinases%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D2511%26epage%3D2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morgan, D. O.</span><span> </span><span class="NLM_article-title">Principles of CDK regulation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1038%2F374131a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=7877684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK2MXkt1yju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=1995&pages=131-134&author=D.+O.+Morgan&title=Principles+of+CDK+regulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of CDK regulation</span></div><div class="casAuthors">Morgan, David O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">6518</span>),
    <span class="NLM_cas:pages">131-4</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">A review with 77 refs.  As key regulators of the cell cycle, the cyclin-dependent kinases (CDKs) must be tightly regulated by extra- and intracellular signals.  The activity of cyclin-dependent kinases is controlled by four highly conserved biochem. mechanisms, forming a web of regulatory pathways unmatched in its elegance and intricacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrQWC7U9kpj7Vg90H21EOLACvtfcHk0ljkXorPpHgL_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkt1yju7s%253D&md5=3dafa23aec02e4887757b100abb52d89</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F374131a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F374131a0%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DD.%2BO.%26atitle%3DPrinciples%2520of%2520CDK%2520regulation%26jtitle%3DNature%26date%3D1995%26volume%3D374%26spage%3D131%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Dyson, N.</span><span> </span><span class="NLM_article-title">The regulation of E2F by pRB-family proteins</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2245</span><span class="NLM_x">–</span> <span class="NLM_lpage">2262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1101%2Fgad.12.15.2245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=9694791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=2245-2262&author=N.+Dyson&title=The+regulation+of+E2F+by+pRB-family+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The regulation of E2F by pRB-family proteins</span></div><div class="casAuthors">Dyson, Nicholas</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2245-2262</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review with over 100 refs.  Topics include: Introduction to the families of E2F and DP proteins (free E2F, complexed E2F), E2F-binding sites mediate both transcriptional activation and repression (E2F as a transcriptional activator, E2F-mediated repression), Activation of E2F-dependent transcription (phosphorylation of pRB-family members, phosphorylation of E2F-1, changes in the subcellular localization of specific E2F complexes, synthesis of new E2Fs), Inactivation of E2F (E2F/DP phosphorylation, degrdn. of free E2F, E2F-repressors), Consequences of elevated E2F activity-ectopic S-phase entry and apoptosis, Is E2F required for S-phase entry, What are the key targets of E2F activity, What is the role of pRB in E2F regulation, Is the ability of pRB to bind E2F important for pRB's role as a tumor suppressor, and How can E2F-1 be both an oncogene and a tumor suppressor gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeXAl9aLvm5bVg90H21EOLACvtfcHk0ljkXorPpHgL_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlagu74%253D&md5=755af21d258487f59a09899698e860e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fgad.12.15.2245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.12.15.2245%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DN.%26atitle%3DThe%2520regulation%2520of%2520E2F%2520by%2520pRB-family%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D1998%26volume%3D12%26spage%3D2245%26epage%3D2262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The retinoblastoma protein and cell cycle control</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2F0092-8674%2895%2990385-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=7736585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFSrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1995&pages=323-330&author=R.+A.+Weinberg&title=The+retinoblastoma+protein+and+cell+cycle+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The retinoblastoma protein and cell cycle control</span></div><div class="casAuthors">Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-30</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review, with 84 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfCbQVri28wrVg90H21EOLACvtfcHk0lh-yD7kDgMwfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFSrs7k%253D&md5=e91678411f19f45ab0cd434d7112a16a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2895%2990385-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252895%252990385-2%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520retinoblastoma%2520protein%2520and%2520cell%2520cycle%2520control%26jtitle%3DCell%26date%3D1995%26volume%3D81%26spage%3D323%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chen, Y. N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bair, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaelin, W. G.,  Jr.</span><span> </span><span class="NLM_article-title">Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">4325</span><span class="NLM_x">–</span> <span class="NLM_lpage">4329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4325-4329&author=Y.+N.+P.+Chenauthor=S.+K.+Sharmaauthor=T.+M.+Ramseyauthor=L.+Jiangauthor=M.+S.+Martinauthor=K.+Bakerauthor=P.+D.+Adamsauthor=K.+W.+Bairauthor=W.+G.+Kaelin&title=Selective+killing+of+transformed+cells+by+cyclin%2Fcyclin-dependent+kinase+2+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BN.%2BP.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DRamsey%26aufirst%3DT.%2BM.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DM.%2BS.%26aulast%3DBaker%26aufirst%3DK.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DSelective%2520killing%2520of%2520transformed%2520cells%2520by%2520cyclin%252Fcyclin-dependent%2520kinase%25202%2520antagonists%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D4325%26epage%3D4329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J. W.</span><span> </span><span class="NLM_article-title">Anticancer drug targets: cell cycle and checkpoint control</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">1645</span><span class="NLM_x">–</span> <span class="NLM_lpage">1653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1999&pages=1645-1653&author=G.+I.+Shapiroauthor=J.+W.+Harper&title=Anticancer+drug+targets%3A+cell+cycle+and+checkpoint+control"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26atitle%3DAnticancer%2520drug%2520targets%253A%2520cell%2520cycle%2520and%2520checkpoint%2520control%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1999%26volume%3D104%26spage%3D1645%26epage%3D1653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Van Den Heuvel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlow, E.</span><span> </span><span class="NLM_article-title">Distinct roles for cyclin-dependent kinases in cell cycle control</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">2050</span><span class="NLM_x">–</span> <span class="NLM_lpage">2054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=1993&pages=2050-2054&author=S.+Van+Den+Heuvelauthor=E.+Harlow&title=Distinct+roles+for+cyclin-dependent+kinases+in+cell+cycle+control"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDen%2BHeuvel%26aufirst%3DS.%26aulast%3DHarlow%26aufirst%3DE.%26atitle%3DDistinct%2520roles%2520for%2520cyclin-dependent%2520kinases%2520in%2520cell%2520cycle%2520control%26jtitle%3DScience%26date%3D1993%26volume%3D262%26spage%3D2050%26epage%3D2054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Loyer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembley, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kidd, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahti, J. M.</span><span> </span><span class="NLM_article-title">Role of CDK/cyclin complexes in transcription and RNA splicing</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2Fj.cellsig.2005.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=15935619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvVWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=1033-1051&author=P.+Loyerauthor=J.+H.+Trembleyauthor=R.+Katonaauthor=V.+J.+Kiddauthor=J.+M.+Lahti&title=Role+of+CDK%2Fcyclin+complexes+in+transcription+and+RNA+splicing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of CDK/cyclin complexes in transcription and RNA splicing</span></div><div class="casAuthors">Loyer, Pascal; Trembley, Janeen H.; Katona, Robert; Kidd, Vincent J.; Lahti, Jill M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1033-1051</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The prodn. of mRNAs in all living organisms is an extremely complex process that includes multiple catalytic activities such as transcription, capping, splicing, polyadenylation, cleavage and export.  All of these processes are controlled by a large group of proteins which form very dynamic complexes interacting with DNA and pre-mRNAs to coordinate these activities.  Phosphorylations play a central role in regulating formation, activation and inactivation of these complexes.  A growing no. of protein kinases have been identified that are capable of phosphorylating proteins involved in mRNA prodn.  Among them, Cyclin-dependent Kinases (CDKs) represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner.  CDK/cyclin complexes were first identified as crucial regulators of cell cycle progression.  More recently, CDK/cyclin complexes have also been implicated in transcription and mRNA processing leading to the concept of an intricate network of CDK/cyclin complexes regulating cell cycle, transcription and mRNA processing via cross-talk between multiple CDKs.  In this review, we discuss the role of CDK/cyclin-dependent phosphorylation in the regulation of transcription and RNA splicing and highlight recent findings that indicate the involvement of CDK/cyclin complexes in connecting transcription and RNA splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQcV5te0YC-bVg90H21EOLACvtfcHk0lh-yD7kDgMwfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvVWktrc%253D&md5=67633beca40a4ba0f9739dedaadd0bf6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DLoyer%26aufirst%3DP.%26aulast%3DTrembley%26aufirst%3DJ.%2BH.%26aulast%3DKatona%26aufirst%3DR.%26aulast%3DKidd%26aufirst%3DV.%2BJ.%26aulast%3DLahti%26aufirst%3DJ.%2BM.%26atitle%3DRole%2520of%2520CDK%252Fcyclin%2520complexes%2520in%2520transcription%2520and%2520RNA%2520splicing%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D1033%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbie, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory Matera, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harlow, E.</span><span> </span><span class="NLM_article-title">NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2283</span><span class="NLM_x">–</span> <span class="NLM_lpage">2297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1101%2Fgad.827700" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=10995386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntVSksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=2283-2297&author=J.+Zhaoauthor=B.+K.+Kennedyauthor=B.+D.+Lawrenceauthor=D.+A.+Barbieauthor=A.+Gregory+Materaauthor=J.+A.+Fletcherauthor=E.+Harlow&title=NPAT+links+cyclin+E-Cdk2+to+the+regulation+of+replication-dependent+histone+gene+transcription"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription</span></div><div class="casAuthors">Zhao, Jiyong; Kennedy, Brian K.; Lawrence, Brandon D.; Barbie, David A.; Matera, A. Gregory; Fletcher, Jonathan A.; Harlow, Ed</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2283-2297</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In eukaryotic cells, histone gene expression is one of the major events that mark entry into S phase.  While this process is tightly linked to cell cycle position, how it is regulated by the cell cycle machinery is not known.  Here we show that NPAT, a substrate of the cyclin E-Cdk2 complex, is assocd. with human replication-dependent histone gene clusters on both chromosomes 1 and 6 in S phase.  We demonstrate that NPAT activates histone gene transcription and that this activation is dependent on the promoter elements (SSCSs) previously proposed to mediate cell cycle-dependent transcription.  Cyclin E is also assocd. with the histone gene loci, and cyclin E-Cdk2 stimulates the NPAT-mediated activation of histone gene transcription.  Thus, our results both show that NPAT is involved in a key S phase event and provide a link between the cell cycle machinery and activation of histone gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRbuObWDETobVg90H21EOLACvtfcHk0lgIG5oazG-o5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntVSksrw%253D&md5=9fb6bc6ddaf471cfff4ef61a7409e175</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1101%2Fgad.827700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.827700%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DB.%2BK.%26aulast%3DLawrence%26aufirst%3DB.%2BD.%26aulast%3DBarbie%26aufirst%3DD.%2BA.%26aulast%3DGregory%2BMatera%26aufirst%3DA.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DHarlow%26aufirst%3DE.%26atitle%3DNPAT%2520links%2520cyclin%2520E-Cdk2%2520to%2520the%2520regulation%2520of%2520replication-dependent%2520histone%2520gene%2520transcription%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D2283%26epage%3D2297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">To cycle or not to cycle: a critical decision in cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1038%2F35106065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=11902577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=222-231&author=M.+Malumbresauthor=M.+Barbacid&title=To+cycle+or+not+to+cycle%3A+a+critical+decision+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Milestones in cell division: to cycle or not to cycle: a critical decision in cancer</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-231</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor cells undergo uncontrolled proliferation, yet tumors most often originate from adult tissues, in which most cells are quiescent.  So, the proliferative advantage of tumor cells arises from their ability to bypass quiescence.  This can be due to increased mitogenic signaling and/or alterations that lower the threshold required for cell-cycle commitment.  Understanding the mol. mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI2EOLFB2ULbVg90H21EOLACvtfcHk0lgIG5oazG-o5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtrg%253D&md5=2bd8961854332a30c814f8ac2f9bd6f4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2F35106065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106065%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DTo%2520cycle%2520or%2520not%2520to%2520cycle%253A%2520a%2520critical%2520decision%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Porter, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heagerty, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firpo, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daling, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span> </span><span class="NLM_article-title">Expression of cell-cycle regulators p27 (Kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1038%2Fnm0297-222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=9018243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK2sXpsFSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=222-225&author=P.+L.+Porterauthor=K.+E.+Maloneauthor=P.+J.+Heagertyauthor=G.+M.+Alexanderauthor=L.+A.+Gattiauthor=E.+J.+Firpoauthor=J.+R.+Dalingauthor=J.+M.+Roberts&title=Expression+of+cell-cycle+regulators+p27+%28Kip1%29+and+cyclin+E%2C+alone+and+in+combination%2C+correlate+with+survival+in+young+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients</span></div><div class="casAuthors">Porter, Peggy L.; Malone, Kathleen E.; Heagerty, Patrick J.; Alexander, Gail M.; Gatti, Laura A.; Firpo, Eduardo J.; Daling, Janet R.; Roberts, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-225</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Mutations in certain genes that regulate the cell cycle, such as p16 and p53, are frequently found in human cancers.  However, tumor-specific mutations are uncommon in genes encoding cyclin E and the CDK inhibitor p27Kip1, two cell-cycle regulators that are also thought to contribute to tumor progression.  It is now known that levels of both cyclin E and p27 can be controlled by posttranscriptional mechanisms, indicating that expression of these proteins can be altered by means other than simply mutation of their resp. genes.  Thus, changes in p27 and cyclin E protein levels in tumors might be more common than previously anticipated and may be indicators of tumor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruaF7He4NtFbVg90H21EOLACvtfcHk0lgIG5oazG-o5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXpsFSlsA%253D%253D&md5=d44e207626ba809dca0002d206e5df4f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm0297-222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0297-222%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DP.%2BL.%26aulast%3DMalone%26aufirst%3DK.%2BE.%26aulast%3DHeagerty%26aufirst%3DP.%2BJ.%26aulast%3DAlexander%26aufirst%3DG.%2BM.%26aulast%3DGatti%26aufirst%3DL.%2BA.%26aulast%3DFirpo%26aufirst%3DE.%2BJ.%26aulast%3DDaling%26aufirst%3DJ.%2BR.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520of%2520cell-cycle%2520regulators%2520p27%2520%2528Kip1%2529%2520and%2520cyclin%2520E%252C%2520alone%2520and%2520in%2520combination%252C%2520correlate%2520with%2520survival%2520in%2520young%2520breast%2520cancer%2520patients%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D222%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Schraml, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kononen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihatsch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirnhofer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, G.</span><span> </span><span class="NLM_article-title">Cyclin E overexpression and amplification in human tumours</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">200</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">382</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1002%2Fpath.1356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=12845634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvF2nsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2003&pages=375-382&author=P.+Schramlauthor=C.+Bucherauthor=H.+Bissigauthor=A.+Nocitoauthor=P.+Haasauthor=K.+Wilberauthor=S.+Seeligauthor=J.+Kononenauthor=M.+J.+Mihatschauthor=S.+Dirnhoferauthor=G.+Sauter&title=Cyclin+E+overexpression+and+amplification+in+human+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin E overexpression and amplification in human tumours</span></div><div class="casAuthors">Schraml, Peter; Bucher, Christoph; Bissig, Heidi; Nocito, Antonio; Haas, Philippe; Wilber, Kim; Seelig, Steven; Kononen, Juha; Mihatsch, Michael J.; Dimhofer, Stefan; Sauter, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-382</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Cyclin E amplification and overexpression have recently been described in several tumor types.  However, many tumor entities have never been examd. for cyclin E alterations.  Numerous and time-consuming expts. were previously required to det. the significance of potential oncogenes across different tumor types.  To overcome this problem, tissue microarrays (TMAs) consisting of 3670 primary tumors from 128 different tumor types, 709 metastases, and 354 normal tissues were generated.  Cyclin E alterations were then analyzed by fluorescence in situ hybridization (FISH) and immunohistochem. (IHC).  Cyclin E gene amplification was obsd. in 15 different tumor types and subtypes, ie rhabdomyosarcoma, urinary bladder cancer (three subtypes), ovarian cancer (two subtypes), malignant fibrous histiocytoma, adenocarcinoma of the small intestine, medullary breast cancer, gall bladder adenocarcinoma, phaeochromocytoma, gastric adenocarcinoma, squamous cell carcinoma of the uterine cervix, colonic adenocarcinoma, and endometrial carcinoma.  Cyclin E protein accumulation was found in 48 different tumor types.  The use of TMA technol. has enabled us to expand considerably our knowledge of cyclin E alterations in human tumors.  The occurrence of amplification and overexpression in many different tumor types suggests that cyclin E plays an important role in tumor biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogqAhzjv-uQbVg90H21EOLACvtfcHk0ljtbKOyue6m4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvF2nsrk%253D&md5=0476c7815a908fff3e508bf16aeca91b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fpath.1356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1356%26sid%3Dliteratum%253Aachs%26aulast%3DSchraml%26aufirst%3DP.%26aulast%3DBucher%26aufirst%3DC.%26aulast%3DBissig%26aufirst%3DH.%26aulast%3DNocito%26aufirst%3DA.%26aulast%3DHaas%26aufirst%3DP.%26aulast%3DWilber%26aufirst%3DK.%26aulast%3DSeelig%26aufirst%3DS.%26aulast%3DKononen%26aufirst%3DJ.%26aulast%3DMihatsch%26aufirst%3DM.%2BJ.%26aulast%3DDirnhofer%26aufirst%3DS.%26aulast%3DSauter%26aufirst%3DG.%26atitle%3DCyclin%2520E%2520overexpression%2520and%2520amplification%2520in%2520human%2520tumours%26jtitle%3DJ.%2520Pathol.%26date%3D2003%26volume%3D200%26spage%3D375%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Soria, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Se Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khuri, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waun, Ki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span> </span><span class="NLM_article-title">Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4000-4004&author=J.+C.+Soriaauthor=J.+Se+Jinauthor=F.+R.+Khuriauthor=K.+Hassanauthor=D.+Liuauthor=Ki%2C+H.+Waunauthor=L.+Mao&title=Overexpression+of+cyclin+B1+in+early-stage+non-small+cell+lung+cancer+and+its+clinical+implication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoria%26aufirst%3DJ.%2BC.%26aulast%3DSe%2BJin%26aufirst%3DJ.%26aulast%3DKhuri%26aufirst%3DF.%2BR.%26aulast%3DHassan%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DWaun%26aufirst%3DKi%252C%2BH.%26aulast%3DMao%26aufirst%3DL.%26atitle%3DOverexpression%2520of%2520cyclin%2520B1%2520in%2520early-stage%2520non-small%2520cell%2520lung%2520cancer%2520and%2520its%2520clinical%2520implication%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4000%26epage%3D4004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Takeno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, W.</span><span> </span><span class="NLM_article-title">Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma</span> <span class="citation_source-journal">Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">2874</span><span class="NLM_x">–</span> <span class="NLM_lpage">2881</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2002&pages=2874-2881&author=S.+Takenoauthor=T.+Noguchiauthor=R.+Kikuchiauthor=Y.+Uchidaauthor=S.+Yokoyamaauthor=W.+Muller&title=Prognostic+value+of+cyclin+B1+in+patients+with+esophageal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeno%26aufirst%3DS.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3DUchida%26aufirst%3DY.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DW.%26atitle%3DPrognostic%2520value%2520of%2520cyclin%2520B1%2520in%2520patients%2520with%2520esophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DCancer%26date%3D2002%26volume%3D94%26spage%3D2874%26epage%3D2881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of cancer cells despite CDK2 inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+cancer+cells+despite+CDK2+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520cancer%2520cells%2520despite%2520CDK2%2520inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widlund, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horstmann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, D. E.</span><span> </span><span class="NLM_article-title">Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=565-576&author=J.+Duauthor=H.+R.+Widlundauthor=M.+A.+Horstmannauthor=S.+Ramaswamyauthor=K.+Rossauthor=W.+E.+Huberauthor=E.+K.+Nishimuraauthor=T.+R.+Golubauthor=D.+E.+Fisher&title=Critical+role+of+CDK2+for+melanoma+growth+linked+to+its+melanocyte-specific+transcriptional+regulation+by+MITF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DWidlund%26aufirst%3DH.%2BR.%26aulast%3DHorstmann%26aufirst%3DM.%2BA.%26aulast%3DRamaswamy%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DW.%2BE.%26aulast%3DNishimura%26aufirst%3DE.%2BK.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26atitle%3DCritical%2520role%2520of%2520CDK2%2520for%2520melanoma%2520growth%2520linked%2520to%2520its%2520melanocyte-specific%2520transcriptional%2520regulation%2520by%2520MITF%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26spage%3D565%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hanse, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelsen, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anttila, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crary, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. H.</span><span> </span><span class="NLM_article-title">Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2802</span><span class="NLM_x">–</span> <span class="NLM_lpage">2809</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=2802-2809&author=E.+A.+Hanseauthor=C.+J.+Nelsenauthor=M.+M.+Gogginauthor=C.+K.+Anttilaauthor=L.+K.+Mullanyauthor=C.+Berthetauthor=P.+Kaldisauthor=G.+S.+Craryauthor=R.+Kuriyamaauthor=J.+H.+Albrecht&title=Cdk2+plays+a+critical+role+in+hepatocyte+cell+cycle+progression+and+survival+in+the+setting+of+cyclin+D1+expression+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanse%26aufirst%3DE.%2BA.%26aulast%3DNelsen%26aufirst%3DC.%2BJ.%26aulast%3DGoggin%26aufirst%3DM.%2BM.%26aulast%3DAnttila%26aufirst%3DC.%2BK.%26aulast%3DMullany%26aufirst%3DL.%2BK.%26aulast%3DBerthet%26aufirst%3DC.%26aulast%3DKaldis%26aufirst%3DP.%26aulast%3DCrary%26aufirst%3DG.%2BS.%26aulast%3DKuriyama%26aufirst%3DR.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BH.%26atitle%3DCdk2%2520plays%2520a%2520critical%2520role%2520in%2520hepatocyte%2520cell%2520cycle%2520progression%2520and%2520survival%2520in%2520the%2520setting%2520of%2520cyclin%2520D1%2520expression%2520in%2520vivo%26jtitle%3DCell%2520Cycle%26date%3D2009%26volume%3D8%26spage%3D2802%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, V. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">9270</span><span class="NLM_x">–</span> <span class="NLM_lpage">9280</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9270-9280&author=D.+Caiauthor=V.+M.+Lathamauthor=X.+Zhangauthor=G.+I.+Shapiro&title=Combined+depletion+of+cell+cycle+and+transcriptional+cyclin-dependent+kinase+activities+induces+apoptosis+in+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DD.%26aulast%3DLatham%26aufirst%3DV.%2BM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DCombined%2520depletion%2520of%2520cell%2520cycle%2520and%2520transcriptional%2520cyclin-dependent%2520kinase%2520activities%2520induces%2520apoptosis%2520in%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9270%26epage%3D9280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianella-Borradori, A.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery and development of cyclin-dependent kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1517%2F13543784.14.4.457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=15882121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksl2ju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=457-477&author=P.+M.+Fischerauthor=A.+Gianella-Borradori&title=Recent+progress+in+the+discovery+and+development+of+cyclin-dependent+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery and development of cyclin-dependent kinase inhibitors</span></div><div class="casAuthors">Fischer, Peter M.; Gianella-Borradori, Athos</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-477</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (CDKs) have long been known to be the main facilitators of the cell proliferation cycle.  However, they also play important roles in the regulation of the RNA polymerase II transcription cycle.  Cancer cells display aberrant cell cycle regulation to gain proliferative advantages and they also appear to have an exaggerated dependence on RNA polymerase II transcriptional activity to sustain pro-survival and antiapoptotic signaling.  A picture is now starting to emerge that both the cell-cycle and transcriptional functions of CDKs can be exploited pharmacol. with CDK inhibitors that possess appropriate selectivity profiles.  In this article, recent advances into these mechanistic insights and how they can guide clin. development in terms of choice of indication are reviewed, as well as combinations with existing chemotherapies.  An overview is also given of recent clin. trial results with the lead CDK inhibitor drug candidates seliciclib (CYC202, (R)-roscovitine; Cyclacel) and alvocidib (flavopiridol; Aventis-NCI), as well as the development of other clin. entries and advanced preclin. compds.  The discussion focuses on oncol., but we point out recent results with CDK inhibitors in virol. and nephrol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBpDr_f4OWpLVg90H21EOLACvtfcHk0lhFJ6Z8nd96Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksl2ju7Y%253D&md5=9720014650efdc6b8fe7e50edcb2c74f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.4.457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.4.457%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DGianella-Borradori%26aufirst%3DA.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520cyclin-dependent%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D457%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">McClue, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhelev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheleva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. P.</span><span> </span><span class="NLM_article-title">In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)</span> <span class="citation_source-journal">In. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1002%2Fijc.10738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=12432547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVOksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=463-468&author=S.+J.+McClueauthor=D.+Blakeauthor=R.+Clarkeauthor=A.+Cowanauthor=L.+Cummingsauthor=P.+M.+Fischerauthor=M.+MacKenzieauthor=J.+Melvilleauthor=K.+Stewartauthor=S.+Wangauthor=N.+Zhelevauthor=D.+Zhelevaauthor=D.+P.+Lane&title=In+vitro+and+in+vivo+antitumor+properties+of+the+cyclin+dependent+kinase+inhibitor+CYC202+%28R-roscovitine%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)</span></div><div class="casAuthors">McClue, Steven J.; Blake, David; Clarke, Rosemary; Cowan, Angela; Cummings, Lorna; Fischer, Peter M.; MacKenzie, Mairi; Melville, Jean; Stewart, Kevin; Wang, Shudong; Zhelev, Nikolai; Zheleva, Daniella; Lane, David P.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">CDK2 inhibitors have been proposed as effective anti-cancer therapeutics.  We show here that CYC202 (R-roscovitine) is a potent inhibitor of recombinant CDK2/cyclin E kinase activity (IC50 = 0.10 μM) with an av. cytotoxic IC50 of 15.2 μM in a panel of 19 human tumor cell lines, and we also demonstrate selectivity for rapidly proliferating cells over non-proliferating cells.  A study of the cell cycle effects of CYC202 in Lovo colorectal carcinoma cells showed that the major effect was not the predicted arrest in one part of the cycle, but rather an induction of cell death from all compartments of the cell cycle.  The max. tolerated dose given i.v. to mice was in excess of 20 mg/kg.  Doses up to 2,000 mg/kg were tolerated when administered orally in mice.  Following repeated i.p. administration (3 times daily for 5 days) of 100 mg/kg to nude mice bearing the Lovo human colorectal tumor, CYC202 induced a significant antitumor effect with a 45% redn. in tumor growth compared to controls.  A second expt. using the human uterine xenograft MESSA-DX5 treated with orally administered CYC202 (500 mg/kg 3 times daily for 4 days) also exhibited a significant redn. in the rate of growth of the tumor (62%).  These data, showing enzyme and cellular potency together with antitumor activity, confirm the potential of CDK2 inhibitors such as CYC202 as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrekWf0QH861LVg90H21EOLACvtfcHk0lhFJ6Z8nd96Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVOksL4%253D&md5=bf8ed57667ec566b9cc11c27158f6b8b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fijc.10738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.10738%26sid%3Dliteratum%253Aachs%26aulast%3DMcClue%26aufirst%3DS.%2BJ.%26aulast%3DBlake%26aufirst%3DD.%26aulast%3DClarke%26aufirst%3DR.%26aulast%3DCowan%26aufirst%3DA.%26aulast%3DCummings%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DMacKenzie%26aufirst%3DM.%26aulast%3DMelville%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhelev%26aufirst%3DN.%26aulast%3DZheleva%26aufirst%3DD.%26aulast%3DLane%26aufirst%3DD.%2BP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520antitumor%2520properties%2520of%2520the%2520cyclin%2520dependent%2520kinase%2520inhibitor%2520CYC202%2520%2528R-roscovitine%2529%26jtitle%3DIn.%2520J.%2520Cancer%26date%3D2002%26volume%3D102%26spage%3D463%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Misra, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulheron, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roongta, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranadive, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. <i>N</i>-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1728</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0305568" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1719-1728&author=R.+N.+Misraauthor=H.+Y.+Xiaoauthor=K.+S.+Kimauthor=S.+Luauthor=W.+C.+Hanauthor=S.+A.+Barbosaauthor=J.+T.+Huntauthor=D.+B.+Rawlinsauthor=W.+Shanauthor=S.+Z.+Ahmedauthor=L.+Qianauthor=B.+C.+Chenauthor=R.+Zhaoauthor=M.+S.+Bednarzauthor=K.+A.+Kellarauthor=J.+G.+Mulheronauthor=R.+Batorskyauthor=U.+Roongtaauthor=A.+Kamathauthor=P.+Maratheauthor=S.+A.+Ranadiveauthor=J.+S.+Sackauthor=J.+S.+Tokarskiauthor=N.+P.+Pavletichauthor=F.+Y.+F.+Leeauthor=K.+R.+Websterauthor=S.+D.+Kimball&title=N-%28Cycloalkylamino%29acyl-2-aminothiazole+Inhibitors+of+Cyclin-Dependent+Kinase+2.+N-%5B5-%5B%5B%5B5-%281%2C1-Dimethylethyl%29-2-oxazolyl%5Dmethyl%5Dthio%5D-2-thiazolyl%5D-4-piperidinecarboxamide+%28BMS-387032%29%2C+a+Highly+Efficacious+and+Selective+Antitumor+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0305568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0305568%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DXiao%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DW.%2BC.%26aulast%3DBarbosa%26aufirst%3DS.%2BA.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DAhmed%26aufirst%3DS.%2BZ.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DB.%2BC.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DBednarz%26aufirst%3DM.%2BS.%26aulast%3DKellar%26aufirst%3DK.%2BA.%26aulast%3DMulheron%26aufirst%3DJ.%2BG.%26aulast%3DBatorsky%26aufirst%3DR.%26aulast%3DRoongta%26aufirst%3DU.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DRanadive%26aufirst%3DS.%2BA.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DWebster%26aufirst%3DK.%2BR.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26atitle%3DN-%2528Cycloalkylamino%2529acyl-2-aminothiazole%2520Inhibitors%2520of%2520Cyclin-Dependent%2520Kinase%25202.%2520N-%255B5-%255B%255B%255B5-%25281%252C1-Dimethylethyl%2529-2-oxazolyl%255Dmethyl%255Dthio%255D-2-thiazolyl%255D-4-piperidinecarboxamide%2520%2528BMS-387032%2529%252C%2520a%2520Highly%2520Efficacious%2520and%2520Selective%2520Antitumor%2520Agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1719%26epage%3D1728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Toogood, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repine, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanderWel, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodfuehrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barvian, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049354h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2388-2406&author=P.+L.+Toogoodauthor=P.+J.+Harveyauthor=J.+T.+Repineauthor=D.+J.+Sheehanauthor=S.+N.+VanderWelauthor=H.+Zhouauthor=P.+R.+Kellerauthor=D.+J.+McNamaraauthor=D.+Sherryauthor=T.+Zhuauthor=J.+Brodfuehrerauthor=C.+Choiauthor=M.+R.+Barvianauthor=D.+W.+Fry&title=Discovery+of+a+potent+and+selective+inhibitor+of+cyclin-dependent+kinase+4%2F6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Inhibitor of Cyclin-Dependent Kinase 4/6</span></div><div class="casAuthors">Toogood, Peter L.; Harvey, Patricia J.; Repine, Joseph T.; Sheehan, Derek J.; VanderWel, Scott N.; Zhou, Hairong; Keller, Paul R.; McNamara, Dennis J.; Sherry, Debra; Zhu, Tong; Brodfuehrer, Joanne; Choi, Chung; Barvian, Mark R.; Fry, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2388-2406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacol. approach to inhibition of cyclin-dependent kinases 4 and 6 (Cdk4/6) using highly selective small mol. inhibitors has the potential to provide novel cancer therapies for clin. use.  Achieving high levels of selectivity for Cdk4/6, vs. other ATP-dependent kinases, presents a significant challenge.  The pyrido[2,3-d]pyrimidin-7-one template provides an effective platform for the inhibition of a broad cross-section of kinases, including Cdks.  It is now demonstrated that the modification of pyrido[2,3-d]pyrimidin-7-ones to include a 2-aminopyridine side chain at the C2-position provides inhibitors with exquisite selectivity for Cdk4/6 in vitro.  This selectivity profile is recapitulated in cells where the most selective inhibitors create a G1 block at concns. up to 100-fold the IC50 for cell proliferation.  On the basis of its selectivity profile and pharmacokinetic profile, compd. I (PD 0332991) was identified as a drug candidate for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX577J5U0r97Vg90H21EOLACvtfcHk0lgf4x_ZhVnjDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGisL0%253D&md5=23cbe58426ff1975695712db7c1b128a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm049354h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049354h%26sid%3Dliteratum%253Aachs%26aulast%3DToogood%26aufirst%3DP.%2BL.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DRepine%26aufirst%3DJ.%2BT.%26aulast%3DSheehan%26aufirst%3DD.%2BJ.%26aulast%3DVanderWel%26aufirst%3DS.%2BN.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DKeller%26aufirst%3DP.%2BR.%26aulast%3DMcNamara%26aufirst%3DD.%2BJ.%26aulast%3DSherry%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DBarvian%26aufirst%3DM.%2BR.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520cyclin-dependent%2520kinase%25204%252F6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2388%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Moon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationships of novel indirubin derivatives as potent antiproliferative agents with CDK2 inhibitory activities</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=237-246&author=M.+J.+Moonauthor=S.+K.+Leeauthor=J.+W.+Leeauthor=W.+K.+Songauthor=S.+W.+Kimauthor=J.+I.+Kimauthor=C.+Choauthor=S.+J.+Choiauthor=Y.+C.+Kim&title=Synthesis+and+structure%E2%88%92activity+relationships+of+novel+indirubin+derivatives+as+potent+antiproliferative+agents+with+CDK2+inhibitory+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DSong%26aufirst%3DW.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DCho%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520novel%2520indirubin%2520derivatives%2520as%2520potent%2520antiproliferative%2520agents%2520with%2520CDK2%2520inhibitory%2520activities%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D237%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Myrianthopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikros, E.</span><span> </span><span class="NLM_article-title">An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4027</span><span class="NLM_x">–</span> <span class="NLM_lpage">4037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070077z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4027-4037&author=V.+Myrianthopoulosauthor=P.+Magiatisauthor=Y.+Ferandinauthor=A.+L.+Skaltsounisauthor=L.+Meijerauthor=E.+Mikros&title=An+integrated+computational+approach+to+the+phenomenon+of+potent+and+selective+inhibition+of+aurora+kinases+B+and+C+by+a+series+of+7-substituted+indirubins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm070077z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070077z%26sid%3Dliteratum%253Aachs%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DMikros%26aufirst%3DE.%26atitle%3DAn%2520integrated%2520computational%2520approach%2520to%2520the%2520phenomenon%2520of%2520potent%2520and%2520selective%2520inhibition%2520of%2520aurora%2520kinases%2520B%2520and%2520C%2520by%2520a%2520series%2520of%25207-substituted%2520indirubins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4027%26epage%3D4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Vougogiannopoulou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettayeb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myrianthopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Soluble 3′,6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase −3 alter circadian period</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6421</span><span class="NLM_x">–</span> <span class="NLM_lpage">6431</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800648y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6421-6431&author=K.+Vougogiannopoulouauthor=Y.+Ferandinauthor=K.+Bettayebauthor=V.+Myrianthopoulosauthor=O.+Lozachauthor=Y.+Fanauthor=C.+H.+Johnsonauthor=P.+Magiatisauthor=A.+L.+Skaltsounisauthor=E.+Mikrosauthor=L.+Meijer&title=Soluble+3%E2%80%B2%2C6-substituted+indirubins+with+enhanced+selectivity+toward+glycogen+synthase+kinase+%E2%88%923+alter+circadian+period"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800648y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800648y%26sid%3Dliteratum%253Aachs%26aulast%3DVougogiannopoulou%26aufirst%3DK.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DBettayeb%26aufirst%3DK.%26aulast%3DMyrianthopoulos%26aufirst%3DV.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DJohnson%26aufirst%3DC.%2BH.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26aulast%3DMikros%26aufirst%3DE.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSoluble%25203%25E2%2580%25B2%252C6-substituted%2520indirubins%2520with%2520enhanced%2520selectivity%2520toward%2520glycogen%2520synthase%2520kinase%2520%25E2%2588%25923%2520alter%2520circadian%2520period%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6421%26epage%3D6431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Beauchard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laborie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouillard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guevel, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guguen-Guillouzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, V.</span><span> </span><span class="NLM_article-title">Synthesis and kinase inhibitory activity of novel substituted indigoids</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6257</span><span class="NLM_x">–</span> <span class="NLM_lpage">6263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6257-6263&author=A.+Beauchardauthor=H.+Laborieauthor=H.+Rouillardauthor=O.+Lozachauthor=Y.+Ferandinauthor=R.+L.+Guevelauthor=C.+Guguen-Guillouzoauthor=L.+Meijerauthor=T.+Bessonauthor=V.+Thiery&title=Synthesis+and+kinase+inhibitory+activity+of+novel+substituted+indigoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauchard%26aufirst%3DA.%26aulast%3DLaborie%26aufirst%3DH.%26aulast%3DRouillard%26aufirst%3DH.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DGuevel%26aufirst%3DR.%2BL.%26aulast%3DGuguen-Guillouzo%26aufirst%3DC.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DThiery%26aufirst%3DV.%26atitle%3DSynthesis%2520and%2520kinase%2520inhibitory%2520activity%2520of%2520novel%2520substituted%2520indigoids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6257%26epage%3D6263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lee, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ann, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span> </span><span class="NLM_article-title">Indirubin-3′-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2Fj.canlet.2008.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=18343569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlWhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=2008&pages=215-225&author=M.+J.+Leeauthor=M.+Y.+Kimauthor=J.+S.+Moauthor=E.+J.+Annauthor=M.+S.+Seoauthor=J.+A.+Hongauthor=Y.+C.+Kimauthor=H.+S.+Park&title=Indirubin-3%E2%80%B2-monoxime%2C+a+derivative+of+a+Chinese+anti-leukemia+medicine%2C+inhibits+Notch1+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Indirubin-3'-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling</span></div><div class="casAuthors">Lee, Mi-Jee; Kim, Mi-Yeon; Mo, Jung-Soon; Ann, Eun-Jung; Seo, Mi-Sun; Hong, Ji-Ae; Kim, Yong-Chul; Park, Hee-Sae</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-225</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Notch proteins perform a crit. function in cell-fate decisions and in differentiation.  In this study, we detd. that indirubin-3'-monoxime reduced Notch1 signaling to a remarkable extent.  Indirubin-3'-monoxime has been shown to inhibit both constitutive active mutants of Notch1 and Notch1-IC-mediated transactivation activity.  However, in such cases, neither the Notch cleavage pattern nor the protein stability of Notch1-IC was detd. to have been significantly altered.  Indirubin-3'-monoxime suppresses Notch1 transcriptional activity via the dissocn. of the Notch1-IC-RBP-Jk complex.  Notably, the transcriptional activity of Notch1-IC was not suppressed significantly in the GSK-3β null cells by indirubin-3'-monoxime as compared to what was obsd. with GSK-3β wild-type cells.  In the previous study, we synthesized a series of indirubin derivs.  Interestingly, some of these indirubin derivs. were characterized as potent inhibitors of Notch1 signaling.  Taken together, the results of this study indicate that indirubin-3'-monoxime downregulated Notch1 signaling in a GSK-3β-dependent and proteosomal degrdn.-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9mgOjx7HfLVg90H21EOLACvtfcHk0lgps1Tadcftlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlWhsLY%253D&md5=b99da155860033dc19c809678cbc08a6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DM.%2BY.%26aulast%3DMo%26aufirst%3DJ.%2BS.%26aulast%3DAnn%26aufirst%3DE.%2BJ.%26aulast%3DSeo%26aufirst%3DM.%2BS.%26aulast%3DHong%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DPark%26aufirst%3DH.%2BS.%26atitle%3DIndirubin-3%25E2%2580%25B2-monoxime%252C%2520a%2520derivative%2520of%2520a%2520Chinese%2520anti-leukemia%2520medicine%252C%2520inhibits%2520Notch1%2520signaling%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D265%26spage%3D215%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Yoon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span> </span><span class="NLM_article-title">5′-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1800</span><span class="NLM_x">, </span> <span class="NLM_fpage">352</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1800&publication_year=2010&pages=352-358&author=J.+H.+Yoonauthor=S.+A.+Kimauthor=S.+M.+Kwonauthor=J.+H.+Parkauthor=H.+S.+Parkauthor=Y.+C.+Kimauthor=J.+H.+Yoonauthor=S.+G.+Ahn&title=5%E2%80%B2-Nitro-indirubinoxime+induces+G1+cell+cycle+arrest+and+apoptosis+in+salivary+gland+adenocarcinoma+cells+through+the+inhibition+of+Notch-1+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BA.%26aulast%3DKwon%26aufirst%3DS.%2BM.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26atitle%3D5%25E2%2580%25B2-Nitro-indirubinoxime%2520induces%2520G1%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520salivary%2520gland%2520adenocarcinoma%2520cells%2520through%2520the%2520inhibition%2520of%2520Notch-1%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1800%26spage%3D352%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Park, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. K.</span><span> </span><span class="NLM_article-title">Novel small molecule activators of β-catenin-mediated signaling pathway: structure−activity relationships of indirubins</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2282</span><span class="NLM_x">–</span> <span class="NLM_lpage">2284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2282-2284&author=E.+J.+Parkauthor=S.+J.+Choiauthor=Y.+C.+Kimauthor=S.+H.+Leeauthor=S.+W.+Parkauthor=S.+K.+Lee&title=Novel+small+molecule+activators+of+%CE%B2-catenin-mediated+signaling+pathway%3A+structure%E2%88%92activity+relationships+of+indirubins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DLee%26aufirst%3DS.%2BK.%26atitle%3DNovel%2520small%2520molecule%2520activators%2520of%2520%25CE%25B2-catenin-mediated%2520signaling%2520pathway%253A%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520indirubins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2282%26epage%3D2284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. S.</span><span> </span><span class="NLM_article-title">Enhancing effect of indirubin derivatives on 1,25-dihydroxyvitamin D<sub>3</sub>- and all-<i>trans</i> retinoic acid-induced differentiation of HL-60 leukemia cells</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6752</span><span class="NLM_x">–</span> <span class="NLM_lpage">6758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6752-6758&author=S.+H.+Kimauthor=S.+W.+Kimauthor=S.+J.+Choiauthor=Y.+C.+Kimauthor=T.+S.+Kim&title=Enhancing+effect+of+indirubin+derivatives+on+1%2C25-dihydroxyvitamin+D3-+and+all-trans+retinoic+acid-induced+differentiation+of+HL-60+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DT.%2BS.%26atitle%3DEnhancing%2520effect%2520of%2520indirubin%2520derivatives%2520on%25201%252C25-dihydroxyvitamin%2520D3-%2520and%2520all-trans%2520retinoic%2520acid-induced%2520differentiation%2520of%2520HL-60%2520leukemia%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6752%26epage%3D6758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Jautelat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumby, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briem, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucking, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prien, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemeister, G.</span><span> </span><span class="NLM_article-title">From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=531-540&author=R.+Jautelatauthor=T.+Brumbyauthor=M.+Schaferauthor=H.+Briemauthor=G.+Eisenbrandauthor=S.+Schwahnauthor=M.+Krugerauthor=U.+Luckingauthor=O.+Prienauthor=G.+Siemeister&title=From+the+insoluble+dye+indirubin+towards+highly+active%2C+soluble+CDK2-inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJautelat%26aufirst%3DR.%26aulast%3DBrumby%26aufirst%3DT.%26aulast%3DSchafer%26aufirst%3DM.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DSchwahn%26aufirst%3DS.%26aulast%3DKruger%26aufirst%3DM.%26aulast%3DLucking%26aufirst%3DU.%26aulast%3DPrien%26aufirst%3DO.%26aulast%3DSiemeister%26aufirst%3DG.%26atitle%3DFrom%2520the%2520insoluble%2520dye%2520indirubin%2520towards%2520highly%2520active%252C%2520soluble%2520CDK2-inhibitors%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D531%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Helen, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, K. C.</span><span> </span><span class="NLM_article-title">Synthesis of bromo-substituted indoxyl esters for cytochemical demonstration of enzyme activity</span> <span class="citation_source-journal">Cytochem. Demon. Enzyme Act.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1960&pages=1187-1189&author=C.+F.+Helenauthor=+Suauthor=K.+C.+Tsou&title=Synthesis+of+bromo-substituted+indoxyl+esters+for+cytochemical+demonstration+of+enzyme+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHelen%26aufirst%3DC.%2BF.%26aulast%3DSu%26aulast%3DTsou%26aufirst%3DK.%2BC.%26atitle%3DSynthesis%2520of%2520bromo-substituted%2520indoxyl%2520esters%2520for%2520cytochemical%2520demonstration%2520of%2520enzyme%2520activity%26jtitle%3DCytochem.%2520Demon.%2520Enzyme%2520Act.%26date%3D1960%26volume%3D82%26spage%3D1187%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Woodhead, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulstridge, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Early, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltell, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reule, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squires, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trewartha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolford, A. J. A.</span><span> </span><span class="NLM_article-title">Identification of <i>N</i>-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4986</span><span class="NLM_x">–</span> <span class="NLM_lpage">4999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4986-4999&author=A.+J.+Woodheadauthor=V.+Berdiniauthor=J.+A.+Boulstridgeauthor=M.+G.+Carrauthor=D.+M.+Crossauthor=D.+J.+Davisauthor=L.+A.+Devineauthor=T.+R.+Earlyauthor=R.+E.+Feltellauthor=E.+J.+Lewisauthor=R.+L.+McMenaminauthor=E.+F.+Navarroauthor=M.+A.+O%E2%80%99Brienauthor=M.+O%E2%80%99Reillyauthor=M.+Reuleauthor=G.+Saxtyauthor=L.+C.+A.+Seaversauthor=D.-M.+Smithauthor=M.+S.+Squiresauthor=G.+Trewarthaauthor=M.+T.+Walkerauthor=A.+J.+A.+Woolford&title=Identification+of+N-%284-Piperidinyl%29-4-%282%2C6-dichlorobenzoylamino%29-1H-pyrazole-3-carboxamide+%28AT7519%29%2C+a+Novel+Cyclin+Dependent+Kinase+Inhibitor+Using+Fragment-Based+X-Ray+Crystallography+and+Structure+Based+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DBoulstridge%26aufirst%3DJ.%2BA.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DCross%26aufirst%3DD.%2BM.%26aulast%3DDavis%26aufirst%3DD.%2BJ.%26aulast%3DDevine%26aufirst%3DL.%2BA.%26aulast%3DEarly%26aufirst%3DT.%2BR.%26aulast%3DFeltell%26aufirst%3DR.%2BE.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%2BL.%26aulast%3DNavarro%26aufirst%3DE.%2BF.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%26aulast%3DReule%26aufirst%3DM.%26aulast%3DSaxty%26aufirst%3DG.%26aulast%3DSeavers%26aufirst%3DL.%2BC.%2BA.%26aulast%3DSmith%26aufirst%3DD.-M.%26aulast%3DSquires%26aufirst%3DM.%2BS.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DWalker%26aufirst%3DM.%2BT.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%2BA.%26atitle%3DIdentification%2520of%2520N-%25284-Piperidinyl%2529-4-%25282%252C6-dichlorobenzoylamino%2529-1H-pyrazole-3-carboxamide%2520%2528AT7519%2529%252C%2520a%2520Novel%2520Cyclin%2520Dependent%2520Kinase%2520Inhibitor%2520Using%2520Fragment-Based%2520X-Ray%2520Crystallography%2520and%2520Structure%2520Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4986%26epage%3D4999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Beauchard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferandin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blairvacq, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiery, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besson, T.</span><span> </span><span class="NLM_article-title">Synthesis of novel 5-substituted indirubins as protein kinases inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6434</span><span class="NLM_x">–</span> <span class="NLM_lpage">6443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6434-6443&author=A.+Beauchardauthor=Y.+Ferandinauthor=S.+Frereauthor=O.+Lozachauthor=M.+Blairvacqauthor=L.+Meijerauthor=V.+Thieryauthor=T.+Besson&title=Synthesis+of+novel+5-substituted+indirubins+as+protein+kinases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeauchard%26aufirst%3DA.%26aulast%3DFerandin%26aufirst%3DY.%26aulast%3DFrere%26aufirst%3DS.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBlairvacq%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DThiery%26aufirst%3DV.%26aulast%3DBesson%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520novel%25205-substituted%2520indirubins%2520as%2520protein%2520kinases%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6434%26epage%3D6443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Shtutman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhurinsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simcha, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Ze’ev, A.</span><span> </span><span class="NLM_article-title">The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5527</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=5522-5527&author=M.+Shtutmanauthor=J.+Zhurinskyauthor=I.+Simchaauthor=C.+Albaneseauthor=M.+D%E2%80%99Amicoauthor=R.+Pestellauthor=A.+Ben-Ze%E2%80%99ev&title=The+cyclin+D1+gene+is+a+target+of+the+%CE%B2-catenin%2FLEF-1+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShtutman%26aufirst%3DM.%26aulast%3DZhurinsky%26aufirst%3DJ.%26aulast%3DSimcha%26aufirst%3DI.%26aulast%3DAlbanese%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Amico%26aufirst%3DM.%26aulast%3DPestell%26aufirst%3DR.%26aulast%3DBen-Ze%25E2%2580%2599ev%26aufirst%3DA.%26atitle%3DThe%2520cyclin%2520D1%2520gene%2520is%2520a%2520target%2520of%2520the%2520%25CE%25B2-catenin%252FLEF-1%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D5522%26epage%3D5527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kim, S.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, J.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J.-H.</span><span> </span><span class="NLM_article-title">Antitumor Activity of Novel Indirubin Derivatives in Rat Tumor Model</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1158%2F1078-0432.CCR-06-1154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=17200363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlWg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=253-259&author=S.-A.+Kimauthor=Y.-C.+Kimauthor=S.-W.+Kimauthor=S.-H.+Leeauthor=J.-J.+Minauthor=S.-G.+Ahnauthor=J.-H.+Yoon&title=Antitumor+Activity+of+Novel+Indirubin+Derivatives+in+Rat+Tumor+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of Novel Indirubin Derivatives in Rat Tumor Model</span></div><div class="casAuthors">Kim, Soo-A.; Kim, Yong-Chul; Kim, Si-Wouk; Lee, Sang-Ho; Min, Jung-Joon; Ahn, Sang-Gun; Yoon, Jung-Hoon</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-259</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The novel indirubin derivs. 5'-nitro-indirubinoxime, 5'-fluoro-indirubinoxime, and 5'-trimethylacetamino-indirubinoxime were designed and tested for antitumor activity both in vitro and in vivo using rat tumor model.  Exptl. Design: Three-week-old male Sprague-Dawley rats were inoculated s.c. on the left flank with 107 RK3E-ras rat kidney epithelial cells harboring k-ras gene.  Alternatively, 5 × 106 RK3E-ras cells were injected into the oral mucosa.  Indirubin deriv. treatment began on the 3rd or 6th day after oral or s.c. cell injection, resp.  Indirubin derivs. were directly injected into the tumor every other day for a total of five times.  Animals were monitored daily and tumor vol. was measured by caliper.  Results: Indirubin derivs. showed potent antiproliferative activity on various human cancer cells and oncogenic RK3E-ras rat kidney cells, with IC50 ranging from 1 to 12 μM.  Treatment with indirubin derivs. induced the activation of caspase-7 followed by apoptosis in RK3E-ras cells.  Indirubin derivs. showed strong antitumor activity in rat solid and oral tumor models.  Direct injection of indirubin derivs. every other day for 10 days induced significant inhibition of tumor growth in Sprague-Dawley rats bearing RK3E-ras-induced tumors.  Histol., treatment with indirubin derivs. caused significant inhibition of tumor formation with increased apoptosis and decreased tumor cell proliferation.  Conclusions: the authors' data showed that novel indirubin derivs. 5'-nitro-indirubinoxime, 5'-fluoro-indirubinoxime, and 5'-trimethylacetamino-indirubinoxime effectively arrested the tumor growth by inhibiting cell proliferation and inducing apoptosis.  These findings provide the potential value of indirubin derivs. as novel candidates for antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaLzbkgyScK7Vg90H21EOLACvtfcHk0liyvUScbd_-zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlWg&md5=b382a30fead8aeccb54df24da8d7dcea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1154%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.-A.%26aulast%3DKim%26aufirst%3DY.-C.%26aulast%3DKim%26aufirst%3DS.-W.%26aulast%3DLee%26aufirst%3DS.-H.%26aulast%3DMin%26aufirst%3DJ.-J.%26aulast%3DAhn%26aufirst%3DS.-G.%26aulast%3DYoon%26aufirst%3DJ.-H.%26atitle%3DAntitumor%2520Activity%2520of%2520Novel%2520Indirubin%2520Derivatives%2520in%2520Rat%2520Tumor%2520Model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D253%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Nam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muehlbeyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vatter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenbrand, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span> </span><span class="NLM_article-title">Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells</span> <span class="citation_source-journal">Proc. Nat. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">5998</span><span class="NLM_x">–</span> <span class="NLM_lpage">6003</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1073%2Fpnas.0409467102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=15837920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1Cmu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=5998-6003&author=S.+Namauthor=R.+Buettnerauthor=J.+Turksonauthor=D.+Kimauthor=J.+Q.+Chengauthor=S.+Muehlbeyerauthor=F.+Hippeauthor=S.+Vatterauthor=K.+H.+Merzauthor=G.+Eisenbrandauthor=R.+Jove&title=Indirubin+derivatives+inhibit+Stat3+signaling+and+induce+apoptosis+in+human+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells</span></div><div class="casAuthors">Nam, Sangkil; Buettner, Ralf; Turkson, James; Kim, Donghwa; Cheng, Jin Q.; Muehlbeyer, Stephan; Hippe, Frankie; Vatter, Sandra; Merz, Karl-Heinz; Eisenbrand, Gerhard; Jove, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5998-6003</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Stat3 protein has an important role in oncogenesis and is a promising anticancer target.  Indirubin, the active component of a traditional Chinese herbal medicine, has been shown previously to inhibit cyclin-dependent kinases, resulting in cell cycle arrest.  Here, the authors show that the indirubin derivs. E564, E728, and E804 potently block constitutive Stat3 signaling in human breast and prostate cancer cells.  In addn., E804 directly inhibits Src kinase activity (IC50 = 0.43 μM) in an in vitro kinase assay.  Levels of tyrosyl phosphorylation of c-Src are also reduced in cultured cells 30 min after E804 treatment.  Tyrosyl phosphorylation of Stat3, which is known to be phosphorylated by c-Src, was decreased, and constitutive Stat3 DNA binding-activity was suppressed in cells 30 min after E804 treatment.  The antiapoptotic proteins Mcl-1 and Survivin, which are encoded in target genes of Stat3, were down-regulated by indirubin derivs., followed by induction of apoptosis.  These results demonstrate that E804 directly blocks the Src-Stat3 signaling pathway, suggesting that the antitumor activity of indirubin compds. is at least partially due to inhibition of this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD6CvqDvoUx7Vg90H21EOLACvtfcHk0liyvUScbd_-zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1Cmu78%253D&md5=6e29db4bde679b92bdc0e8e9648781df</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0409467102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0409467102%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DS.%26aulast%3DBuettner%26aufirst%3DR.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DJ.%2BQ.%26aulast%3DMuehlbeyer%26aufirst%3DS.%26aulast%3DHippe%26aufirst%3DF.%26aulast%3DVatter%26aufirst%3DS.%26aulast%3DMerz%26aufirst%3DK.%2BH.%26aulast%3DEisenbrand%26aufirst%3DG.%26aulast%3DJove%26aufirst%3DR.%26atitle%3DIndirubin%2520derivatives%2520inhibit%2520Stat3%2520signaling%2520and%2520induce%2520apoptosis%2520in%2520human%2520cancer%2520cells%26jtitle%3DProc.%2520Nat.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D5998%26epage%3D6003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kim, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. G.</span><span> </span><span class="NLM_article-title">5′-Nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1016%2Fj.canlet.2008.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=18926623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=2009&pages=72-77&author=S.+A.+Kimauthor=S.+W.+Kimauthor=S.+Changauthor=J.+H.+Yoonauthor=S.+G.+Ahn&title=5%E2%80%B2-Nitro-indirubinoxime+induces+G2%2FM+cell+cycle+arrest+and+apoptosis+in+human+KB+oral+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">5'-nitro-indirubinoxime induces G2/M cell cycle arrest and apoptosis in human KB oral carcinoma cells</span></div><div class="casAuthors">Kim, Soo-A.; Kim, Si-Wouk; Chang, Sunghoe; Yoon, Jung-Hoon; Ahn, Sang-Gun</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-77</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Our previous study demonstrated that the novel indirubin deriv., 5'-nitro-indirubinoxime (5'-NIO), effectively arrested the tumor growth through the inhibition of cell proliferation and the induction of apoptosis.  However, the precise mol. mechanisms underlying 5'-NIO-induced antitumor activity remain unclear.  Here, we report that 5'-NIO inhibits the proliferation of human KB oral carcinoma cells via the cell cycle arrest in G2/M phase.  5'-NIO reduced the activity of Cdc2/cyclin B complex through the inhibition of the PLK1 expression.  Partially, 5'-NIO also arrested cell cycle in G1/S phase via the redn. of CDK4 and cyclin D1/D3 levels by p16 and induction of the level of p21waf1.  Using flow cytometry anal., we showed that 5'-NIO-induced cell cycle arrest is followed by apoptosis.  We detd. further that 5'-NIO-induced apoptosis is accomplished by the mitochondria-dependent activation of the caspase cascade.  Overall, these observations suggest the potential value of 5'-NIO as a candidate for a therapeutic modality for the treatment of oral cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8UnoqTG8pOLVg90H21EOLACvtfcHk0liyvUScbd_-zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCmsLvO&md5=a1b74b7204ad1fccfd0a219a5726e586</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DS.%2BA.%26aulast%3DKim%26aufirst%3DS.%2BW.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DJ.%2BH.%26aulast%3DAhn%26aufirst%3DS.%2BG.%26atitle%3D5%25E2%2580%25B2-Nitro-indirubinoxime%2520induces%2520G2%252FM%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520human%2520KB%2520oral%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2009%26volume%3D274%26spage%3D72%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mclauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=12534346" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&author=J.+Bainauthor=H.+Mclauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The specificities of protein kinase inhibitors: an update</span></div><div class="casAuthors">Bain, Jenny; McLauchlan, Hilary; Elliott, Matthew; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">199-204</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">We have previously examd. the specificities of 28 com. available compds., reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases.  In the present study, we have extended this anal. to a further 14 compds.  Of these, indirubin-3'-monoxime, SP 600125, KT 5823 and ML-9 were found to inhibit a no. of protein kinases and conclusions drawn from their use in cell-based assays are likely to be erroneous.  Kenpaullone, Alsterpaullone, Purvalanol, Roscovitine, pyrazolopyrimidine 1 (PP1), PP2 and ML-7 were more specific, but still inhibited two or more protein kinases with similar potency.  Our results suggest that the combined use of Roscovitine and Kenpaullone may be useful for identifying substrates and physiol. roles of cyclin-dependent protein kinases, whereas the combined use of Kenpaullone and LiCl may be useful for identifying substrates and physiol. roles of glycogen synthase kinase 3.  The combined use of SU 6656 and either PP1 or PP2 may be useful for identifying substrates of Src family members.  Epigallocatechin 3-gallate, one of the main polyphenolic constituents of tea, inhibited two of the 28 protein kinases in the panel, dual-specificity, tyrosine-phosphorylated and regulated kinase 1A (DYRK1A; IC50 = 0.33 μM) and p38-regulated/activated kinase (PRAK; IC50 = 1.0 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKsdbPJWI3krVg90H21EOLACvtfcHk0lgrRMYXhTVpgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlCitrg%253D&md5=f1cd5b518b683906b398d9bb79dc14fc</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D199%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Columbus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadari, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kussie, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labelle, M.</span><span> </span><span class="NLM_article-title">Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5474</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5474-5477&author=W.+Panauthor=H.+Liuauthor=Y.+J.+Xuauthor=X.+Chenauthor=K.+H.+Kimauthor=D.+L.+Milliganauthor=J.+Columbusauthor=Y.+R.+Hadariauthor=P.+Kussieauthor=W.+C.+Wongauthor=M.+Labelle&title=Pyrimido-oxazepine+as+a+versatile+template+for+the+development+of+inhibitors+of+specific+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DMilligan%26aufirst%3DD.%2BL.%26aulast%3DColumbus%26aufirst%3DJ.%26aulast%3DHadari%26aufirst%3DY.%2BR.%26aulast%3DKussie%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DW.%2BC.%26aulast%3DLabelle%26aufirst%3DM.%26atitle%3DPyrimido-oxazepine%2520as%2520a%2520versatile%2520template%2520for%2520the%2520development%2520of%2520inhibitors%2520of%2520specific%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5474%26epage%3D5477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm100080z&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm100080z&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm100080z&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer+drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lgrRMYXhTVpgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer%2520drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BHE','PDB','2BHE'); return false;">PDB: 2BHE</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a href="/doi/suppl/10.1021/jm100080z">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21575"></div></div></div></div></div><hr /></hr><p class="last">IC<sub>50</sub> values of antiproliferative activity including mean ± SD, FACS analysis data of <b>3a</b>, analytical data of HPLC analysis of final compounds for purity, solubility data of compound <b>1</b>, <b>2</b>, <b>3a</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100080z/suppl_file/jm100080z_si_001.pdf">jm100080z_si_001.pdf (1.84 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100080z&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm100080z" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100080z" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679abfa47bc23c2e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
